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Abstract
Several areas of prostate cancer (PCa) management, such as imaging permanent brachytherapy
implants or small, aggressive lesions, benefit from high image resolution. Current PCa imaging
methods can have inadequate resolution for imaging these areas. Endorectal digital prostate
tomosynthesis (endoDPT), an imaging method that combines an external x-ray source and an
endorectal x-ray sensor, can produce three-dimensional images of the prostate region that have
high image resolution compared to typical methods. This high resolution may improve PCa
management and increase positive outcomes in affected men.
This dissertation presents the initial development of endoDPT, including system design, image
quality assessment, and examples of possible applications to prostate imaging. Experiments using
computational phantoms, physical phantoms, and canine prostate specimens were conducted.
Initial system design was performed computationally and three methods of endoDPT image
reconstruction were developed: shift and add (SAA), backprojection (BP), and filtered BP (FBP).
A physical system was developed using an XDR intraoral x-ray sensor and a GE radiography unit.
The resolution and radiation dose of endoDPT were measured and compared to a GE CT scanner.
Canine prostate specimens that approximated clinical cases of PCa management were imaged and
compared using endoDPT, the above CT scanner, and a GE MRI scanner.
This study found that the resolution of endoDPT was significantly higher than CT. The
radiation dose of endoDPT was significantly lower than CT in the regions of the phantom that
were not in the endoDPT field of view (FoV). Inside the endoDPT FoV, the radiation dose ranged
from significantly less than to significantly greater than CT. The endoDPT images of the canine
prostate specimens demonstrated qualitative improvements in resolution compared to CT and
MRI, but endoDPT had difficulty in visualizing larger structures, such as the prostate border.

xix

Overall, this study has demonstrated endoDPT has high image resolution compared to typical
methods of PCa imaging. Future work will be focused on development of a prototype system that
improves scanning efficiency that can be used to optimize endoDPT and perform pre-clinical
studies.
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Chapter 1. Background
1.1 The Prostate Gland
The prostate is a muscular exocrine gland that is located medially within the male pelvis, fused
and inferior to the urinary bladder, and anterior to the rectum. In adults, the healthy prostate is
approximately walnut-shaped with diameters of 4 cm lateral, 3 cm cranial-caudal, and 2 cm
ventral-dorsal (Tortora 2014).
Approximately two-thirds of the prostate is glandular tissue that slowly secretes and
accumulates prostatic fluid, which nourishes, protects, and improves motility of the sperm (Tortora
2014). This glandular tissue is divided into the peripheral zone, central zone, and transition zone,
which comprise about 70%, 20-25%, and 5-10% of the glandular tissue volume, respectively
(McNeal 1981, McNeal 1988). Most of the remaining third of the prostate volume is the anterior
fibromuscular stroma, a non-glandular stromal tissue (McNeal 1981). The anterior fibromuscular
stroma aids in the expulsion of semen, a fluid comprised primarily of sperm, seminal fluid, and
prostatic fluid, during ejaculation (Tortora 2014). A pseudo-capsule composed of an outer sheath
of collagen over a smooth muscle layer surrounds most of the prostate (Udeh 1982, Ayala 1989).
The four most common diseases of the prostate are prostatitis, prostatic atrophy, benign
prostate hyperplasia (BPH), and prostate cancer (PCa). Prostatitis is any temporary pain or
swelling in the prostate region and is most commonly associated with inflammation (Sutcliffe
2015). Atrophy is a reduction in size of the prostate glandular volume due to cell degeneration
(McNeal 1988). BPH is the non-malignant hyperplasia of glandular tissue in the TZ (Mcneal 1978,
Roehrborn 2005). PCa is the primary motivation for this study.
1.2 Current State of Prostate Cancer Management
In the United States, PCa is the most common non-skin malignancy and the third leading cause
of cancer-related death in men, with an estimated 161,360 new PCa diagnoses and 26,730 PCa
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deaths in 2017 (Siegel 2017). The 5-year survival rates for all races diagnosed with local, regional,
or metastatic PCa are >99%, >99%, and 29%, respectively (Siegel 2017). At the time of diagnosis,
80% of PCa presents as local only, 12% presents with regional spread to the pelvic lymph nodes,
4% presents with distant metastasis, and 4% is not staged (Howlader 2016, Siegel 2017). These
figures underestimate the total number of men with PCa, as autopsy studies have shown that the
rate of incidental PCa, which is often symptomless, is much higher than clinically diagnosed PCa
(McNeal 1969).
PCa is usually detected in suspected or at-risk individuals using the digital rectal exam (DRE)
and/or through measurement of prostate specific antigen (PSA) levels in the blood serum. The
DRE is the digital palpation of the prostate through the rectum. Any abnormalities compared to
typical anatomy, such as increased stiffness or nodularity, can indicate PCa (Qaseem 2013). The
PSA serum analysis measures of the amount of PSA, an antigen made by the secretory epithelial
cells in the prostate, per unit volume of blood serum (Kuriyama 1980, Kuriyama 1981). Elevated
PSA levels, velocity, and density in the blood serum have been correlated to increased incidence
and grade of PCa (De Angelis 2007). Both DRE and PSA serum analysis are inexpensive and
simple to perform, and have been effective at increasing the detection rates of PCa (Roobol 2015).
However, neither test provides a definitive diagnosis. Other diseases or disruptions to the prostate,
such as BPH, can change tissue stiffness or nodularity (Sharma 2014), or can increase PSA levels
(Scarpato 2016). In addition, some cancers cannot be felt through palpation (Sharma 2014) and/or
do not elevate serum PSA levels (Scarpato 2016).
Biopsy, generally using ultrasound guidance and systematic random sampling, is the only
method in clinical use that can definitively diagnose PCa in situ, other than a pathological
examination after surgical excision (Bhavsar 2014, Futterer 2015). The biopsy samples are scored
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using the Gleason histological grading system, which provides a measure of disease aggressiveness
and is the dominant predictor for patient prognosis (Gleason 1966, Humphrey 2004). The Gleason
score classifies PCa based on histologic appearance (level of differentiation) of malignant cells
prior to any treatment on a scale of Pattern 1 to Pattern 5, with Pattern 5 being most malignant and
least differentiated (Gleason 1966). Because PCa is usually multi-focal in origin, the reported
Gleason score is the sum of the first and second most common pattern numbers (Gleason 1966).
PCa is also staged to characterize the extent of disease, assess prognosis, and guide treatment
(Reese 2016). Current staging uses the TNM model defined by the American Joint Committee on
Cancer, where the T value indicates the extent of local disease, the N value indicates if the regional
lymph nodes were assessed and if PCa has invaded this site, and the M value indicates if and where
the disease has metastatic involvement (Reese 2016). There is a strong correlation between high
Gleason scores, advanced stage, and increased PCa mortality (Gleason 1974).
After clinical diagnosis, PCa can be treated or closely monitored. The two main curative
treatments for PCa are radical prostatectomy, which is the surgical excision of the prostate gland,
and radiation therapy, which is the treatment of PCa using external beam radiation therapy and/or
brachytherapy (BT). Curative rates for radical prostatectomy and radiation therapy are high but
these treatments also result in a high incidence of both urinary incontinence and erectile
dysfunction (McLaughlin 2005, Gomella 2016). Chemotherapy and hormonal therapy are
common adjuvants to radical prostatectomy and radiation therapy for cases of curative intent, and
can be used palliatively for advanced disease (Catalona 1994, Bilusic 2016). Several new
therapies, such as high intensity focused ultrasound (Monn 2016) and cryotherapy (Chipollini
2016), are under investigation because they can be used focally, sparing normal prostatic tissue
and reducing side effects (Mendhiratta 2016).
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Delaying or precluding PCa treatment by monitoring the prostate can improve quality of life
by not subjecting the patient to procedures that may damage their urinary, sexual, or reproductive
integrity until medically necessary (Adolfsson 2008). The two monitoring techniques used for PCa
management are watchful waiting and active surveillance (Klotz 2005, Adolfsson 2008). Watchful
waiting is prescribed for elderly patients with short life expectancies and/or competing
comorbidities. PCa treatment in these patients is either precluded or, if the disease advances,
palliative. Active surveillance is prescribed for patients with low-risk PCa and longer life
expectancy. Treatment in these patients is delayed until deemed necessary by the physician, and
when treatment occurs, it is of curative intent.
After definitive treatment, PCa can recur as local, regional, or metastatic disease (Kitajima
2013). Biochemical relapse, which is the elevation of PSA serum levels above nadir, is usually the
first sign of recurrence (Kitajima 2013). Biochemical relapse occurs in one in three men within 10
years of definitive treatment (Freedland 2007).
1.3 Current State of PCa Imaging
The most common PCa imaging modalities are magnetic resonance imaging (MRI), transrectal
ultrasound (TRUS), computed tomography (CT), and nuclear medicine. The general application
of these modalities to PCa imaging is described in this section; specific concerns that directly relate
to endorectal digital prostate tomosynthesis, the subject matter of this dissertation, are detailed in
Chapter 2.
1.3.1 Magnetic Resonance Imaging
MRI is the gold standard diagnostic modality for PCa imaging due to excellent soft tissue
contrast and the ability to collect multiple anatomical and functional image sets during a single
multiparametric MRI examination (Futterer 2015, Dulaney 2016). Prostate MRI is often completed
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with an endorectal probe, which improves image quality but results in additional time, cost, and
patient discomfort (Heijmink 2011).
There are several MRI scan types useful for local PCa imaging, including T1 weighted (T1W)
imaging, T2 weighted (T2W) imaging, diffusion weighted imaging, dynamic contrast enhanced
MRI (DCE-MRI), and magnetic resonance spectroscopy. Anatomic T1W and T2W scans and
functional diffusion weighted imaging and DCE-MRI scans are often combined into a
multiparametric MRI examination (Bhavsar 2014). The examination results are compiled into a
standardized scoring matrix known as the Prostate Imaging Reporting and Data System (PIRADS) to assess disease extent, aggressiveness, and prognosis (Weinreb 2015).
Due to limitations in sensitivity and specificity, MRI cannot be used as the sole modality for
PCa detection, staging, and diagnosis (de Rooij 2014, de Rooij 2016). However, some studies have
reported MRI as effective at identifying significant (aggressive) PCa, thus reducing unnecessary
treatment and biopsy for low-risk disease and improving guidance for biopsy and treatment
(Thompson 2014, Dulaney 2016, Mendhiratta 2016). The potential benefits of MRI for imaging
low-risk disease remain controversial; screening or routine MRI examinations are not indicated
for potential low-risk cases (Porten 2014).
1.3.2 Transrectal Ultrasound
TRUS collects images of the prostate using a transrectal probe and is the most common
imaging method for the prostate because it is fast, inexpensive, and does not use ionizing radiation
(Sankineni 2016). Several common methods of TRUS prostate imaging are standard grayscale
imaging, Doppler ultrasound, and contrast enhanced ultrasound (CEUS).
The most common applications of TRUS are biopsy guidance, BT implant guidance, and
measuring the prostate volume (Sankineni 2016). Overall, TRUS cannot consistently identify PCa
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and is heavily dependent on operator skill, which precludes the use of TRUS as a sole modality
for PCa detection, staging, and diagnosis (Halpern 2006, Harvey 2012).
1.3.3 Computed Tomography
CT has no standard or established use in the current practice of local PCa diagnosis due to poor
soft-tissue contrast between PCa and normal tissues (Heijmink 2011, Luczynska 2014). CT can be
used to image advanced local PCa with severe extra-prostatic extension, seminal vesicle invasion,
or invasion into nearby anatomy such as the bladder (Sharma 2014). CT is commonly used to
image the pelvic lymph nodes and other distant areas to stage metastatic involvement or recurrence
(Jung 2012, Eifler 2016).
1.3.4 Nuclear Medicine Imaging
Positron emission tomography (PET) and single photon emission computed tomography
(SPECT) are currently used to image PCa by attaching radioisotopes to macromolecules that have
preferential uptake by or preferentially react with PCa. PCa cells exhibit increased uptake of
choline, acetate, some amino acids, and androgen analogs such as dihydrotestosterone compared
to normal prostatic tissues (Catalona 1994, Krause 2013). Some compounds, such as capromab
pentetide (more commonly known as ProstaScint®, Cytogen Corporation, Princeton, New Jersey)
preferentially react with the prostate specific membrane antigen, which is overexpressed in PCa,
(Tang 2016). Despite the many radiotracers available for PCa imaging, the utility of PET and
SPECT remains low due to nonspecific uptake of radiopharmaceuticals by other diseases such as
BPH, limited resolution, and background accumulations of radiopharmaceuticals in nearby
anatomy such as the bladder and urethra (Krause 2013, Sharma 2014, Eifler 2016).
1.4 Overview of Tomosynthesis
Conventional tomography (Littleton 1996) provides the foundation for tomosynthesis
(Dobbins 2003). In conventional tomography, a patient is positioned between a film and an x-ray
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source. A single exposure is collected as the film and x-ray source move in unison in an opposed
manner; a linear scan (Fig. 1.1) is one possible motion pattern. Structures within the plane of the
fulcrum of the film and x-ray source motion project to fixed locations on the film, generating a
single tomographic image plane; structures above and below this plane are blurred from visibility.
This reduces the appearance of structures above and below the image plane, providing an
advantage over projection radiographs. Residual blur artifacts from the structures located outside
the tomographic image plane and the generation of only one tomographic image plane per scan
were problematic limitations. Tomosynthesis was developed as an extension to conventional
tomography to address some of these limitations.

Figure 1.1: Conventional tomography with linearly opposed motion. The x-ray source and film
occupy planes that are parallel and separated by distance 𝑧𝑠 . The tomographic image plane
𝑧 containing the object 𝑃 is generated by moving the x-ray source and film such that 𝑧 is
located at the fulcrum of motion, assuming a parallel x-ray beam. This results in 𝑃
projecting to the same location 𝑃′ on the film during the entire exposure.
Tomosynthesis originated as the discretization of conventional tomography (Ziedses des
Plantes 1935, Ziedses Des Plantes 1938, Grant 1972). A single set of projection images on separate
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films was collected as the x-ray source moved in known, discrete steps. Tomographic image planes
located at any height 𝑧 above and parallel to the image acquisition (film) plane were reconstructed
by shifting and overlaying the films on a film reader. The direction and magnitude of the shift was
dependent both on 𝑧 and on the film and x-ray source locations for each discrete image.
This method of analog tomosynthesis imaging saw limited use because it was bulky and slow,
thus difficult to implement clinically (Garrison 1969, Miller 1971, Miller 1974). Film was phased
out in favor of x-ray image intensifiers in the 1970s and 1980s which improved efficiency but
suffered from poor image quality (Sone 1991), particularly in comparison to CT which was rapidly
becoming a mainstay in the medical imaging community (Goodsitt 2014). In the early 1990s,
primarily due to the advent of digital flat panel detectors capable of high-resolution and high
frame-rate scans, tomosynthesis truly became clinically feasible (Dobbins 2003).
Linear parallel tomosynthesis, shown in Fig. 1.2, is the simplest implementation of digital
tomosynthesis and is widely used (Niklason 1997, Dobbins 2003, Wu 2004, Dobbins 2009a). A
typical linear parallel tomosynthesis imaging system consists of an x-ray source that travels along
a linear path in a plane above and parallel to a stationary digital x-ray detector, with projection
images acquired at discrete x-ray source locations. Key parameters used to define the scan are the
x-ray source travel and the spatial step size. The x-ray source travel is the distance the x-ray source
moves in one dimension during the scan (for example, travel in 𝑥̂ from −𝑥𝑚𝑎𝑥 = −40 cm to
𝑥𝑚𝑎𝑥 = 40 cm, where −𝑥𝑚𝑎𝑥 is the starting source position and 𝑥𝑚𝑎𝑥 is the ending source
position). This motion is typically termed sweep angle in the digital breast tomosynthesis (DBT)
literature; sweep angle is the half-angle that the central ray of the x-ray beam sweeps over, and
ranges from 7.5∘ to 45∘ (Reiser 2007, Gennaro 2016). The spatial step size defines the number of
projection images typically acquired at equal increments (for example, every 2 cm). This is
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analogous to the DBT term angular increment. Typically, the spatial or angular spacing will be
such that 9-60 images are acquired (Reiser 2007, Gennaro 2016). In general, smaller values of xray source travel and spatial step size improve in-plane image resolution at the cost of decreased
resolution in the slice thickness (𝑧̂ ) direction (Reiser 2007).

Figure 1.2: Tomosynthesis scanning geometry, showing three projection image acquisitions.
Once the projection data are acquired, tomosynthesis image planes can be reconstructed using
two broad categories of algorithms – analytical and algebraic. Analytic methods assume the system
is ideal and a solution can be derived exactly. Some common analytic methods include the shift
and add (SAA) algorithm (Niklason 1997), backprojection (BP) and filtered backprojection (FBP)
(Lauritsch 1998), and matrix inversion tomosynthesis (Dobbins 1990). The more advanced
analytical techniques such as FBP and matrix inversion tomosynthesis better remove blur artifacts
from the reconstructed images. Algebraic methods numerically find the approximate solution of
discrete voxels within the reconstructed volume, usually with iterative techniques that reduce the
error matrix between the solution and the true projection data to below a predetermined threshold
(Colsher 1977). Some common algebraic algorithms are expectation maximum and total variation
minimization (Reiser 2007).
Tomosynthesis has been applied for imaging much of the human body, with the most common
applications to the breast and chest (Goodsitt 2014). DBT was initially demonstrated in 1997
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(Niklason 1997) and over the past two decades has experienced rapid growth because it supplies
depth information with in-plane resolution and radiation dose comparable to two-field projection
mammography (Dobbins 2003, Wu 2003, Reiser 2007, Chen 2013). Chest tomosynthesis has been
widely used to assess lung lesions, primarily in the differentiation of small nodules from
calcifications that benefit from high resolution and removal of tissue superposition, at a lower
radiation dose than CT (Sone 1993, Dobbins 2009b, Horvath 2016).
Several efforts have been reported to image the prostate region using tomosynthesis, although
not with an endorectal x-ray sensor. Such uses have included radiotherapy treatment verification
as an alternative to cone-beam CT or portal imaging (Yoo 2009), and prostate BT implant
localization. The latter prostate tomosynthesis application is discussed further in Chapter 2.
Despite substantial interest in tomosynthesis due to allowing high resolution and depth
information at comparable radiation dose to projection radiography, tomosynthesis is limited by
sampling over a small angular range. This results in a non-isotropic reconstructed volume, with
resolution in the depth direction (normal to reconstructed image planes) an order of magnitude
worse than in-plane resolution; a significant blur artifact can result from out-of-plane (OOP)
structures (Reiser 2007, Dobbins 2009a, Sechopoulos 2013a). The limited angular sampling makes
it difficult to quantitatively determine the density of the imaged volume (Reiser 2007) unlike CT,
and hinders removal of blurring artifacts in reconstructed images (Dobbins 2003).
1.5 Radiographic Image Quality and Dose
Many metrics are available to assess image quality of radiographic images; many methods
provide quantitative measures to compare images taken under known conditions. In this work,
modulation transfer function (MTF), noise power spectrum (NPS), artifact spread function (ASF),
and radiation dose were used to quantify the image quality of endoDPT.
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Classically, the limiting spatial resolution of an imaging system is described as the minimum
object size visible or the minimum separation required to differentiate two objects (Bushberg
2012). There are several methods to directly measure this quantity, such as use of line pair
phantoms. However, it is often more convenient to quantify the resolution of the imaging system
through measurement of the MTF. The MTF of an imaging system describes how well the system
can map frequency domain characteristics of the input signal (the object) to the output signal (the
image of the object) (Qian 2013). Measurement of the MTF is the accepted standard for
characterization of spatial resolution in digital x-ray imaging systems such as radiography,
mammography, and CT (Bushberg 2012, Qian 2013). The frequency value at which the MTF
reaches 10% of its zero-frequency magnitude is often quoted as the limiting resolution of an
imaging system (Bushberg 2012).
Noise is unwanted signal or unwanted variations in signal in an image (Bushberg 2012).
Unwanted variations in signal are primarily due to the stochastic nature of x-ray photon
interactions. The noise per pixel element, σ, in the detector system is directly related to the number
of photons, 𝑁, incident on that pixel element by 𝜎 ∝ √𝑁 (Bushberg 2012). Higher x-ray source
energies and currents result more incident photons on a given detector element, which results less
relative noise compared to measured signal; the increase in the signal-to-noise ratio is proportional
to 𝑁⁄𝜎 = √𝑁. The level of noise in images is often quantified in the frequency domain through
measurement of the NPS. The NPS reports the variance of an image as a function of frequency in
the frequency domain, and is a primary image quality metric for medical imaging (Chen 2014).
As noted, the primary disadvantage of tomosynthesis is that limited sampling of the imaged
volume results in OOP structure blur artifacts in the reconstructed planes (Dobbins 2003, Wu
2004). OOP structures present as a ghosting artifact that replicates the imaging geometry (Reiser
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2007). In linear parallel tomosynthesis, the artifact appears as a band of repeated structures, and
this effect is particularly significant when the OOP structures have high space density
(Sechopoulos 2013b). The severity of blurring artifact decreases with increasing distance of the
OOP object to the reconstruction plane, and can be quantified using the ASF, which is commonly
used as a metric to assess slice thickness resolution in DBT (Wu 2004, Sechopoulos 2013a).
One of the primary disadvantages of x-ray imaging is exposing the patient to radiation dose.
Dose is the energy from ionizing radiation absorbed in a medium per unit mass and is measured in
Gy (Attix 1986). Radiation dose can induce negative health effects (Hall 2006). Deterministic
effects occur if a specific threshold ionizing radiation dose is breached, increase in severity as
ionizing radiation dose is increased, and can present as early or late effects, such as skin erythema
and cataract genesis, respectively. Stochastic effects can occur at any level of ionizing radiation
dose, where the probability of the effect increases as a function of ionizing radiation dose; the
severity is binary, for example, cancer is either induced or not induced. Stochastic effects are the
principle concern at the dose levels encountered with radiological imaging. Because of this, it is
important to reduce the dose to the lowest level that still allows for diagnostic evaluation of x-ray
images.
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Chapter 2. Project Overview and Hypothesis
2.1 Introduction and Goals
This dissertation describes the development of endorectal digital prostate tomosynthesis
(endoDPT), a high-resolution method for imaging the prostate region. endoDPT utilizes a
stationary endorectal x-ray sensor combined with an external x-ray source (Fig. 2.1). A typical
endoDPT scan consists of discrete projection images collected of the prostate region as the x-ray
source moves along a linear path in a plane above and parallel to the x-ray sensor. These projection
images are reconstructed into image planes above and parallel to the x-ray sensor through the
prostate region using tomosynthesis.

Figure 2.1: (a) Anticipated clinical implementation of endoDPT. A probe system places an x-ray
sensor within the rectum directly adjacent to the prostate. (b) X-rays from various source
positions enter the anterior of the patient to create projection images of the prostate region.
One source position is shown.
There have been several efforts to develop endorectal x-ray or gamma-ray sensor probe
systems like endoDPT, with the most similar being BrachyView. BrachyView consists of several
small, high-resolution gamma-ray sensors that are coupled with pinhole collimators to form
miniature gamma cameras that can be used to determine the location of low dose rate or high dose
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rate BT sources (Petasecca 2013, Safavi-Naeini 2013, Safavi-Naeini 2015, Alnaghy 2017). Recent
efforts have demonstrated that if the planar detectors used in BrachyView are located outside of
the rectum using a male pelvic phantom, radiographic contrast between prostate-simulating and
other soft tissue-simulating gels can be observed (Loo 2014), but this system has not been used or
assessed for endorectal tomosynthesis imaging of the prostate region.
endoDPT has the potential to provide high-resolution images of the prostate due to 1) the
utilization of a high-resolution x-ray sensor and 2) a large source-to-image plane distance (SID)
with a small object-to-image plane distance (OID) which minimizes focal spot blur (see Appendix
A for details on focal spot blur reduction). Increased resolution of the prostate region may aid
physicians in PCa cancer diagnosis, treatment, and management by improving the conspicuity of
small structures within the prostate that may not be visible or, if visible, not easily discernable,
with conventional imaging methods.
The goals of this study were to develop endoDPT, to assess the image quality and dose of
endoDPT, and to image representative simulations of typical PCa management cases. Ideally,
endoDPT will provide higher in-plane resolution with less radiation dose compared to CT. While
CT currently has no standard clinical use in local PCa diagnosis due to poor soft tissue contrast
between PCa and normal prostate tissues (Luczynska 2014), CT is still a widely used technique
for visualizing the prostate region, including applications such as post-implant imaging of
permanent BT sources (Yu 1999, Nath 2009).
To achieve these goals, first the endoDPT imaging system was computationally designed,
tomosynthesis image reconstruction algorithms were derived, and the theoretical image resolution
of the system was measured using simulated phantoms. Next, a small, high-resolution x-ray sensor
and a commercial radiography source were used to physically assess image quality in endoDPT,
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focusing on measurement of image resolution and dose. These metrics were compared to
equivalent measurements made using a typical CT scanner. Finally, ex vivo canine prostate
specimens were imaged and compared using endoDPT, CT, and MRI. The deliverable associated
with achieving the project goals is a well-characterized test bed imaging system that can move
towards prototyping and clinical implementation.
2.2 Clinical Motivation
The motivation for this study arises from three areas of PCa that may benefit from highresolution: imaging of low dose rate brachytherapy (LDRBT) seeds after implantation into the
prostate; imaging of the periprostatic adipose tissue (PPAT) layer surrounding the prostate; and
imaging of increased microvessel density within PCa lesions using contrast agents.
2.2.1 Low Dose Rate Brachytherapy
LDRBT is a PCa treatment in which 40-100 radioactive metal pellets encased in a thin metal
shell (collectively known as seeds) are implanted permanently into the prostate to deliver dose to
local disease while sparing nearby critical structures such as the bladder and rectum (Zaorsky
2016). The seeds are small, with lengths from 3 mm to 5 mm and diameters of approximately 0.8
mm (shell) and 0.5 mm (core), with the shell having a thickness on the order of 0.05 mm (Khan
2014). The seeds deliver dose at a low rate (defined as < 2 Gy/hr but typically << 2 Gy/hr) over a
relatively long decay time (weeks to months). The number of seeds implanted is dependent on
seed type, desired coverage of the prostate, and physician preference. Implantation of seeds is
typically done manually by the physician using needle applicators through the perineum with
TRUS guidance.
Due to uncertainties in seed implantation, the seeds are imaged after the procedure to assess
dose to the prostate and to nearby organs at risk (OAR) such as the rectum, bladder, and urethra
(Yu 1999). Initially, seed locations were determined stereoscopically through use of radiographs
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taken at multiple angles. This technique was not optimal because the prostatic borders could not
be visualized with radiography, and so it was difficult to compute dose to the prostate (Yu 1999).
Currently, the American Brachytherapy Society recommends that post-implant dosimetry be
performed with CT within 60 days of the treatment (Davis 2012). CT is preferred because the highdensity seed cores show up extremely well and the prostate border can usually be distinguished
(Nath 2009). Despite being the current standard for imaging of seeds, the in-plane and slice
thickness resolutions are on the order of seed diameter and seed length, respectively, which leads
to partial volume averaging that makes it difficult to identify seed orientations or to differentiate
neighboring seeds in close proximity (Nath 2009, Collins Fekete 2014). This can be problematic
because the seeds emit radiation anisotropically due to source construction (Collins Fekete 2014,
Khan 2014). The American Association of Physicists in Medicine recommends a two-dimensional
dose calculation formalism that models this anisotropy for post-implant dosimetry (Nath 2009).
Because of the limited resolution of CT, it is assumed that the long axis of the seeds is aligned
with the axis of the CT scanner (Chng 2012). Any variations in seed orientation, and therefore
anisotropic dose distributions, are ignored (Nath 1997, Nath 2009, Davis 2012, Collins Fekete
2014). Variations in seed tilt from the CT scanner axis are expected to have a negligible to small
effect on the final dose to the prostate and OAR due to the large number of seeds used (Ellis 2002,
Chng 2012), but it has been shown that dose to OAR can vary by up to 10% (2.1% on average)
when seed tilt is explicitly modeled (Collins Fekete 2014).
TRUS, projection x-ray imaging, and MRI have all been assessed for use as an adjunct or sole
modality for LDRBT implant dosimetry. The potential benefits of these methods include higher
resolution images capable of determining seed orientation and differentiating adjacent seeds, a
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reduction or removal of ionizing radiation dose to the patient, and the possibility of intraoperatively
assessing dose distribution in the prostate in real-time.
TRUS post-implant dosimetry is attractive because the TRUS probe is already in the rectum
during the implantation procedure and the prostate border is easily identifiable (Han 2003b). This
allows for real-time dosimetry and modification of treatment plans while in the operating suite
(Mitri 2009, Mehrmohammadi 2014). However, TRUS has difficulty in visualizing seeds both at
certain angles and when many seeds are implanted within the prostate (Han 2003b). New
techniques, such as vibro-acoustography TRUS, have shown improvement in this area, but seed
detection rates are suboptimal (75%-90%) so TRUS is not sufficient for real-time dosimetry
(Mehrmohammadi 2014).
Techniques using projection x-ray imaging with an x-ray sensor external to the body such as
radiography, fluoroscopy, and tomosynthesis provide excellent resolution and contrast of the highdensity seeds and can be used intraoperatively to assess dosimetry in real-time. Radiography and
fluoroscopy typically consist of images acquired for at least three angles to stereoscopically assess
seed position using a variety of seed matching algorithms (Su 2004, Lee 2011, Kuo 2014).
Tomosynthesis removes the need for complex seed matching algorithms as seed depth can be
visualized in the reconstructed image planes. Tomosynthesis seed imaging is typical performed in
the operating suite with C-arm radiography units and several studies have automatically localized
seeds with good spatial accuracy. Fusing the tomosynthesis images to CT or TRUS images
facilitates dose assessment to the prostate volume (Tutar 2003, Brunet-Benkhoucha 2009).
MRI provides excellent soft tissue contrast of the prostate region which can be used to
accurately assess prostate volume for dose calculation. MRI is not used for LDRBT procedures
(De Brabandere 2006); in general, seeds are difficult to visualize in MRI. Fusion of CT seed images
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to MRI anatomical images (Kunogi 2015, Quivrin 2015, Schieda 2015) and use of MRI specific
high-contrast markers paired with seeds (Lim 2016) is common. Replacing CT entirely is one of
the most attractive possibilities of MRI LDRBT imaging, because it removes the radiation dose
from CT to the body; it also removes variability caused by registration and patient setup when
fusing images between modalities. A recent study has shown no significant differences in
dosimetric results between post-implant dosimetry computed using only MRI and an MRI-CT
fusion (De Brabandere 2012).
The primary benefit of endoDPT is that the high-resolution images obtained using the
endorectal sensor may allow for better determination of seed tilt and position. The raw data
collected during the endoDPT scan can be reconstructed using tomosynthesis or can be analyzed
using stereoscopic techniques to find seed locations and orientations. Due to the small size of the
detector, a small x-ray beam can be used which reduces whole body radiation dose to the patient.
endoDPT may be able to offer more insight into the effect of seed anisotropy and orientation (tilt)
on LDRBT implant dosimetry, along with the potential to improve efficiency of seed counting,
particularly for seeds near one another. Like other radiographic techniques, the primary difficulty
encountered by endoDPT is determination of the prostate border to calculate dose to the prostate
region. The endoDPT detector could be conjoined with an TRUS probe to determine prostate
volume, if prostate volume cannot be determined by endoDPT alone.
2.2.2 Periprostatic Adipose Tissue
PPAT is a visceral fat that partially or fully surrounds the prostate. Research efforts to
determine if PPAT is a valuable biomarker for PCa are relatively recent and sparse; most studies
have focused on linking PCa with obesity (Bhindi 2012). Some work has been published using
CT, TRUS, and MRI that shows positive correlations of increased levels of PPAT to increased
incidence and aggressiveness of PCa (van Roermund 2010, van Roermund 2011, Bhindi 2012,
18

Woo 2015). While the exact mechanism that links increased PPAT to PCa is unknown, it is
believed that the adipose tissue surrounding the prostate acts not just as an energy reservoir but
also produces hormones and cytokines that increase PCa growth (Finley 2009, Laurent 2016).
Several studies have shown that increased PPAT secretions correlated to higher Gleason scores
(Finley 2009) and to increased likelihood of metastasis (Ribeiro 2012, Laurent 2016). Using CT,
patients with the highest risk PCa were reported to have the largest areas of PPAT coverage over
the prostate; the correlation between PPAT and PCa was stronger than the correlation between
subcutaneous fat (obesity) and PCa (van Roermund 2011). Using TRUS, it was reported that for
each millimeter of increased PPAT layer thickness, there was an approximate 12% increase in
detecting PCa and a 20% increase in detecting high-grade PCa, with a mean PPAT thickness of
5.3 mm (Bhindi 2012). It was also reported that the thickness, measured with TRUS, of the anterior
PPAT layer between the rectal wall and the prostate was a good predictor of recurrence (Sumitomo
2010). Using MRI, it was reported that obese patients with more PPAT had higher blood vessel
density in the PPAT and increased proliferation of PCa cells, indicating increased risk for
metastasis (Venkatasubramanian 2014). Additionally, it was reported that the Gleason score was
positively correlated with PPAT layer thickness measured using MRI (Woo 2015).
These studies show an apparent association of the amount of PPAT surrounding the prostate
to PCa risk and aggressiveness. endoDPT could prove to be a useful alternative or adjunct method
for imaging this fat layer, potentially identifying sub-millimeter trends in fat thickness with
improved spatial resolution.
2.2.3 Microvessel Density Imaging of PCa
As malignant tumors approach diameters of 1-2 mm diameter, they leave their avascular state
and enter a more aggressive and faster growing angiogenic state (Folkman 1990). This occurs
because existing vasculature cannot supply adequate nutrients and oxygen to sustain tumor growth
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(Folkman 1990, West 2001). Increased angiogenesis can be observed through measurement of the
microvessel density of thin tissue sections viewed at 40x-100x magnification (Silberman 1997)
and is usually reported as the mean number of blood vessels (Brawer 1993) or the area of blood
vessels (Tretiakova 2013) in a given area. Multiple groups have reported microvessel density was
increased in PCa compared to normal prostatic tissue (Bigler 1993, Siegal 1995, Borre 1998) and
that microvessel density increases with stage and Gleason score of PCa (Brawer 1993, Weidner
1993, Borre 1998, Mucci 2009).
Perfusion imaging can be used to view these areas of increased angiogenesis and increased
microvessel density in vivo, providing a valuable biomarker to assess PCa extent and
aggressiveness (Halpern 2006). Perfusion imaging measures the wash-in and wash-out of contrast
media from areas of interest, where perfusion is a function of the same factors that increase
microvessel density, primarily the number, surface area, and permeability of small blood vessels
(Padhani 2005, Petralia 2010). Many clinical studies have demonstrated DCE-MRI, CEUS, and
perfusion CT (pCT) can detect PCa by enhancing areas of increased angiogenesis.
DCE-MRI assesses tissue vascularity by rapidly obtaining T1W images before, during, and
after a gadolinium chelate contrast agent is injected intravenously. PCa presents as an area of
intense and rapid signal enhancement when the contrast agent perfuses into the lesion, which is
easily differentiable from the slow and progressive uptake of normal prostatic tissues (Bittencourt
2014). Studies have shown DCE-MRI improves PCa detection and localization (Futterer 2006,
Tan 2015) and increases detection rates using biopsy and success rates of treatments by providing
improved image guidance (Hara 2005, Haider 2008, Yakar 2010). DCE-MRI is attractive because
it can be combined with T2W imaging and diffusion weighted imaging to provide high-contrast
images of the entire prostate region. However, MRI has many contraindications such as
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pacemakers and stents, which are much more common in the aging population of men most at risk
for PCa (Luczynska 2014). MRI has high operating costs to the patient (Luczynska 2014). Several
authors have commented that improvements in resolution would be desirable for improved
detection of small, aggressive PCa tumors (Bittencourt 2014, Barentsz 2016).
CEUS assesses tissue vasculature by measuring the reflected signal of gas microbubbles (1-10
μm diameters) that are introduced intravenously and then trapped within capillaries vessels (Errico
2015). Because the microbubbles have enhanced reflectivity of sound waves compared to normal
tissue by a factor of about 1000, areas of increased angiogenesis are highlighted using this method
(Ferrara 2007), including blood vessels that are too small to be imaged directly with Doppler
ultrasound (Halpern 2006, Wells 2006). Several recent studies have shown that targeted biopsies
to densely sample areas of high microbubble concentration resulted in more positive PCa findings
compared to systematic biopsy (Sano 2011, Zhao 2013, Sharma 2014). CEUS had better lesion
detection rates than standard grayscale TRUS and Doppler imaging (Strazdina 2011). Despite
theoretical image resolution on the order of 50 μm (Halpern 2006), CEUS cannot typically image
PCA lesions smaller than 1 cm in diameter (Strazdina 2011). Image quality depends heavily on
operator skill level (Sankineni 2016). Doppler imaging can also be used to image increased
angiogenesis (Heijmink 2011) but is not described further because CEUS using microbubbles
outperforms Doppler imaging (Strazdina 2011).
Use of pCT with iodine contrast was shown to be feasible using a dynamic contrast enhanced
protocol and a single detector row CT scanner (Prando 2000). Improvements in CT technology,
primarily the advent of wide multi-detector arrays, has made pCT into a more viable method (Ives
2005), but scanners with axial detector lengths greater than 4 cm, required to image the prostate
with no table motion, are costly and limited in availability (Osimani 2012). Two recent studies
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have shown pCT was able to identify areas of increased microvessel density at doses of 10 mSv
(Osimani 2012) and 16 mSv (Luczynska 2014); these doses are comparable to typical CT scans.
endoDPT has theoretical resolution that is high compared to pCT and DCE-MRI (true
perfusion methods) and is similar to clinical CEUS (which does not supply a true measure of
perfusion). Currently DCE-MRI and CEUS can detect lesions with diameters greater than 1 cm
(Strazdina 2011, Eifler 2016), with no literature assessing minimum tumor diameters detectable
with pCT. Detecting PCa using perfusion imaging between the beginning of angiogenesis (1-2 mm
diameter) and after several doubling times (~1 cm diameter) is currently difficult. The high
resolution of endoDPT combined with true perfusion imaging may allow for detection of lesions
at 1-2 m diameter as they leave the avascular state and enter the angiogenic state. Perfusion
imaging using endoDPT could occur at extremely fast rates by using multiple sources and
electronic voltage switching, as demonstrated in tuned aperture tomosynthesis (Klotz 1976, Groh
1977). Other advantages of endoDPT may include reduced dose compared to CT, reduced cost
compared to CT and MRI, and greater flexibility in operator skill levels compared to TRUS. This
could make endoDPT a valuable alternative or addition to current patient care.
2.3 Hypothesis
We hypothesized that endoDPT would provide images of the prostate region with significantly
higher in-plane resolution (𝑝 < 0.05) and significantly lower dose (𝑝 < 0.05) compared to a
typical CT scan of the prostate region. CT was chosen for comparison because CT is the most
similar of the typical prostate imaging techniques to endoDPT in terms of image acquisition and
processing. CT is also the only other common prostate imaging technique that results in dose from
x-rays. Providing a demonstrable improvement in spatial resolution at a reduced dose compared
to CT will place endoDPT in an excellent position for prototyping and pre-clinical studies. The
effort of this research is divided into three specific aims that examine and test the hypothesis.
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2.4 Specific Aims
The first aim was to develop a computational endoDPT system, to derive tomosynthesis
reconstruction methods for endoDPT, and to assess the theoretical image resolution of endoDPT
using simulated phantoms. To accomplish this aim, clinically available technology was modeled;
specifically, an intraoral dental sensor, which has high resolution and a small form factor, and a
commercial radiography source. Analytic reconstruction methods SAA, BP, and FBP were
implemented because these algorithms are common in clinical tomosynthesis implementations, are
widely understood, and are robust. The theoretical resolution was assessed through measurement
of the MTF using methods previously utilized for resolution measurements in radiography and
DBT.
The second aim was to characterize experimentally the image quality of endoDPT in terms of
spatial resolution, noise, and artifacts. Radiation dose was also measured. Specifically, the detector
MTF was measured using an edge method and was combined with the reconstruction algorithm
resolution from Aim 1 to find the system resolution of endoDPT. The NPS was measured using a
featureless acrylic phantom, while the ASF was measured using high-density, small metal spheres.
Dose was measured using thermoluminescent dosimeters (TLDs). For comparison resolution of
CT was measured using a commercial CT performance phantom; CT dose measured using TLDs.
Where appropriate, measurements were made as a function of x-ray source potential (measured in
kVp) of x-ray time integrated current (measured in mAs). At the end of this aim, the hypothesis
was tested using the student t-test.
The third aim was to compare endoDPT, CT, and MRI images of canine prostates implanted
with LDRBT seeds, surrounded by thin PPAT layers, and embedded with surrogate vasculature.
The qualitative differences between the modalities, including relevant artifacts, were assessed. One
comparison was the ability to visualize, differentiate, and count the LDRBT seeds. Another was
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the visibility and discernibility of the PPAT layer. A third comparison was the visibility and
discernibility of small diameter silicone rubber tubing filled with contrast agent.
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Chapter 3. Aim 1, Development of Imaging System and Reconstruction Method
3.1 Overview
In this aim, endoDPT was computationally designed. A computational test bed system was
modeled on existing clinical technologies, specifically, a dental intraoral digital x-ray sensor and
a standard radiography unit. Analytical tomosynthesis reconstruction algorithms based on existing
methods of image reconstruction for DBT and chest tomosynthesis were derived for the test bed
system. To test the effectiveness of the test bed system and image reconstruction algorithms, two
computational phantoms were modeled and simulated projection images of both were collected.
The simulated image sets were processed and/or reconstructed as appropriate, and the
computational detector and reconstruction algorithm MTFs were determined. The commercial
software package MATLAB® R2015A (The MathWorks Inc., Natick, Massachusetts) was used
for all computational modeling, image reconstruction, and image analysis.
3.2 System Geometry
endoDPT, as shown in Fig. 3.1, has the geometry of a linear parallel tomosynthesis system.
Linear parallel tomosynthesis is the typical tomosynthesis method for imaging the chest and
abdomen (Dobbins 2009a, Dobbins 2009b) and is often considered the best starting point for
derivation of new or modified image reconstruction algorithms with new imaging methods (Nett
2007). Minimizing the motion in the directions (𝑦̂, 𝑧̂ ) not associated with the scan motion (𝑥̂)
reduces the propensity for error.
Assuming the patient is positioned as shown in Fig. 2.1 a, 𝑥̂, 𝑦̂, and 𝑧̂ are perpendicular to the
patient’s sagittal, axial, and coronal planes, respectively. The detection plane is the coronal plane
at 𝑧 = 0 cm. The center of the detection plane has the coordinates (𝑥𝐷 , 𝑦𝐷 , 𝑧𝐷 ) = (0 cm, 0 cm, 0
cm). During the tomosynthesis scan, 𝑁 projection images are obtained, with the 𝑖 𝑡ℎ source location
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at (𝑥𝑆𝑖 , 𝑦𝑆 , 𝑧𝑆 ). The x-ray source is nominally located at a constant 𝑧𝑆 = 100 cm and 𝑦𝑆 = 0 cm.
The x-ray source is directed at the center of the detection plane for each source location. During
the tomosynthesis scan, the x-ray source travel in 𝑥̂ has a maximum range of ±𝑥𝑚𝑎𝑥 . For this
dissertation, 41 projection images were collected with 𝑥𝑚𝑎𝑥 = 40 cm and a spatial step size of 2
cm. This range of motion is consistent with other tomosynthesis methods (Reiser 2007, Dobbins
2009b, Chen 2013, Choi 2015, Gennaro 2016), including prostate tomosynthesis with an external
x-ray sensor (Brunet-Benkhoucha 2009), and represents a maximum angle of incidence (central
ray) of 𝜃max ≈ 21.8∘ .

Figure 3.1: endoDPT system geometry. The detection plane remains stationary and the x-ray
source travels along 𝑥̂ with no motion along 𝑦̂ or 𝑧̂ .
3.3 Computational System Design
The geometry shown in Fig. 3.1 was computationally modeled for assessment of both the
digital detector MTF and the reconstruction algorithm MTF. Similar computational studies have
been widely employed in tomosynthesis (Tutar 2003, Chen 2005, Orman 2006, Reiser 2007, Zhou
2007, Chen 2008, Zhao 2008, Cong 2011, Mainprize 2011, Choi 2015) and radiography (Samei
1998, Saunders 2003) because they are simple and cost-effective to implement.
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The endoDPT test bed imaging system was developed by modeling a small, digital x-ray sensor
and a point source with the travel of a typical radiography source. The physical x-ray sensor and
radiography unit for these models are discussed in Chapter 4. The x-ray sensor was modeled as a
two-dimensional detection plane with 2.5992 cm width (along 𝑥̂), 3.6024 cm length (along 𝑦̂), and
19 µm pixel size and pitch. This form factor and pixel size are consistent with most intraoral dental
sensors (Farman 2005a). The x-ray source was modeled as a monoenergetic point source with a
uniform diverging beam. The central ray of the x-ray source was directed towards the center of the
detector array for each x-ray source position during the endoDPT scan.
3.4 Computational Phantoms and Simulated Scanning
Two computational phantoms were modeled to assess endoDPT resolution. The first phantom
was a sharp, attenuating edge. Such simulated edge phantoms are commonly used to measure of
the detector resolution in radiography (Samei 1998, Saunders 2003, Saunders 2005) and DBT
(Chen 2007a). The second phantom was a simulated point impulse suspended above the center of
the detector. Such point impulse phantoms have been previously used to assess reconstruction
algorithm resolution in DBT (Chen 2005, Chen 2007a, Chen 2008, Chen 2014).
3.4.1 Edge Phantom Design and Image Simulation
The edge phantom was modeled and imaged using a two-part simulator, similar to previously
developed techniques (Tutar 2003, Mainprize 2011). In part one of the simulator, an edge phantom
that was 1 mm thick, 3 mm wide, and 20 mm long was modeled with voxel dimensions of 10 µm
by 10 µm by 10 µm in the center of an arbitrary computational space. The voxel size was chosen
to be smaller than the computational detector pixel size to reduce artifacts in projection imaging
(Reiser 2014). The edge phantom was rotated by 𝜃 = 1.5∘ with respect to the 𝑦̂-axis using a 3D
rotation matrix. A translation matrix was used to place the center point of the 20 mm long edge on
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the centermost pixel of the computational detector, with the edge in direct contact with the
computational detector. The plan view of this computational phantom is shown in Fig. 3.2.

Figure 3.2: Edge phantom modeled on computational detector. The solid line marks the edge used
for the MTF calculation.
In part two of the simulator, projection images of the edge phantom were created. The analytic
photon path to each computational detector element through the edge phantom was determined
with the source located at (𝑥𝑆 , 𝑦𝑆 , 𝑧𝑆 ) = (0 cm, 0 cm, 100 cm) using a layer-by-layer ray tracing
method (Siddon 1985). Computationally, this was calculated by adding an index of 1 to each
computational detector element for each layer of the phantom traversed. The resultant pixel values
were then multiplied by the path length through one layer, which is constant for a given ray
traveling from a single computational detector element to the x-ray source location.
The modeled x-ray sensor recorded values in 12-bit format with no signal being the value 1
and the maximum recordable signal being the value 4096. It was assumed that for an x-ray beam
with perpendicular incidence on the surface of the x-ray sensor, the signal value of a pixel element
under the 1 mm thick edge was 600 and the value of an unobstructed pixel element was 2400,
representing a transmission factor of 25%. While a transmission factor of 10% was used in the
study that this experiment was modeled after (Samei 1998), 25% transmission was chosen because
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it more closely matched the image signal of high-density metal structures compared to background
signal in a preliminary imaging study with the intraoral dental sensor.
Using this transmission factor, an approximate attenuation coefficient for the simulated edge
phantom material was calculated as
−

ln(I⁄𝐼0 )
=μ
𝑡

(3.1)

where 𝐼 is the beam intensity after attenuation (𝐼 = 25%), 𝐼0 is the incident beam intensity
(𝐼0 = 100%), 𝑡 is the thickness of the phantom (𝑡 = 0.1 cm), and 𝜇 (cm−1 ) is the unknown
attenuation coefficient of the edge. Solving Eq. 3.1 for these variables results in 𝜇 = 13.86 cm−1 .
𝜇 was completely arbitrary and was based solely on the step function with 25% transmission.
The projection image was formed by analytically calculating the photon transmission for each
pixel (𝑚, 𝑛) on the computational detector, with the pixel value for pixel (𝑚, 𝑛) calculated as
𝑣(𝑚, 𝑛) = I = I0 𝑒 −𝜇𝑡𝑡𝑜𝑡𝑎𝑙(𝑚,𝑛)

(3.2)

where 𝑡𝑡𝑜𝑡𝑎𝑙(𝑚,𝑛) was the total path length through the edge phantom defined as the sum of path
lengths through each layer of the edge phantom from the point source to each pixel (𝑚, 𝑛), and 𝐼0
was 2400. The full unattenuated photon fluence with a signal intensity of 2400 was assigned to
any computational detector element where the path did not intersect the edge phantom. After image
formation, a correction for 𝑟02 /𝑟 2 photon fluence falloff was applied, where 𝑟0 = 100 cm and 𝑟
was the distance from the x-ray source to a given computational detector pixel (𝑚, 𝑛). At the
centermost pixel, 𝑟02 /𝑟 2 = 1.
Following simulation of this noiseless projection image, a noisy projection image was created
by sampling a random number from a Poisson distribution for each pixel element (𝑚, 𝑛) on the
detector, subtracting the distribution mean from the random number, and then adding the meansubtracted random number value to the pixel element (Samei 1998, Reiser 2007). The mean of the
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sampled Poisson distribution for each pixel was equal to the value of the detector element (𝑚, 𝑛).
The noisy projection image is shown in Fig. 3.3. The projection image data was output with a 12bit pixel depth identical to the output from the x-ray sensor used in Chapter 4.

Figure 3.3: (a) Projection image of the edge phantom with added Poisson noise at 𝑥𝑆 = 0 cm. (b)
Surface plot of the projection image with added Poisson noise. The color scale in the (b) is
illustrative only.
3.4.2 Point Impulse Phantom Design and Image Simulation
The point impulse phantom was designed using a method previously developed for DBT (Chen
2005, Chen 2007a, Chen 2007b, Chen 2008, Chen 2014), which provided a convenient method to
evaluate reconstruction algorithm resolution while controlling or removing sources of error, such
as error in source location (Reiser 2014). The simulated point impulse was created by modeling
nine delta functions in a plane 1.5 cm above and parallel to the computational detector. The delta
functions were modeled such that for the simulated x-ray source located at (𝑥𝑆 , 𝑦𝑆 , 𝑧𝑆 ) =
(0 cm, 0 cm, 100 cm), the delta functions projected to the center of the computational detector as
shown in Fig. 3.4, where 𝐿 = (0.019/3) mm. For this source position, the centermost delta
function projected to (𝑥𝐷 , 𝑦𝐷 , 𝑧𝐷 ) = (0 cm, 0 cm, 0 cm). Nine delta functions evenly distributed
within an area the size of a single pixel, rather than a single delta function, were used to estimate
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the average overall point impulse with less sensitivity to location versus pixel boundaries (Chen
2014).

Figure 3.4: Projection of nine simulated delta functions onto the computational detector with the
source located at (𝑥𝑠 , 𝑦𝑠 , 𝑧𝑠 ) = (0 cm, 0 cm, 100 cm). The projections of the delta
functions are equally spaced with 𝐿 = (0.019/3) mm.
Ray tracing was used to collect an ideal image set of each of the nine delta functions with the
source located at 41 discrete locations along 𝑥̂ with x-ray source travel of ±40 cm and a spatial
step size of 2 cm with (𝑦𝑆 , 𝑧𝑆 ) = (0 cm, 100 cm). For delta functions that did not project to an
integer computational detector element, linear interpolation was used to proportionately split the
delta function magnitude between the nearest four computational detector elements. No noise was
added to the projection images; this phantom was used to measure and assess differences between
the ideal frequency response of the reconstruction algorithms. By summing the projections of each
of the nine delta functions for each discrete source location, the simulated point impulse projection
image set was formed. This image set was normalized by the number of delta functions that were
modeled and was saved in the same format as the simulated edge phantom images. The projection
image of the composite point impulse acquired at (𝑥𝑆 , 𝑦𝑆 , 𝑧𝑆 ) = (0 cm, 0 cm, 100 cm) is shown in
Fig. 3.5.
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Figure 3.5: Composite point impulse projection image with source location (𝑥𝑆 , 𝑦𝑆 , 𝑧𝑆 ) =
(0 cm, 0 cm, 100 cm). Only a 0.2 mm by 0.2 mm of the detector is shown for clarity. The
color scale is illustrative only.
3.4.3 Source Location Error
In addition to the ideal composite simulated point impulse set created in Section 3.4.2,
additional image sets were generated by applying systematic offsets to the source location
(𝑥𝑆 , 𝑦𝑆 , 𝑧𝑆 ) during the projection imaging process. This step was performed to assess the impact of
systematic source location offset error on reconstruction algorithm resolution. A total of 12
simulated point impulses was created with systematic offsets from the nominal 41 discrete source
locations as summarized in Table 3.1. Systematic offsets were only applied in one direction for 𝑥̂
and 𝑦̂ because these projection images were symmetric. Offsets in 𝑧̂ were not symmetric and so
projection image sets were created with the source location offset by amounts both closer to and
further from the computational detector. Simultaneous source offset errors in 𝑥̂ and 𝑧̂ were also
investigated by modeling offsets of 1 mm and 3 mm along diagonals in the 𝑥̂, 𝑧̂ plane; preliminary
work found that source offset error in 𝑦̂ had little effect on the reconstruction algorithm MTF, so
offsets in the (𝑦̂, 𝑧̂ ) plane and (𝑥̂, 𝑦̂) plane were not investigated.
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Table 3.1: Systematic source offsets used to create simulated projection images sets of the nine
delta functions. Source location errors in projection x-ray imaging of these typical
magnitudes have been previously reported (Lee 2011).
Simulated Point
Impulse Number
1
2
3
4
5
6
7
8
9
10
11
12

̂
Offset in 𝒙
(mm)
1
3
0
0
0
0
0
0
1⁄√2
3⁄√2
1⁄√2
3⁄√2

̂
Offset in 𝒚
(mm)
0
0
1
3
0
0
0
0
0
0
0
0

Offset in 𝒛̂
(mm)
0
0
0
0
1
3
-1
-3
1⁄√2
3⁄√2
− 1⁄√2
− 3⁄√2

3.5 Tomosynthesis Reconstruction
Three analytical methods of linear parallel tomosynthesis reconstruction were implemented for
endoDPT: shift and add (SAA), backprojection (BP), and filtered backprojection (FBP). These
analytic techniques are well understood, easily implementable, and often used for evaluation of
tomosynthesis imaging systems (Niklason 1997, Wu 2004, Levakhina 2013). For all three
reconstruction algorithms, image planes were reconstructed above and parallel to the detector face;
these planes have the highest possible in-plane resolution (Dobbins 2003).
3.5.1 Image Pre-Processing
All image reconstruction algorithms used the same image pre-processing prior to
reconstruction. The primary purpose of pre-processing was to read in the projection data, to
convert the pixel values from 12-bit unsigned integer values to double precision, and to perform a
logarithmic transform on the data. This process is summarized in Fig. 3.6.
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Figure 3.6. Summary of projection image pre-processing used for all endoDPT image
reconstruction methods.
The pixel values were converted to double values to maintain precision and to avoid truncation
errors during calculations. The logarithmic transform was performed because the value of a given
detector pixel in a single projection image is the line integral of all attenuation values over the path
length from source to pixel. Unlike CT, the reconstruction algorithms used in this work reconstruct
only an approximate attenuation coefficient in the reconstructed image plane through the addition
of pixel values from every projection image. Addition of line integrals to find an approximate
attenuation coefficient is not a linear process whereas addition of the logarithmic transformed data
(which removes the exponential term) is. Dobbins and Godfrey described why this is particularly
important in tomosynthesis (Dobbins 2003), and their result is rederived in Appendix B.
3.5.2 Shift and Add
SAA was the first x-ray imaging method capable of reconstructing any arbitrary plane in an
imaged volume from a single set of discrete projection images (Ziedses Des Plantes 1938) and
remains in clinical use today (Dobbins 2009a). SAA has been thoroughly described and widely
used clinically (Niklason 1997, Dobbins 2003, Wu 2004, Chen 2008, Chen 2013, Zhou 2015) and
is often a starting point for more advanced algorithms (Dobbins 1990, Chen 2006, Godfrey 2006b).
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Image acquisition and reconstruction using SAA with linear parallel tomosynthesis is shown
in Fig. 3.7. During image acquisition, the radiographic shadows of the two structures in the imaged
volume (the square and triangle) project to the stationary detector, forming projection images. To
reconstruct a plane through the imaged volume, the projection images are shifted by amounts
dependent on 𝑥𝑆𝑖 , 𝑧𝑆 , and 𝑧 (where 𝑧 is the height of the reconstructed plane above the detector)
and are then superimposed. Structures located within the reconstruction plane register while
structures located outside of the reconstructed plane blur or smear out.

Figure 3.7: Image acquisition and SAA reconstruction of two discrete planes, adapted from (Miller
1971) and (Dobbins 2003).
Fig. 3.7 illustrates the reconstruction of the planes containing either the square or the triangle
in the bottom row. Because the square is located farther from the detector, larger shifts are required
to register the projection images such that the squares overlap while the triangles blur out across
the image. SAA relies on this blurring of OOP structures to make them less noticeable to the
observer.
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Fig. 3.8 summarizes the SAA algorithm developed for endoDPT. This algorithm can
reconstruct any arbitrary image plane located at 𝑧 above and parallel to the detector plane. The
shift 𝑆(𝑥𝑆𝑖 , 𝑧𝑆 , 𝑧) for the 𝑖 𝑡ℎ of N projection images, occurs in the direction of x-ray source motion.
𝑆(𝑥𝑆𝑖 , 𝑧𝑆 , 𝑧) depends only the x-ray source location (𝑥𝑆𝑖 , 𝑦𝑆 , 𝑧𝑆 ) and 𝑧. The shift was calculated
using a parallel beam assumption. This assumption was required for SAA because each discrete
image experiences a single shift (Dobbins 2003). This improved the efficiency of the
reconstruction, but results in reduced image quality as one moves off axis in 𝑥̂ or 𝑦̂ because beam
divergence was ignored

Figure 3.8: Process diagram for the SAA algorithm. Shifts are calculated based on acquisition
geometry and the height of reconstruction planes. Images are shifted and added together.
The reconstructed image is normalized based on the number of additions that occur for
each reconstructed voxel.
Fig. 3.9 shows how the shift was determined for a given projection image. Assuming a parallel
beam, the structure 𝑃 located at height 𝑧 above the detector plane projects to the detector pixel
located at 𝑥𝑃0 for source location (𝑥𝑆0 , 𝑦𝑆 , 𝑧𝑆 ). For source location (𝑥𝑆1 , 𝑦𝑆 , 𝑧𝑆 ), 𝑃 projects to the
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detector pixel located at 𝑥𝑃1 . The difference of 𝑥𝑃0 and 𝑥𝑃1 was the shift required to register the
images such that 𝑃0 and 𝑃1 superimposed in the reconstructed plane. The shift was calculated as
𝑥𝑆
𝑆(𝑥𝑆𝑖 , 𝑧𝑆 , 𝑧) = 𝑥𝑝1 − 𝑥𝑝0 = ( 𝑖 ) 𝑧
𝑧𝑆

(3.3)

Due to the parallel beam assumption, the shift was constant for all pixels for a given projection
image and occurred only in 𝑥̂.

Figure 3.9: SAA shift determination example for a structure 𝑃 located at height 𝑧 above the
detector plane, using the parallel beam assumption.
After the shifts for each projection image were determined for a given 𝑧, the individual
projections were shifted relative to the projection obtained at (0,0, 𝑧𝑆 ) in Fig. 3.9 and summed.
Bilinear interpolation was used between the two nearest pixel elements within each row to get the
shifted values for the additions. Each reconstructed voxel was normalized by the number of
additions occurring in that voxel. This normalization factor was not constant for the entire
reconstructed image plane due to the small size of the XDR sensor; for some source locations,
some rays projected beyond the detector’s edge. Normalizing by the 𝑁 projection images would
result in a severe banding artifact at the image edges perpendicular to the source motion, known
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as truncation artifact (Sechopoulos 2013b). To minimize this artifact, the number of additions per
reconstruction voxel was tracked, similar to a previously developed method for DBT (Li 2007).
The primary limitations of endoDPT SAA reconstruction are the parallel beam assumption and the
lack of a mechanism for removal of OOP structure blur.
3.5.3 Backprojection
BP is an extension of the SAA algorithm in which beam divergence is modeled. BP has been
widely used in tomosynthesis reconstruction (Lauritsch 1998, Dobbins 2003, Wu 2004, Chen
2007b, Chen 2008, Levakhina 2013, Choi 2015, Zhou 2015). Linear parallel tomosynthesis using
BP to reconstruct planes above and parallel to the detector plane is illustrated in Fig. 3.10.

Figure 3.10: Projection imaging (top) and backprojection (bottom) of a point impulse in linear
parallel tomosynthesis. The top row shows the acquisition of three discrete projection
images. The bottom row shows that the point impulse can be reconstructed by
backprojecting the projection image pixel values to the source, going from a very discrete
case (three projections, left), a reconstruction more typical of tomosynthesis (11
projections, middle), and the continuous case (infinite projections, right).
The top row of Fig. 3.10 shows the projection imaging process for linear parallel tomosynthesis
in two dimensions. The projection imaging process maps the three-dimensional object 𝑓(𝑥, 𝑦, 𝑧)
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to the projection images 𝑝𝑖 (𝑥𝐷 , 𝑦𝐷 , 0). The signal values recorded by each detector element (𝑚, 𝑛)
for each discrete image 𝑖 are the line integrals of attenuation through 𝑓(𝑥, 𝑦, 𝑧) from the source
location (𝑥𝑆 𝑖 , 𝑦𝑆 , 𝑧𝑆 ) to 𝑝𝑖 (𝑥𝐷 , 𝑦𝐷 , 0). To reconstruct 𝑓(𝑥, 𝑦, 𝑧) from the projection images using
BP, this process is reversed. For each projection image, rays are traced from each detector element
(𝑚, 𝑛) to the assumed point source located at (𝑥𝑆 𝑖 , 𝑦𝑆 , 𝑧𝑆 ). The value of each detector element
(𝑚, 𝑛) is added to the voxel in the reconstruction plane, located at height 𝑧 above and parallel to
the detector, that the ray from (𝑚, 𝑛) to (𝑥𝑆 𝑖 , 𝑦𝑆 , 𝑧𝑆 ) traverses. This operation is performed for all
N projection images and is illustrated in the bottom row of Fig. 3.10. Each voxel in the
reconstructed image plane is the average of all ray sums that traverse that voxel during the BP
process over the entire projection image set. The bottom row of Fig. 3.10 also demonstrates the
primary blur artifact associated with the backprojection process. This blur artifact is a primary
limitation of image quality for BP.
Assuming a parallel beam, if a point input is located at (0,0, 𝑧) above the detector plane and if
the x-ray source travels continually over ±𝑥𝑆,𝑚𝑎𝑥 during a single exposure, an integrating detector
records the image as a line of length 𝑙 given by
𝑙 = 2𝑧 (

𝑥𝑆,𝑚𝑎𝑥
)
𝑧𝑆 − 𝑧

(3.4)

where 𝑙 describes the imaging geometry as shown in Fig. 3.11. If a constant exposure rate to the
integrating detector is assumed for the entire continuous scan and it is assumed that the integrating
detector has a linear response, the integrated intensity of the background subtracted complement
of line 𝑙 will be a constant value 𝐶. This results in any discrete portion of 𝑙, 𝑑𝑙, having signal
intensity that is inversely proportional to the x-ray source travel distance and the ratio 𝑧⁄𝑧𝑆 for a
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constant 𝑧𝑆 . In the limiting case where the x-ray source travel distance is 0 or 𝑧⁄𝑧𝑆 = 0, 𝑙 becomes
a delta function.

Figure 3.11: Imaging geometry of a point impulse that results in a line of length 𝑙 on an integrating
detector.
Overall, this shows that the line 𝑙 is a rect function with a constant integrated area of 𝐶, which
decreases in width and increases in magnitude for smaller x-ray source travel distances and smaller
ratios of 𝑧⁄𝑧𝑠 . This is the spatial domain equivalent of the slice transfer function (Grant 1972).
The slice transfer function is defined as the Fourier transform of the image of the impulse response;
it describes how structures are transferred to reconstructed image planes surrounding the plane
they occupy (Grant 1972, Mertelmeier 2014). In linear parallel tomosynthesis, the slice transfer
function is the Fourier transform of Eq. 3.4, which is a sinc function given by
𝑙
2

∫ rect(𝑥) ∗ 𝑒 −𝑗𝜔𝑥 𝑥 𝑑𝑥 =
−

𝑙
2

𝑙
sin (2 ∗ 𝜔𝑥 )
𝑙
2 ∗ 𝜔𝑥

𝑙
= sinc ( ∗ 𝜔𝑥 )
2

(3.5)

where 𝜔
̂𝑥 is the frequency space analog of 𝑥̂ in the spatial domain. The slice transfer function is
constant in 𝜔
̂𝑦 , the frequency space analog of 𝑦̂ in the spatial domain, due to the parallel beam
assumption (Grant 1972).
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In linear parallel tomosynthesis, the point impulse response (spatial domain transfer function)
can be used to assess how an object located in the plane at 𝑧 will affect (or be transmitted to) a
plane located at 𝑧 ± 𝑑𝑧, where 𝑑𝑧 is a non-zero value. This is the point spread function, ℎ𝑝 (𝑥, 𝑧)
(Grant 1972, Haerer 2002, Mertelmeier 2014), given by
1+
ℎ𝑝 (𝑥, 𝑧) =

(𝑧0 − 𝑧)2
(𝑥0 − 𝑥)2

2 tan 𝜃𝑚𝑎𝑥 ∗ |(𝑥0 − 𝑥)|√1 +

2

(𝑧0 − 𝑧)2
(𝑥0 − 𝑥)2

√1 + 𝑧 2
𝑥
=
2 tan 𝜃𝑚𝑎𝑥 ∗ |𝑥|

(3.6)

for the two-dimensional case shown in Fig. 3.11 with invariance in 𝑦̂, with the point of interest in
the imaged volume located at (𝑥0 , 𝑧0 ). ℎ𝑝 (𝑥, 𝑧) is bound to the sampled region of
(𝑥0 − 𝑥)/(𝑧0 − 𝑧) < tan(𝜃𝑚𝑎𝑥 ), where 𝜃𝑚𝑎𝑥 = tan−1(𝑙 ⁄2𝑧). This is shown in Fig. 3.12 and is
identical to the result obtained by Haerer, Lauritsch, and Zellerho (Haerer 2002).

Figure 3.12: The reconstructed point spread function of a point impulse located at (𝑥0 , 0, 𝑧0 ) in a
volume imaged with linear parallel tomosynthesis using endoDPT geometry.
This study used a pixel-by-pixel BP algorithm. The algorithm had the ability to reconstruct any
arbitrary image plane above and parallel to the detector plane. The process of the algorithm is
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summarized in Fig. 3.13. Image planes 𝑅(𝑥, 𝑦, 𝑧) are reconstructed at 𝑧 above the detector plane
with the reconstructed voxel size set to 20 µm by 20 µm using the formalism
𝑁

𝑅(𝑥, 𝑦, 𝑧) = 𝒩 [∑ ℬ[𝑝𝑖 (𝑥𝐷 , 𝑦𝐷 , 0)]]

(3.7)

𝑖=1

where 𝑁 projection images 𝑝𝑖 (𝑥𝐷 , 𝑦𝐷 , 𝑧𝐷 ) are reconstructed into 𝑅(𝑥, 𝑦, 𝑧) using ℬ, the
backprojection operator, and then normalized using 𝒩, the normalization operator.

Figure 3.13: Process diagram for the BP Algorithm. Each voxel in the reconstructed plane is
divided into 4 sub-voxels. Pixel values from the detector are backprojected to these subvoxels to form the reconstructed image, which is normalized based on the number of subvoxels and the number of additions occurring for each sub-voxel.
Prior to backprojection, each voxel in the reconstruction plane was split into four sub-voxels
(10 µm per side) to improve sampling from the projection image. To perform the backprojection
for each 𝑖 𝑡ℎ source position, a ray was projected from (𝑥𝑆𝑖 , 𝑦𝑆 , 𝑧𝑆 ) through the known center of
each sub-voxel in 𝑅(𝑥, 𝑦, 𝑧) to the detector (𝑥𝐷 , 𝑦𝐷 , 𝑧𝐷 ). If the ray projected to the center of a
detector pixel, the value of the pixel in the projection image corresponding to (𝑥𝐷 , 𝑦𝐷 , 𝑧𝐷 ) was
added to the sub-voxel in the reconstruction plane; if the ray did not project to the center of a
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detector pixel, linear interpolation between the nearest four detector pixels was used to add a
proportional value to the sub-voxel in the reconstruction plane. The (𝑥𝐷 , 𝑦𝐷 , 𝑧𝐷 ) for each source
location and each sub-voxel was found by
𝑥𝑆𝑖 − 𝑥 𝑥𝑆𝑖 − 𝑥𝐷 𝑥𝑆𝑖 − 𝑥𝐷
𝑥𝑆 − 𝑥
=
=
→ 𝑥𝐷 = 𝑥𝑆𝑖 − ( 𝑖
) ∗ 𝑧S
𝑧𝑆 − 𝑧
𝑧S − 𝑧𝐷
𝑧S
𝑧S − 𝑧

(3.8)

𝑦S − 𝑦 𝑦S − 𝑦𝐷 𝑦S − 𝑦𝐷
𝑦S − 𝑦
=
=
→ 𝑦𝐷 = 𝑦S − (
) ∗ 𝑧𝑆
𝑧𝑆 − 𝑧 𝑧𝑆 − 𝑧𝐷
𝑧𝑆
𝑧S − 𝑧

(3.9)

and

noting that 𝑧𝐷 = 0, and that the 𝑥̂ and 𝑦̂ components are separable. These relationships are
illustrated in Fig. 3.14.

Figure 3.14: Geometry of the backprojection process. Similar triangles were used to derive the
equations for projection from the source through the reconstructed image plane to the
projection image.
This process was repeated for every sub-voxel in the reconstructed image plane. The subvoxels were then summed back into their parent voxel in the reconstructed image plane and
normalized. This process was repeated for all 𝑁 projection images, building the reconstructed
image plane as the sum of backprojected values from all projections. Like the SAA algorithm, the
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final reconstructed image voxels were normalized based on the number of additions occurring for
each reconstructed voxel to minimize the truncation artifact. BP improves upon SAA by
incorporating beam divergence, but like SAA there is no mechanism for blur reduction.
3.5.4 Filtered Backprojection
To reduce the blur inherent in the BP process, a filter can be applied that modifies the projection
images prior to BP. FBP is the most common tomosynthesis reconstruction method used for
tomosynthesis blur reduction (Dobbins 2003, Chen 2013, Sechopoulos 2013b, Mertelmeier 2014).
In tomosynthesis, FBP only reduces the blur; unlike CT, FBP cannot completely remove the blur
due to limited sampling (Lauritsch 1998, Wu 2004, Mertelmeier 2014).
Filter design for tomosynthesis reconstruction has been extensively described (Lauritsch 1998,
Claus 2004, Wu 2004, Claus 2006, Erhard 2012, Mertelmeier 2014). Typically, the first step in
the filtering process is the transformation of the projection images 𝑝𝑖 (𝑥𝐷 , 𝑦𝐷 , 𝑧𝐷 ), which are twodimensional because 𝑧𝐷 = 0, to frequency space images 𝑃𝑖 (𝜔𝑥 , 𝜔𝑦 ). A parallel beam is often
assumed for filtration because inaccuracies due to limited sampling overpower the inaccuracies
due to the divergent x-ray beam, particularly when the source-to-object and SID are large and the
detection plane area is small (Stevens 2001, Zhao 2008, Mertelmeier 2014). This is the case for
the geometry of endoDPT, which has an assumed source to object (center of prostate) distance of
98.5 cm, a SID of 100 cm, and a detector size of 2.5992 cm by 3.6024 cm. Using the parallel beam
assumption, the transformation of the spatial domain projection images to the frequency domain
is completed using a one-dimensional Fourier transform along 𝑥̂. The frequency space projections
are filtered with the blur-reduction function, are inverse Fourier transformed along 𝜔
̂𝑥 , and then
are backprojected to form reconstructed image planes.
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The frequency space projection images are related to the entire frequency space object by the
central slice theorem (CST) (Hsieh 2009, Mertelmeier 2014). Due to the limited sampling in
tomosynthesis (in endoDPT, the imaged volume is sampled over ±21.8∘ ), the frequency space
projections do not completely sample the frequency space object. A typical tomosynthesis scan
results in lines of information in the frequency space as shown in Fig. 3.15, which is often referred
to as a double-wedge (Mertelmeier 2014). Because frequency space is not fully sampled, it is
impossible to remove all of the blur from BP by filtration (Mertelmeier 2014) and additional
considerations are required for the sharp discontinuity between the sampled and unsampled space
(Lauritsch 1998) which can result in a ringing artifact in the spatial domain (Mertelmeier 2014).

Figure 3.15: Incomplete Fourier space data from projection images collected at different source
positions in tomosynthesis. This figure shows the frequency coverage of projections
collected over ±40 cm in 2 cm steps with endoDPT geometry.
The steps for tomosynthesis filter design have been described in detail in several previous
studies (Lauritsch 1998, Wu 2004, Mertelmeier 2014). The filter design starts with the system
equation given by
𝐺(𝝎) = 𝐻(𝝎) ∗ 𝐹(𝝎)
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(3.10)

where 𝐺(𝝎) is the reconstructed object in the frequency domain, 𝐻(𝝎) is the system MTF due to
the projection and backprojection imaging process, 𝐹(𝝎) is the true object in the frequency
domain, and 𝝎 = (𝜔𝑥 , 𝜔𝑦 , 𝜔𝑧 ).
𝐻(𝝎) can be split into a projection-backprojection term 𝐻𝑃→𝐵𝑃 (𝝎) which describes how the
object blurs due to the projection-backprojection process and a filter term 𝐻𝑓 (𝝎), where 𝐻(𝝎) =
𝐻𝑃→𝐵𝑃 (𝝎) ∗ 𝐻𝑓 (𝝎). The goal of the filter term is to approximately invert the blur caused by the
projection-backprojection term, 𝐻𝑓 (𝝎) ≈ [𝐻𝑃→𝐵𝑃 (𝝎)]−1, so that the reconstructed object
approximates the true object, 𝐺(𝝎) ≈ 𝐹(𝝎).
Because of the invariance in 𝜔
̂𝑦 due to the parallel beam assumption, 𝐻𝑓 (𝝎) becomes
𝐻𝑓 (𝜔𝑥 , 𝜔𝑧 ). In tomosynthesis, 𝐻𝑓 (𝜔𝑥 , 𝜔𝑧 ) is typically divided into three discrete filter functions
(Lauritsch 1998, Mertelmeier 2014): 𝐻𝑖𝑛𝑣𝑒𝑟𝑠𝑒 (𝜔𝑥 , 𝜔𝑧 ) inverts the Fourier transform of the point
impulse response ℎ𝑝 (𝑥, 𝑧) from Eq. 3.6 to deblur the reconstructed images; 𝐻𝑠𝑝𝑒𝑐𝑡𝑟𝑎𝑙 (𝜔𝑥 ) reduces
noise exacerbated by 𝐻𝑖𝑛𝑣𝑒𝑟𝑠𝑒 (𝜔𝑥 , 𝜔𝑧 ); and 𝐻𝑝𝑟𝑜𝑓𝑖𝑙𝑒 (𝜔𝑧 ) addresses the sharp discontinuity
observed in Fig. 3.15 between the sampled and unsampled data in the frequency space. In the
simplest form, 𝐻𝑠𝑝𝑒𝑐𝑡𝑟𝑎𝑙 (𝜔𝑥 ) and 𝐻𝑝𝑟𝑜𝑓𝑖𝑙𝑒 (𝜔𝑧 ) are windowing functions (Mertelmeier 2014), such
as Hanning windows given by
1
𝜋𝜔𝑥
𝐻𝑠𝑝𝑒𝑐𝑡𝑟𝑎𝑙 (𝜔𝑥 ) = { 2 (1 + cos ( 𝐴 )) ,
0

if |𝜔𝑥 | ≤ 𝐴

(3.11)

otherwise

and
1
𝜋𝜔𝑧
(1
+
cos
(
)) ,
𝐻𝑝𝑟𝑜𝑓𝑖𝑙𝑒 (𝜔𝑧 ) = { 2
𝐵
0
where 𝐴 and 𝐵 are tunable parameters.
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if |𝜔𝑧 | ≤ 𝐵 and
|𝜔𝑧 | < tan(𝜃𝑚𝑎𝑥 ) |𝜔𝑥 |
otherwise

(3.12)

Because the axis of the x-ray source was on the central pixel of the x-ray sensor for endoDPT,
the two-dimensional filter can be reduced to single-dimensionality through use of the cosine
function (Wu 2004) as
𝐻𝑓 (𝜔𝑥 , 𝜔𝑧 ) = 𝐻𝑓 (𝜔𝑥 ) ∗ cos(𝜃𝑖 )
1

(3.13)

1

where − 2Δ ≤ 𝜔𝑥 ≤ 2Δ, Δ is the pixel size, and 𝜃𝑖 is the angle the parallel x-ray beam makes relative
to 𝑧̂ for the 𝑖 𝑡ℎ projection image. A filter with single-dimensionality was chosen for initial
development of endoDPT because it reduced the number of tunable parameters; conceptually,
application of 𝐻𝑓 (𝜔𝑥 ) ∗ cos(𝜃𝑖 ) to the frequency space projection images is equivalent to filtration
in CT which is robust and well understood (Wu 2004). Full details on this transformation are
reported by Wu et al. (Wu 2004). The filter for endoDPT becomes
𝐻𝑓 (𝜔𝑥 ) ∗ cos(𝜃𝑖 ) = 𝐻𝑖𝑛𝑣𝑒𝑟𝑠𝑒 (𝜔𝑥 ) ∗ 𝐻𝑛 (𝜔𝑥 ) ∗ cos(𝜃𝑖 )

(3.14)

where 𝐻𝑖𝑛𝑣𝑒𝑟𝑠𝑒 (𝜔𝑥 ) is the inverse of the point spread function given in Eq. 3.6 in the frequency
domain at 𝜔𝑍 = 0 and is given by (Haerer 2002)
𝐻𝑖𝑛𝑣𝑒𝑟𝑠𝑒 (𝜔𝑥 ) = 2 tan 𝜃𝑚𝑎𝑥 ∗ |𝜔𝑥 |

(3.15)

and 𝐻𝑛 (𝜔𝑥 ) is a Hanning window given by
1
𝜋𝜔𝑥
(1
+
cos
(
)) , if 𝜔𝑥 ≤ 𝑎
𝐻𝑛 (𝜔𝑥 ) = { 2
𝑎
0
otherwise

( 3.16)

where 𝑎 is a tunable cutoff parameter. For this work, 𝑎 = 20 mm−1; 20 mm−1 corresponds to
0.025 mm in the spatial domain and was twice the spatial frequency (one-half the size) of the
smallest structure expected to be visualized in this study, the shell of a typical LDRBT seeds (0.05
mm thickness). The filter used for the projection image taken at (𝑥𝑆 , 𝑦𝑆 , 𝑧𝑆 ) =
(0 cm, 0 cm, 100 cm) is shown in Fig. 3.16. Wu et al. reported that this method of FBP had good
results compared to iterative techniques (Wu 2004).
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Figure 3.16: endoDPT filter for the image taken at (𝑥𝑆 , 𝑦𝑆 , 𝑧𝑆 ) = (0 cm, 0 cm, 100 cm).
The frequency space projection images were filtered by multiplying each row along 𝜔
̂𝑥 by
𝐻𝑓 (𝜔𝑥 ) ⋅ cos(𝜃𝑖 ) where 𝜃𝑖 = tan−1(𝑥𝑆𝑖 ⁄𝑧𝑆 ). Because of the parallel beam assumption, all rows
(along 𝜔
̂𝑦 ) in a given projection had the same filter applied. After filtration, the frequency space
projection images were transformed back to the spatial domain and then reconstructed with BP.
Alternatively, one could interpolate in frequency space followed by a two-dimensional
transformation directly to the reconstructed image in the spatial domain (no BP needed), but
interpolation artifacts in frequency space can be severe (Hsieh 2009).
OOP structure blur is not eliminated in FBP reconstruction, but is reduced compared to SAA
and BP. More advanced FBP techniques and algebraic reconstruction methods can further reduce
the OOP structure blur, but were not explored in this study. An additional artifact in FBP due to
the filtration is an overshoot, or edge-enhancement, artifact (Nett 2007, Reiser 2007, Sechopoulos
2013b, Mertelmeier 2014). This artifact occurs due to the application of 𝐻𝑖𝑛𝑣𝑒𝑟𝑠𝑒 (𝜔) on a set of
projections that did not fully sample the object (a limited angle scan of less than 180∘ ). The
overshoot artifact manifests as a dark border along edges of objects in the direction of x-ray source
motion (Mertelmeier 2014).
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3.6 Computational Detector Resolution
The detector MTF (MTFdetector) was measured using an edge method (Samei 1998) that has
been widely employed for measurement of the resolution of digital imaging systems (Saunders
2003, Saunders 2005, Chen 2007a, Chen 2014). To find the computational MTFdetector , profiles
were measured perpendicular to the sharp edge of the edge phantom modeled in Section 3.4.1.
Multiple profiles were averaged to form a composite edge spread function (ESF), which was
differentiated to find the line spread function (LSF). The Fourier transform of the LSF is
MTFdetector .
Proper calculation of MTFdetector requires the profiles to be orthogonal to the edge, so one
must account for any tilt angle of the edge relative to the detector pixel grid. To find this angle the
image was first cropped to the edge region of interest (Fig. 3.17 a) and then binarized. A
MATLAB® function was used to find the edge in the image using Sobel’s method (Sobel 1968)
(Fig. 3.17 b). The Radon transform (Radon 1917) was used to find the angle of the edge line. First,
a coarse Radon transform (0∘ ± 15∘ in 0.5∘ increments) was taken of the edge. A Gaussian
function was fit to each angle bin in the resultant sinogram, and the angle bin with the maximum
amplitude of the Gaussian peak was the coarse angle of the edge, 𝜃coarse . A second Radon
transform (𝜃coarse ± 1∘ in 0.01∘ increments) was taken of 𝑝edge . A Gaussian function was fit to
each angle bin in the resultant sinogram, with the angle bin with the maximum amplitude of the
Gaussian peak resulting in the edge angle 𝜃. This method could exactly reproduce the known tilt
angle (1.50∘ ) of the computational edge phantom.
Eight hundred profiles that were perpendicular to the edge (𝜃 + 90∘ ) and extended 1 mm to
either side of the edge were measured over a 1.52 mm length of the edge in increments of 0.1 pixel
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(Fig. 3.18 a). Measuring the profiles in increments of 0.1 pixels results in a pre-sampled MTF that
minimizes aliasing effects (Samei 1998). A single profile is shown in Fig. 3.18 (b).

Figure 3.17: (a) Cropped image of the simulated (noisy) projection image of the edge phantom.
(b) An edge finding function was applied to the binary image to find the edge.

Figure 3.18: (a) The location of one profile (green) and the total region along the edge used for
measurement of ESFs (red line). A red box is drawn around the sampled region for clarity.
(b) The profile shown by the green line in the left pane, showing Poisson noise. The portion
of the profile with more attenuation (under the attenuating edge) shows more noise.
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If a measured point on the profile did not fall on the center of a pixel, linear interpolation
between the four neighboring pixels was used. The profiles were averaged to form a composite
ESF (Fig. 3.19). The composite ESF was differentiated to find the LSF, also shown in Fig. 3.19.
The tails of the LSF were fit with a linear function and then corrected for decreased photon fluence
due to inverse squared falloff. In addition, a Hanning window (cutoff of 2 mm) was applied to the
LSF to reduce the effect of high frequency noise in the tails (Samei 1998). Finally, the LSF was
Fourier transformed, resulting in the computational MTFdetector . The MTF was normalized to unit
magnitude at zero frequency, as is customary.

Figure 3.19: The composite ESF and LSF derived from the noisy simulated edge image.
3.7 Reconstruction Algorithm Resolution
The reconstruction algorithm resolution was measured using methodology that has been
previously described (Chen 2007a, Chen 2008, Chen 2014). The projection images of the
simulated delta functions (see Section 3.4.2 and Section 3.4.3) were reconstructed using SAA, BP,
and FBP. All image sets were reconstructed assuming the same geometry as in Section 3.4.2. Fig.

51

3.20, Fig. 3.21, and Fig. 3.22 show the reconstructed images of the point impulse projection images
with no source location error, reconstructed using SAA, BP, and FBP, respectively, at 𝑧 = 1.5 cm
above the detection plane.

Figure 3.20: Reconstruction of point impulse projection data at 𝑧 = 1.5 cm using SAA. The plot
was normalized to the maximum value.

Figure 3.21: Reconstruction of point impulse projection data at 𝑧 = 1.5 cm using BP. The plot was
normalized to the maximum value.
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Figure 3.22: Reconstruction of point impulse projection data at 𝑧 = 1.5 cm using FBP. The plot
was normalized to the maximum value. The negative side lobes adjacent to the peak are
the overshoot artifact.
For these reconstructed point impulses, the entire image set (all 41 images) was used for the
reconstruction. Because the SAA algorithm assumed a single shift for each projection image, the
point impulse function spreads in the reconstructed plane in the scan direction – this is a limitation
of SAA (Chen 2007b). The BP and FBP profiles were sharper in the scan direction due to
incorporation of divergent beam geometry. FBP displayed the characteristic edge-enhancement
artifact in the direction of scan motion associated with the filtration process (Mertelmeier 2006,
Mertelmeier 2014).
In addition to reconstructing the simulated point impulse projection images using all source
locations, the point impulse was also reconstructed using smaller x-ray source travel distances
and/or larger spatial step sizes to assess the effect of these parameters. The combinations of these
parameters are summarized in Table 3.2. The composite point impulse image sets with source
location error (Section 3.4.3) were reconstructed using the same procedure and assumed source
locations as described above for the ideal image set.
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Table 3.2: Combinations of x-ray source travel and spacings used to reconstruct the point impulse
phantom.
X-ray source
travel (cm)
-40 to 40
-40 to 40
-40 to 40
-20 to 20
-20 to 20
-10 to 10

̂
Spatial step size in 𝒙
between images (cm)
2
4
8
2
4
2

Number of
images used
41
21
11
21
11
11

To find the reconstruction algorithm resolution, the profile that traversed the point of maximum
intensity in the reconstructed point impulse along 𝑥̂ was Fourier transformed, which resulted in
the reconstruction algorithm MTF (MTFrecon ). MTFrecon was measured for all point impulse
image sets, all reconstruction methods, and all combinations of source travel and step size.
MTFrecon was normalized to unit magnitude at zero frequency for SAA and BP, as is customary.
For FBP, MTFrecon was normalized to unit magnitude at the point of maximum intensity on the
FBP MTFrecon curve; due to the limited sampling of the object, much of the low frequency
information in FBP is removed, and the FBP MTFrecon was therefore relative.
3.8 Results
3.8.1 Computational Detector Resolution
Fig. 3.23 shows the pre-sampled computational MTFdetector of the simulated edge images. The
frequency values at which MTFdetector was reduced to 90%, 50%, and 10% of the maximum value
at zero frequency were 9.3 mm-1, 23.1 mm-1, and 38.6 mm-1 for the noiseless image. The addition
of Poisson noise did not have a substantial effect on the measured MTF due to the large number
of profiles used to determine the average detector MTF; 800 profiles were measured over the 1.52
mm length of the edge in increments of 0.1 pixel.
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Figure 3.23: Pre-sampled MTFdetector of the simulated edge image with and without added
Poisson noise.
3.8.2 Reconstruction Algorithm Resolution
Fig. 3.24, Fig. 3.25, and Fig. 3.26 show MTFrecon curves generated from the reconstructed
point impulses with no source location error for each reconstruction algorithm using the source
travel and step size given in Table 3.2. The 90%, 50%, and 10% MTFrecon for SAA for all
reconstruction parameters are given in Table 3.3. The 90% and 50% MTFrecon for BP for all
reconstruction parameters are given in Table 3.4; note that the BP MTFrecon was not reduced to
10% over the frequency range investigated, possibly due to aliasing (pre-sampling was not used
for measurement of MTFrecon ). A similar effect was observed in the study this aim was modeled
from (Chen 2007a). Table 3.5 gives the frequency of the point of the maximum MTFrecon for FBP
for all reconstruction parameters. The FBP MTFrecon was not normalized to MTFrecon (0) = 1;
low-frequency information in the projections was removed using the endoDPT filter 2 tan 𝜃𝑚𝑎𝑥 ∗
|𝜔𝑥 | and was not fully reintroduced to the image due to sampling over a limited angular range of
21.8∘ . In contrast, CT reconstruction using > 180∘ angular sampling theoretically fully
reintroduces the low frequency information. Normalization to MTFrecon (0) was therefore not
meaningful (Chen 2007a) and the FBP MTFrecon was normalized to its maximum value; this made
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it a relative measure that demonstrated an artificially improved frequency response in comparison
to BP.

Figure 3.24: MTFrecon for SAA reconstruction with no source localization error for various
combinations of x-ray source travel and spatial step size (inc).

Figure 3.25: MTFrecon for BP reconstruction with no source localization error for various
combinations of x-ray source travel and spatial step size (inc).
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Figure 3.26: MTF curves for FBP reconstruction with no source localization error for various
combinations of x-ray source travel and spatial step size (inc).
Table 3.3: Summary of MTFrecon for SAA using various combinations of x-ray source travel and
spatial step size (inc).
Reconstruction
Parameters
-40 cm to 40 cm, 2 cm inc.
-40 cm to 40 cm, 4 cm inc.
-40 cm to 40 cm, 8 cm inc.
-20 cm to 20 cm, 2 cm inc.
-20 cm to 20 cm, 4 cm inc.
-10 cm to 10 cm, 2 cm inc.

Frequency of 90%
MTF (mm-1)
1.33
1.30
1.25
2.49
2.40
4.09

Frequency of 50%
MTF (mm-1)
3.25
3.17
3.03
6.12
5.89
10.29

Frequency of 10%
MTF (mm-1)
4.99
4.88
4.66
9.68
9.29
17.32

Table 3.4: Summary of MTFrecon for BP using various combinations of x-ray source travel and
spatial step size (inc).
Reconstruction
Parameters
-40 cm to 40 cm, 2 cm inc.
-40 cm to 40 cm, 4 cm inc.
-40 cm to 40 cm, 8 cm inc.
-20 cm to 20 cm, 2 cm inc.
-20 cm to 20 cm, 4 cm inc.
-10 cm to 10 cm, 2 cm inc.

Frequency of 90%
MTF (mm-1)
5.38
5.38
5.38
5.49
5.49
5.65
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Frequency of 50%
MTF (mm-1)
13.65
13.64
13.62
14.42
14.37
15.25

Table 3.5: Summary of MTFrecon for FBP using various combinations of x-ray source travel and
spatial step size (inc).
Reconstruction
Parameters
-40 cm to 40 cm, 2 cm inc.
-40 cm to 40 cm, 4 cm inc.
-40 cm to 40 cm, 8 cm inc.
-20 cm to 20 cm, 2 cm inc.
-20 cm to 20 cm, 4 cm inc.
-10 cm to 10 cm, 2 cm inc.

Frequency of maximum
relative MTF (mm-1)
7.08
7.08
7.08
7.08
7.08
7.08

3.8.3 Reconstruction Algorithm Resolution with Source Location Error
Fig. 3.27-3.29 show MTFrecon curves generated from the reconstructed point impulse with no
source location error (Section 3.4.2) and with source location error (Section 3.4.3) for SAA
reconstruction. Fig. 3.30-3.32 show MTFrecon curves generated from the reconstructed point
impulse with no source location error (Section 3.4.2) and with source location error (Section 3.4.3)
for BP reconstruction. Fig. 3.33-3.35 show MTFrecon curves generated from the reconstructed
point impulse with no source location error (Section 3.4.2) and with source location error (Section
3.4.3) for FBP reconstruction.
All the data shown in Fig. 3.27-3.35 are for the tomosynthesis scan with ±40 cm source travel
and 2 cm step size. The same trends seen for various combinations of x-ray source travel and
spatial step size are expected, although the source location error can change the magnitude of the
trends. The largest x-ray source travel (±40 cm) and smallest spatial step size (2 cm) were used
because they result in the largest reconstructed plane cm field of view (FoV) with the finest
sampling. All future endoDPT tomosynthesis scans (Chapter 4 and Chapter 5) were acquired using
±40 cm source travel and 2 cm step size because a typical prostate has an average diameter of 3
cm; using the largest reconstructed image plane possible reduces the propensity for truncation
artifact and other detractors of image quality.
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Figure 3.27: MTFrecon for SAA reconstruction with ±40 cm source travel and 2 cm step size with
source location error in +𝑥̂ and +𝑦̂. MTF curves for error in −𝑥̂ and −𝑦̂ were not generated
because of symmetry in the endoDPT geometry. Note the shorter frequency range
compared to BP and FBP, used here for clarity.

Figure 3.28: MTFrecon for SAA reconstruction with ±40 cm source travel and 2 cm step size with
source location error in +𝑧̂ and −𝑧̂ . Note the shorter frequency range compared to BP and
FBP, used here for clarity.
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Figure 3.29: MTFrecon for SAA reconstruction with ±40 cm source travel and 2 cm step size. The
total source location error is √𝑥 2 + 𝑧 2 , where the 𝑥 and 𝑧 values used in each plot are given
in the legend. Note the shorter frequency range compared to BP and FBP, used here for
clarity.

Figure 3.30: MTFrecon for BP reconstruction with ±40 cm source travel and 2 cm step size with
source location error in +𝑥̂ and +𝑦̂. MTF curves for error in −𝑥̂ and −𝑦̂ were not generated
because of symmetry in the endoDPT geometry.
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Figure 3.31: MTFrecon for BP reconstruction with ±40 cm source travel and 2 cm step size with
source location error in +𝑧̂ and −𝑧̂ .

Figure 3.32: MTFrecon for BP reconstruction with ±40 cm source travel and 2 cm step size. The
total source location error is √𝑥 2 + 𝑧 2 , where the 𝑥 and 𝑧 values used in each plot are given
in the legend.
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Figure 3.33: MTFrecon for FBP reconstruction with ±40 cm source travel and 2 cm step size with
source location error in +𝑥̂ and +𝑦̂. MTF curves for error in −𝑥̂ and −𝑦̂ were not generated
because of symmetry in the endoDPT geometry.

Figure 3.34: MTFrecon for FBP reconstruction with ±40 cm source travel and 2 cm step size with
source location error in +𝑧̂ and −𝑧̂ .
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Figure 3.35: MTFrecon for FBP reconstruction with ±40 cm source travel and 2 cm step size. The
total source location error is √𝑥 2 + 𝑧 2 , where the 𝑥 and 𝑧 values used in each plot are given
in the legend.
3.9 Discussion
In this aim, the endoDPT system was computationally modeled, endoDPT reconstruction
algorithms were derived, and the computational MTFdetector and MTFrecon were assessed. The
computational system model followed previous efforts in tomosynthesis with x-ray sensors
external to the body (Tutar 2003, Chen 2007a, Reiser 2007, Mainprize 2011, Chen 2014) and in
radiography (Samei 1998, Saunders 2003). This computational system design allowed for a
convenient and cost-effective method to assess endoDPT, including providing comparisons to
experimental measurements on a test system (see Chapter 4).
MTFdetector and MTFrecon derived using simulated phantoms showed that high image
resolution was achievable in endoDPT. The endoDPT MTFdetector was higher than the
computational study (Samei 1998) that this work was based on; Samei and Flynn measured the
frequency of the 10% MTFdetector on a simulated detector with 200 µm pixels to be 22 mm−1
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whereas the frequency of 10% MTFdetector of endoDPT (19 µm pixel) was 38.6 mm-1. There was
not a 1:1 correspondence to smaller pixel size because the edge phantom image created by Samei
and Flynn was a perfect step function; the image was not created using a divergent beam source.
This resulted in a narrower LSF and broader MTFdetector relative to pixel size. Because many
profiles were averaged into the ESF, the added Poisson noise in the study had little effect on the
measurement.
MTFrecon showed high resolution compared to BP MTFrecon and FBP MTFrecon measured in
the computational study this work was based on (Chen 2007a); Chen created projection images
(partial isocentric tomosynthesis with 25 projections equiangularly spaced over 25∘ ) of nine point
impulses spaced within a single pixel (pixel size = 85 µm) located 25 mm above the detection
plane and reconstructed using BP and FBP. Chen reported the frequencies of the 50% BP
MTFrecon , the maximum of FBP MTFrecon , and the minimum of FBP MTFrecon to be 4 mm-1, 2.2
mm-1, and 5.8 mm-1, respectively. The corresponding values measured for endoDPT were 13.6
mm-1, 7.08 mm-1, and 20 mm-1, respectively. endoDPT increased MTFrecon by a factor of three to
four compared to Chen’s work, which was expected due to using a pixel size approximately four
times smaller in endoDPT.
Both the BP and FBP algorithms showed that retention of higher frequencies than achieved
by SAA was possible, although the measured FBP MTFrecon was relative and FBP was limited to
the tunable parameter 𝑎 of the Hanning window, which resulted in all frequencies above 𝑎 being
reduced to zero. SAA MTFrecon demonstrated a marked dependence on x-ray source travel. Small
travel distances resulted in SAA MTFrecon approaching BP MTFrecon . Larger travel distances
reduced SAA MTFrecon . This occurred because SAA assumes a parallel beam. In all instances for
a given amount of travel, increasing the number of images by using a smaller step size improved
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the MTFrecon . BP showed that larger x-ray source travel distances decreased MTFrecon in the high
frequency region, but to a much lesser extent than that seen in SAA. The BP MTFrecon is larger
than the SAA MTFrecon because BP incorporates beam divergence. The BP MTFrecon decreases
for larger x-ray source travel distances because this induces a greater blur (the reconstructed image
moves closer to what would be visualized in CT compared to radiography for larger source travel
distances). No differences were noted for variations in the step size for a given x-ray source travel
distance in BP. FBP showed little variation in the MTFrecon for variations in source travel distances
or in the step size. This occurred because the high-frequency range of the image (which was where
most of MTFrecon variation was observed in BP) was attenuated in FBP by the Hanning window.
Due to the limited angular sampling of the object and the filtration process, FBP MTFrecon was
relative and assumed the approximate shape of the point impulse inversion filter windowed by the
Hanning function (Mertelmeier 2006, Chen 2007a, Zhou 2007, Cong 2011). This occurred because
FBP MTFrecon was measured across the reconstructed point impulse in the direction of scan
motion. The blur artifact of tomosynthesis had a small impact on this view in BP due to the limited
angular sampling, whereas in CT, the blur would affect this in-plane view because the blur artifact
occurs over the entire reconstructed point impulse. The profile of the FBP reconstructed point
impulse had negative values, which resulted in an overshoot or edge-enhancement artifact that
translated to the FBP MTFrecon .
Small, systematic errors to source location in 𝑥̂, 𝑦̂, and 𝑧̂ resulted in changes of MTFrecon that
varied for each reconstruction algorithm and were most pronounced in the high frequency range.
Source location error in 𝑥̂ reduced MTFrecon for SAA and BP. For SAA, a larger source location
error in 𝑥̂ worsened MTFrecon . For BP, the opposite effect occurred; a 1 mm source location error
worsened MTFrecon more so than the 3 mm source location error. This occurred because the
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geometry of the 3 mm source location error resulted in projection images with the point impulse
more closely spaced about a single pixel than with 1 mm source location error. This effect occurred
due to the use of discrete detector elements. Source location errors in 𝑦̂ affected MTFrecon to a
much lesser degree than offsets in 𝑥̂ for SAA due to the parallel beam assumption. In BP, the
worsening of MTFrecon with increasing 𝑦̂ source location error was more evident than SAA
because MTFrecon covered a larger frequency range and because BP incorporated divergent beam
geometry. Source location error in 𝑥̂ and 𝑦̂ showed little effect on the FBP MTFrecon ; the highfrequency components of the BP MTFrecon were where worsening of the MTFrecon was observed
and these components were attenuated by the Hanning window in FBP.
Source location error in ±𝑧̂ showed a much greater effect of the MTFrecon compared to error
in 𝑥̂ and 𝑦̂. The SAA MTFrecon improved for source location errors that increased the SID; this
improved the imaging geometry of SAA by making the x-ray source more like a parallel beam
which decreased beam divergence. The SAA MTFrecon worsened for negative 𝑧̂ source location
errors for the same reason. The beam became less parallel and beam divergence played a larger
role. The BP MTFrecon and FBP MTFrecon showed a slight worsening for positive 𝑧̂ source
location errors but showed a much larger effect for negative 𝑧̂ source location errors, due to the
larger effect of beam divergence at smaller SID.
Source location error in both (+𝑥̂, +𝑧̂ ) and (+𝑥̂, −𝑧̂ ) combined the effects described above for
the SAA MTFrecon and the BP MTFrecon . Source location error in (+𝑥̂, +𝑧̂ ) did not affect the FBP
MTFrecon but source location error in (+𝑥̂, −𝑧̂ ) decreased the MTFrecon . For the FBP MTFrecon
source location error in (+𝑥̂, −𝑧̂ ), there was little difference for a 1 mm offset and a 3 mm source
location error; this is again believed to be the product of attenuation of the high-frequency
components of MTFrecon by the Hanning window. These results demonstrate that for a physical
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system, precise knowledge of the system geometry will be important to limit potential reductions
in system resolution. These results also highlight the usefulness of linear parallel tomosynthesis
geometry; a source constrained to move in a straight line along a single direction (𝑥̂) should aid
minimization of source location error.
This aim had several limitations and sources of error. The primary limitation was that the edge
phantom and the point impulse phantom were modeled and imaged geometrically. Material-photon
interactions, the polychromatic x-ray spectrum of a kV imaging system, x-ray scatter, focal spot
size, pixel fill factor, detector gain, and detector scintillation layer were not considered. In a
physical system, the detector resolution will be decreased. Most dental imaging sensors have
limiting high-contrast clinical resolutions of approximately 9-20 lp/mm-1 (Farman 2005a). This
resolution is lower than the computational limits in this study, but is still high compared to other
methods for prostate imaging. When the physical detector resolution is combined with the
reconstruction algorithm resolution, it is expected that the total system resolution will be higher
that than typical methods of prostate imaging.
3.10 Conclusion
The main objectives of this aim were to develop a computational model to perform endoDPT
simulations and to develop analytical tomosynthesis reconstruction methods for the endoDPT
geometry. Both objectives were completed. The computational endoDPT system developed with
idealized parameters demonstrated that high detector resolution is achievable, which was expected
due to the small pixel size used. The reconstruction algorithm resolution demonstrated a similar
result for the same reason. Further, it was demonstrated that small errors in source location affect
the resultant MTF, although not to a large degree. This aim developed the endoDPT concept and
provided a clear indication that high resolution is achievable with endoDPT.
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Chapter 4. Aim 2: endoDPT Image Quality and Dose Assessment
4.1 Overview
A test system to assess image quality of endoDPT was assembled using an intraoral dental xray sensor and a standard radiography unit. The small size and high-resolution of the x-ray sensor
and the range of x-ray source travel of the radiography unit were appropriate for testing endoDPT.
The MTF, NPS, ASF, and dose were measured using this physical system. The MTF and dose
were also measured for a typical CT scanner to provide a comparison to endoDPT. Differences
were considered significant for 𝑝 < 0.05.
4.2 endoDPT System Components
The physical system was designed by adapting an intraoral dental sensor and a standard
radiography unit to perform endoDPT scans. An intraoral dental sensor was chosen for this study
because it had both high resolution (19 µm pixel size) and a form factor similar to the size of large
(≈ 24 mm diameter) TRUS probes in clinical use (Koprulu 2012). The size of the intraoral dental
sensor was also similar to the size of an endorectal gamma-ray detector (≈ 25 mm width and ≈
80 mm length) currently under investigation (Safavi-Naeini 2015, Alnaghy 2017). A typical
radiography unit was chosen for this study because the x-ray source travel associated with general
radiography can easily accommodate the range required for tomosynthesis imaging. A drawback
is that the radiography source required manual positioning. Additionally, the technology used in
these devices is both readily available and inexpensive, resulting in a high level of technology
readiness for implementation of endoDPT.
4.2.1 endoDPT X-ray Sensor
The endoDPT x-ray sensor was an XDR Size 2 Intraoral dental x-ray sensor (S/N: 526388,
XDR Radiology, Los Angeles, California), shown in Fig. 4.1. This XDR sensor comprises a layer
of scintillating CsI(Tl) needles over a CMOS chip with an optimal energy response for x-ray
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spectra of 60 kV to 80 kVi. The active area is 25.992 mm (1368 pixels) by 36.024 mm (1896
pixels) with pixel size of 19 μm; the overall size was 40 mm length, 30 mm width, 5 mm thickness.
The XDR sensor is powered by and interfaces to a personal computer via USB connection.

Figure 4.1: The XDR sensor used in the physical endoDPT system.
Projection images were collected with the XDR sensor using the image acquisition software
provided by XDR Radiology (XDR Digital Radiographic System, Version 3.2.10, XDR
Radiology, Los Angeles, California). This software allowed for the manual collection of a single
projection image every 5-7 seconds. Prior to output of the projection image, a gain uniformity
correction was applied, which included a linear interpolation step to provide a signal intensity
value for any dead pixel elements. This was the only pre-processing step that occurred at the XDR
sensor level. The resultant projection images were output at a 12-bit pixel depth (where a pixel
value of 4096 indicates no signal has been collected) with a total image size of about 5 MB.
A sample projection image collected with the XDR sensor is shown in Fig. 4.2. Each corner of
the image comprised a triangular area of pixels that do not respond to radiation exposure (these
areas are covered by sensor clips in intraoral dental imaging). These corner areas of unresponsive
pixels were not used in any reconstruction or data analysis steps.

i

Dr. Doug Yoon (XDR Radiology), personal communication, September 3, 2015
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Figure 4.2: Representative projection image acquired with the XDR sensor of 10 LDRBT seeds
(titanium shell is ≈ 5 mm long with diameter ≈ 0.8 mm, silver core is ≈ 3.5 mm long with
diameter ≈ 0.3 mm) implanted in a Styrofoam plug.
4.2.2 X-ray Source
For physical testing, a GE Proteus XR/a radiography unit (Model: 6124101, SN: 106888HL1,
General Electric Company, Waukesha, Wisconsin), shown in Fig. 4.3, was used. This GE Proteus
XR/a is ceiling mounted at Pennington Biomedical Research Center, with the ability to translate
the unit source head in three-dimensions. The source can additionally be rotated by 𝜃 in the (𝑥̂, 𝑧̂ )
plane as shown in Fig. 4.3 for endoDPT imaging. This three-phase 65 kW radiography unit
operates from 40 kVp to 150 kVp in 1 kVp increments using x-ray source currents up to 400 mA
with the small focal spot setting; the small focal spot setting of 0.6 mm on the rhenium-tungsten
target was used for all endoDPT imaging. This radiography unit has an inherent filtration of 1.1
mm aluminum equivalent at 75 kVp in the head (MX100 x-ray tube) and added filtration of 1.5
mm aluminum equivalent at 75 kVp in the collimator (Eclipse Proteus Collimator). No additional
filters were used for this study.
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Figure 4.3: The GE Proteus XR/a radiography unit used in the physical endoDPT system.
The digital radiography flat panel x-ray detector associated with this radiography unit, a
wireless GE FlashPad (General Electric Company, Waukesha, Wisconsin) with a 40.4 cm by 40.4
FoV and 200 µm pixel size, was also used in this study to verify the x-ray source locations relative
to the XDR sensor through use of wire fiducials in the endoDPT phantom. The FlashPad detector
was only used for this x-ray source localization.
4.3 CT Scanner
A GE Lightspeed RT16 CT scanner (SID: 22515CT1, General Electric Company, Waukesha,
Wisconsin) was used in this study (Fig. 4.4). This is a 16 slice CT scanner used for radiation
therapy treatment planning and simulation at Mary Bird Perkins Cancer Center. The scanner
operates at 80, 100, 120, or 140 kVp, can use either a constant x-ray source setting or an automatic
exposure setting, has both axial and helical scanning modes with 1.25 mm, 2.5 mm, 5 mm, or 10
mm slice thicknesses, and reconstructs objects using a 512 by 512 matrix. In this study, a 25 cm
FoV was used for all scans, resulting in a 0.488 mm reconstructed voxel size.
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Figure 4.4: The GE LightSpeed RT16 CT scanner used in this study.
4.4 endoDPT Phantoms
4.4.1 Modular Acrylic Phantom
A modular phantom was created using 1” and 2” thick plates of acrylic plastic. This phantom
was used to measure the MTF, NPS, ASF, and dose. Acrylic was chosen as the phantom material
because it is easily machinable, similar in composition to soft tissue, and is inexpensive (Robertson
2012). The modular phantom had overall dimensions of 11.5” (292.1 mm) width, 5.5” (139.7 mm)
depth, and 6” (152.4 mm) height. Some plates were configured for specific purposes, while the
remainder were solid material. The combination and ordering of plates could be changed to
accommodate the various measurements. Every plate had four identical alignment holes that were
used with machined acrylic bolts to clamp the plates together reproducibly.
Two plates were configured as shown in Fig. 4.5, one to hold the wire fiducials for alignment
verification and the other to hold the XDR sensor. The fiducial plate was always the base of the
phantom (Fig. 4.5 a), with tapped holes to secure the alignment bolts. The 1” thick fiducial plate
had two features to facilitate alignment verification of the x-ray source. First, a 150 mm ruled scale
was epoxied into a recess milled along one edge to help set up the phantom during imaging.
Second, three small recesses were milled into both the top and bottom faces of the plate; 38 mm
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long sections of 0.8 mm diameter piano wire were epoxied into these recesses for use as fiducial
markers to determine imaging geometry with the FlashPad detector (Section 4.5). The detector
holder plate was 1” thick with a cut-out for the XDR sensor (Fig. 4.5 b). The cutout was lined with
foam to ensure the detector was placed in a reproducible position. The detector holder plate was
typically placed directly above the fiducial plate. Fig. 4.6 shows one arrangement of the modular
acrylic phantom assembled with two solid acyclic slabs above the fiducial plate and detector holder
plate. This phantom was used for measurement of the NPS.

Figure 4.5: (a) Modular acrylic phantom bottom plate, with slots for wire fiducials (localization)
and a scale (setup). (b) Plate to hold the XDR sensor.

Figure 4.6: Configuration of modular acrylic phantom for measurement of NPS. The fiducial plate
(1) and detector holder plate (2) were illustrated in Fig. 4.5. Two solid plates (4) were each
2” thick and 4 acrylic bolts (7) were used to clamp the assembly together.
73

The sample holder plate is shown in Fig. 4.7. This 2” thick plate had a large cavity (7.75”
width, 1-7/16” thickness, 1-13/16” depth) milled into the center of the top face; there was 4.76 mm
of acrylic plastic separating the XDR sensor face from the bottom of the cavity during imaging.
The cavity housed various objects that were imaged in this work, such as metal spheres suspended
in carrageenan gel for measurement of ASF (Section 4.6.3) and canine prostate specimens
suspended in carrageenan gel (Chapter 5).

Figure 4.7: (a) Sample holder plate. (b) and (c) Configurations of modular acrylic phantom for
ASF measurement and prostate specimen imaging showing fiducial plate (1), detector
holder plate (2), sample holder plate (3), and solid plate (4). 4 acrylic bolts (7) were used
to clamp the assembly together.
4.4.2 Carrageenan Gel Inserts
Carrageenan gel, which is solid at room temperature, was used to suspend phantom materials
within the cavity in the sample holder plate, as well as to create pliable sheets (1” thick) that could
be substituted for 1” slabs in the modular acrylic phantom for dose measurements (Section 4.6.4).
The recipe for this gel was adapted at our institution (Lamberto 2014) as a variation of a previously
reported recipe (Hattori 2013).
The gel was made by first dissolving the materials listed in Table 4.1 in distilled water at room
temperature. The solution was heated in a hot water bath to 90∘ C and continuously stirred at this
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temperature for 5 minutes to create the gel. To remove air bubbles, the gel rested in a hot water
bath at 90∘ C for 20 additional minutes. The gel was poured either into the sample holder cavity or
into a form with the same length and width dimensions as the acrylic plates. The gel was allowed
to solidify for 12 hours at 20-25∘ C. When filling the sample holder, the cavity was overfilled to
compensate for shrinkage and any excess gel was trimmed flush with the top face of the sample
holder plate. For gel slabs, the form was overfilled and then two 1” thick pieces of acrylic were
place on either side of the slab as guides to trim the gel to 1” thick. When not in use for imaging,
the gel samples were tightly wrapped in plastic wrap and refrigerated to prevent shrinkage.
Table 4.1: Materials and concentrations used to create a muscle-like gel with T1 and T2 relaxation
behavior with a 3T MRI (Lamberto 2014). w/w indicates percent by weight in water. An
example calculation for material amounts to create 500 g of gel is given in Appendix C.
Material
Agarose
GdCl3

Quantity
1.200% w/w
55.0 µmol/kg

Carrageenan

3% w/w

NaCl
NaN3

0.291% w/w
0.03% w/w

Purpose
Adjusts T2
Adjusts T1
Provides for
gelatinization
Alters conductivity
Anti-microbial

Carrageen was the gelatinizing agent used to solidify the gel (Hattori 2013). The amounts of
GdCl3 , agarose, and NaCl in the recipe controlled the T1 relaxation time, T2 relaxation time, and
conductivity, respectively, to produce similar MRI characteristics as human muscle tissue
(Lamberto 2014). While these characteristics were not important for endoDPT, they facilitated
comparative imaging with MRI (Chapter 5). The NaN3 was an anti-microbial to prevent mold and
mildew (Hattori 2013, Lamberto 2014). The carrageenan was purchased through Research
Products International (Mt Prospect, IL) while the other materials were purchased through Fisher
Scientific (Fair Lawn, NJ). An example calculation for materials to create 500 g of gel is given in
Appendix C.
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4.5 X-ray Source Localization
Determining of the x-ray source location relative to the XDR sensor was accomplished with
wires in the fiducial plate (Fig. 4.5 a) of the modular acrylic phantom. This method was based on
previously developed methods for determining the location of the x-ray source by mapping a threedimensional fiducial (or set of fiducials) onto a two-dimensional x-ray detector in fluoroscopy
(Jain 2005, Kuo 2014, Szczykutowicz 2016, Lee 2017) and tomosynthesis (Li 2010). The wires
were in the same positions relative to the XDR sensor for all endoDPT scans.
From the beam’s eye view, the wires were located distal to the XDR sensor but before the
FlashPad detector, which was located within the table bucky of the Proteus x-ray unit. For each
discrete source location (𝑥𝑆𝑖 , 𝑦𝑆𝑖 , 𝑧𝑆𝑖 ) during the endoDPT scan a projection image was formed of
the wires on the FlashPad detector. An example image is shown in Fig. 4.8. The coordinates of the
endpoints of the wires were manually found by displaying each projection image in ImageJ
(https://imagej.nih.gov/ij/); ImageJ’s cursor tool was used to determine the pixel coordinates,
which were converted to spatial coordinates using the 200 µm pixel size of the FlashPad detector.

Figure 4.8: Projection image collected on the FlashPad detector to show relative locations of
fiducial wires and XDR sensor with the x-ray source located nominally at (𝑥𝑆 , 𝑦𝑆 , 𝑧𝑆 ) =
(40 cm, 0 cm, 100 cm) relative to the center point of the XDR sensor. The wires are
numbered 1-6. This projection image is in the (𝑥̂, 𝑦̂) plane of endoDPT geometry, with 𝑧̂
out of the page.
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To determine the absolute positions of the wires relative to the XDR sensor, CT scans were
taken of the modular acrylic phantom and XDR sensor with CT slices oriented in the (𝑥̂, 𝑧̂ ) plane
of the phantom (Fig. 4.9 a) and rotated 90∘ for CT slices in the (𝑦̂, 𝑧̂ ) plane (Fig. 4.9 b). In the CT
image sets, wire and XDR sensor locations were found manually using ImageJ. The locations of
the wire endpoints and the XDR sensor center point are given in Table 4.2.

Figure 4.9: CT slices of the modular acrylic phantom and XDR sensor, showing the x-ray source
localizing wires relative to the XDR sensor. The + symbol on the XDR sensor marks
(𝑥, 𝑦, 𝑧) = (0,0,0). The labels on the wires (1-6) correspond to the labels in Table 4.2. (a)
CT slice in the (𝑥̂, 𝑧̂ ) plane. (b) CT slice in the (𝑦̂, 𝑧̂ ) plane. The XDR sensor has an inferior
(I) and superior (S) side; the cord of the XDR sensor in on the I side.
Table 4.2: Inferior and superior wire endpoint locations. The (𝑥, 𝑧) location of the wires did not
change along (𝑦̂). The wire numbers correspond to the labels in Fig. 4.8 and Fig. 4.9.

XDR Sensor Center
Wire 1
Wire 2
Wire 3
Wire 4
Wire 5
Wire 6

Inferior Wire Endpoint
𝒙 (mm) 𝒚 (mm) 𝒛 (mm)
0
0
0
-25.4
-19.1
-24.9
-25.4
-19.8
-48.8
0
-18.6
-25.4
0
-19.2
-48.8
25.4
-18.6
-25.4
25.4
-19.1
-49.1

Superior Wire Endpoint
𝒙 (mm) 𝒚 (mm) 𝒛 (mm)
0
0
0
-25.4
19.8
-24.9
-25.4
20.0
-48.8
0
20.0
-25.4
0
20.0
-48.8
25.4
20.0
-25.4
25.4
20.0
-49.1

The relative locations of the wires both to one another and to the XDR sensor were drawn in
SolidWorks (Dassault Systèmes, Waltham, Massachusetts). The center point of the XDR sensor
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was placed at the origin of the drawing. This drawing was first used to determine the location of
the FlashPad detector along 𝑧̂ relative to the XDR sensor. This step was performed because leaving
both the location of the source and the location of the FlashPad detector unconstrained made the
geometrical problem too complex for the modeling software to read and input dimensions from a
spreadsheet that contained the wire-to-wire distances (known as a design table). Because the same
radiography table, table bucky, FlashPad detector, and endoDPT phantom were used for all
endoDPT scans, it was assumed the location of the FlashPad detector relative to the XDR sensor
and wires along 𝑧̂ was constant; this assumed constraint simplified the drawing and made it
possible to find the source location using a design table.
The location of the FlashPad detector was found assuming it was in a horizontal plane (𝑥̂, 𝑦̂)
below the endoDPT phantom. By considering only the wire center points in the (𝑥̂, 𝑧̂ ) plane
because the center points of the wires did not vary along 𝑦̂, six rays were drawn from an arbitrary
source point through each wire’s center to a horizontal line (the FlashPad detector). At this stage,
the x-ray source location was not constrained (the x-ray source could be located at any 𝑥 or 𝑧) and
the FlashPad detector location was constrained only to be parallel to 𝑥̂ (it could be located at any
𝑧). This is shown in Fig. 4.10.

Figure 4.10: (𝑥̂, 𝑧̂ ) plane at 𝑦 = 0 (through the XDR sensor center point) of the modular acrylic
phantom. For clarity, this figure is not drawn to scale.
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To constrain both the x-ray source location (𝑥, 𝑧) and the location of the FlashPad detector
along 𝑧̂ in the (𝑥̂, 𝑧̂ ) plane, three wire-to-wire distances were required. Three sets of three wire-towire distances were selected randomly in each image of a projection image set acquired in the
normal manner nominally with 𝑥𝑆𝑖 = ±40 cm in 2 cm increments, 𝑦𝑆 = 0 cm, and 𝑧𝑆 = 100 cm.
From these 123 measurements the mean 𝑧 position of the FlashPad detector was 𝑧 = −132.2 ±
0.1 mm, relative to the XDR sensor located at 𝑧 = 0 mm.
With the location of the FlashPad detector constrained, the complexity of finding the source
location (𝑥𝑆𝑖 , 𝑦𝑆 , 𝑧𝑆 ) was reduced. To further reduce the complexity of finding (𝑥𝑆𝑖 , 𝑦𝑆 , 𝑧𝑆 ), the
source location (𝑥𝑆𝑖 , 𝑧𝑆𝑖 ) was first determined; only two wire-to-wire distances were required to
constrain the source location in the (𝑥̂, 𝑧̂ ) plane for each FlashPad detector image. It was possible
to automate this process by choosing wire-to-wire distances that continually increased or decreased
over the range of projection images. There were six wire-to-wire distances that continually
increased or decreased, resulting in a total of 15 combinations of two wire-to-wire distances that
could be used. Of those 15 combinations, 10 combinations were randomly chosen and input into
the modeling software. 𝑥𝑆𝑖 was taken to be the mean of the 10 measurements of 𝑥𝑆𝑖 for each
projection image. Because 𝑧𝑆 did not vary (the x-ray source did not move in 𝑧̂ during the scan),
the mean value of all measurements of 𝑧𝑆𝑖 was used for reconstruction. Typical uncertainties
(standard deviation) in 𝑥𝑆𝑖 and 𝑧𝑆 were on the order of 2 mm to 7 mm. With 𝑧𝑆 constrained, a
similar process was used to find 𝑦𝑆 . Only one distance, the endpoint of one wire to the endpoint of
separate wire in a superimposed (𝑦̂, 𝑧̂ ) plane, was needed to estimate 𝑦𝑆𝑖 . Because no motion
occurred in 𝑦̂, the mean value of all 𝑦𝑆𝑖 was used for reconstruction. Typical uncertainties in 𝑦𝑆
were on the order of 2 mm to 7 mm. These uncertainties in source location are slightly higher than
source location uncertainties (0.3 mm to 3 mm) from similar studies using fiducials to localize an
79

x-ray source (Jain 2005, Lee 2011, Kuo 2014). As an example, a partial set of the measured source
locations and uncertainty for the ASF image set (Section 4.6.3) is presented in Table 4.3.
Table 4.3: Measured source locations and uncertainty for the ASF image set. The average (𝑦, 𝑧)
location for this source was (0.57 cm, 102.48 cm). For all endoDPT image sets,
uncertainties in source location ranged from 2-7 mm.
Image Number

𝒙𝑺𝒊 (cm)

𝝈𝒙𝑺 (cm)

𝒚𝑺𝒊 (cm)

𝝈𝒚𝑺 (cm)

𝒛𝑺𝒊 (cm)

𝝈𝒛𝑺 (cm)

1
2
3
4
5
⋮
37
38
39
40
41

-40.29
-38.58
-36.82
-33.89
-31.00
⋮
32.88
34.47
36.09
38.74
40.79

0.35
0.53
0.43
0.45
0.39
⋮
0.53
0.39
0.52
0.53
0.46

0.75
0.59
0.72
0.71
0.13
⋮
0.62
0.82
0.29
-0.09
0.22

0.47
0.41
0.40
0.43
0.41
⋮
0.49
0.33
0.48
0.58
0.40

102.07
102.59
103.03
102.81
102.40
⋮
102.17
102.74
102.90
101.69
102.04

0.45
0.34
0.34
0.57
0.43
⋮
0.44
0.55
0.33
0.29
0.43

𝒊

𝒊

𝒊

4.6 endoDPT Image Quality Metrics
4.6.1 MTF
The system resolution of endoDPT, MTFendoDPT , was found as
MTFendoDPT (𝜔) = MTFrecon (𝜔) ∗ MTFdetector (𝜔)

(4.1)

which is the multiplication of two MTF stages; the computational MTFrecon (determined in
Chapter 3) and the physical MTFdetector of the XDR sensor measured in this section. MTFendoDPT
was determined for various combinations of reconstruction algorithms (all with x-ray source travel
of ±40 cm and spatial step size of 2 cm), x-ray source energy, and x-ray source current.
The physical MTFdetector was measured with a Leeds MTF-TO test device (Leeds Test Objects
LTD, Roecliffe, York, United Kingdom). The test edge device was made of 1 mm thick tungsten
with a sharp edge (< 5 µm ripple). For the radiographic unit accelerating voltages of interest (60
kVp to 100 kVp), this edge was considered fully opaque. MTFdetector was measured from a
projection image of the edge using the same procedure discussed in Chapter 3; this procedure is
80

recommended by the International Electrotechnical Commission international standard 62220-1
(IEC 2003). This procedure was previously utilized with opaque edges to measure the MTF of
digital detectors that had a scintillating layer and CCD or CMOS chipsets (Neitzel 2004, Illers
2005), and thus is appropriate for the XDR sensor.
Fifteen sets of 10 projection images each were acquired of the test edge device using the x-ray
source kVp and mAs settings in Table 4.4. The x-ray source currents for each kVp setting resulted
in signal (pixel value) to the exposed XDR sensor of ≈ 3000 (low mAs), ≈ 2000 (medium mAs),
and ≈ 1000 (high mAs), allowing for comparison of low, medium, and high signal levels.
Table 4.4: Imaging parameters for the MTFdetector measurements.
Image Set
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15

kVp
60
60
60
70
70
70
80
80
80
90
90
90
100
100
100

mAs
16.0
32.0
50.0
12.5
20.0
32.0
8.0
12.5
20.0
6.3
10.0
16.0
4.0
8.0
12.5

The test edge device was placed in contact with the XDR sensor external housing (Fig. 4.11).
All images were acquired with the x-ray source located 100 cm above the XDR sensor center point
using the small focal spot setting (0.6 mm). To reduce afterglow artifacts, a scrubber image (test
edge device removed) was taken between each projection image of the test edge device. The test
edge device was rotated through a random angle (±10∘ relative to 𝑦̂) for each projection.
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Figure 4.11: Test edge device in position on top of the XDR sensor in the detector holder plate of
the modular acrylic phantom.
Eight hundred profiles perpendicular to the edge in the projection images were measured using
the same procedure as discussed in Chapter 3. Fig. 4.12 (a) shows a typical projection image of
the edge acquired on the XDR sensor and Fig. 4.12 (b) shows an example profile. The profiles
collected over the 1.52 mm length were averaged for each projection to obtain the ESF, which was
differentiated to find the LSF (Fig. 4.13). The LSF for each projection was Fourier transformed to
obtain MTFdetector . MTFdetector was normalized to MTFdetector (0) = 1. A representative
MTFdetector for a single projection is shown in Fig. 4.14. The average MTFdetector for each kVp
and mAs setting was found for the 10 projections acquired at each x-ray source setting.

Figure 4.12: (a) The location of one profile (green line) and the total path along the edge upon
which profiles were measured (red line) superimposed over one edge image (80 kVp, 12.5
mAs). A red box is drawn around the sampled region for clarity. (b) The ESF profile shown
by the green line in the left pane.
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Figure 4.13: The composite ESF and LSF for a single physical edge image taken at 80 kVp, 12.5
mAs.

Figure 4.14: MTFdetector for a single edge image acquired at 80 kVp, 12.5 mAs.
MTFendoDPT was found using Eq. 4.1 for each reconstruction algorithm (SAA, BP, and FBP,
using an x-ray source travel of ±40 cm and a spatial step size of 2 cm), for each kVp and mAs
setting listed in Table 4.4. Because MTFrecon was computationally determined, there was no
associated uncertainty in this term. Uncertainty in MTFdetector was determined as the standard
deviation of the measured frequency values at the 90%, 50%, and 10% MTF from the 10 scans
and was propagated to find the uncertainty of MTFendoDPT .
4.6.2 NPS
The NPS of endoDPT was measured at 80 kVp using three different x-ray source currents (25
mAs, 50 mAs, and 100 mAs) with the small focal spot setting (0.6 mm) using the modular acrylic
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phantom with two solid plates (Fig. 4.6). These x-ray source currents resulted in detector signals
of ≈ 3000 (low mAs), ≈ 2000 (medium mAs), and ≈ 1000 (high mAs). The procedure for
imaging the phantom and computing the NPS was adapted from existing methods (Dobbins 1995,
Godfrey 2006a, Chen 2014). 10 identical scans for each x-ray source current were acquired in the
normal manner with 𝑥𝑆𝑖 = ±40 cm in 2 cm steps, 𝑦𝑆 = 0 cm, and 𝑧𝑆 = 100 cm. The central ray
of the x-ray source was directed towards this center point on the XDR sensor for each source
position.
The 𝑧 = 1.5 cm plane of each projection image set was reconstructed using SAA, BP, and FBP
using all 41 projection images. The plane at 𝑧 = 1.5 cm was reconstructed because this is the plane
at which the reconstruction algorithm resolution was determined; the NPS and MTFrecon in the
same plane were needed to compute the noise equivalent quanta (NEQ) (see below). The NPS was
determined using only the full image set (41 images) because the noise properties of the
reconstructed image depend on x-ray exposure to the XDR sensor (Godfrey 2006a).
A mean background subtraction was performed on all reconstructed images for each given xray source current and each method of image reconstruction. The purpose of the mean background
subtraction was to remove possible structured noise components in the source, phantom, or XDR
sensor (Godfrey 2006a, Chen 2014). The mean of each voxel calculated from all reconstructed
images for each x-ray source current and reconstruction method was subtracted from the
corresponding voxel value of each reconstructed image.
Each mean background-subtracted reconstructed image was divided into 60 regions of interest
(ROIs) of 128 by 128 voxels in size (Godfrey 2006a, Chen 2014). The ROIs were placed in the
central region of the image, to avoid edge effects and truncation artifacts. Fig. 4.15 shows the
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central region of the image used for NPS analysis and a single ROI. The ROIs were used to
compute NPS for each reconstructed image using
NPS(𝜔𝑥 , 𝜔𝑦 ) = 𝐶 ∗

< |ℱ2𝐷 [𝐼(𝑥, 𝑦) − 𝐼 ]̅ |2 >
Δ𝑥Δ𝑦
𝑁𝑥 𝑁𝑦

(4.2)

where 𝐼(𝑥, 𝑦) is the ROI, 𝐼 ̅ is the global mean intensity, ℱ2𝐷 is the two-dimensional Fourier
transform, Δ𝑥 = Δ𝑦 = 0.019 mm (voxel size for SAA) or Δ𝑥 = Δ𝑦 = 0.020 mm (voxel size for
BP and FBP), and 𝑁𝑥 = 𝑁𝑦 = 128 voxels, the size of each ROI (Dobbins 1995). The term corrects
for the reduction in image variance after performing the mean background subtraction, with a value
of 𝑁⁄(𝑁 − 1) where 𝑁 is the number of repeat scans (10 here).

Figure 4.15: BP reconstructed image of the modular acrylic phantom used for measurement of
NPS. The central region that comprises all ROIs is drawn with the thin red line. A single
ROI is drawn with a bold red line. ROIs were only located in the central FoV to avoid
truncation artifacts and edge effects.
The resultant NPS(𝜔𝑥 , 𝜔𝑦 ) was a two-dimensional function while the NPS is typically reported
as a one-dimensional function, NPS(𝜔). NPS(𝜔) was calculated by integrating in 𝜔
̂𝑦 (Godfrey
2006a). The value of the NPS at 𝜔 = 0 was excluded from further analysis because NPS(0) may
contain background trends in the data (such as the heel effect) that may have remained after
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background subtraction (Dobbins 1995). The NPS for each x-ray source current and image
reconstruction method was calculated as the mean of the 10 reconstructed images using those
parameters.
NPS(𝜔) provided the variance amplitude at a given spatial frequency in the reconstructed
image. NPS(𝜔) can be used with MTFrecon (𝜔) and MTFdetector (𝜔) to calculate NEQ, which is
analogous to the signal-to-noise ratio (Chen 2014). The NEQ can be used to directly compare
image reconstruction algorithms, assuming all image acquisition parameters are identical for each
stage (Chen 2014). The NEQ was calculated using
NEQ(𝜔) =

2
2
(𝜔) ∗ MTFdetector
(𝜔) ∗ 𝑘1 ∗ 𝑘2
MTFrecon
NPS(𝜔)

(4.3)

where 𝑘1 was the inverse of the normalization factor that scaled MTFrecon (0) = 1 for SAA and
BP or the maximum value of MTFrecon to unity for FBP, and 𝑘2 was the inverse of the
normalization factor that scaled MTFdetector (0) = 1. This method using the total, unnormalized
frequency response allows for comparison between the three reconstruction algorithms for a given
level of exposure to the XDR sensor (Chen 2007a).
4.6.3 ASF
The phantom used to measure the ASF consisted of six tungsten BBs of 0.79 mm (1/32”)
nominal diameter suspended in carrageenan gel at varying heights above the XDR sensor along
the central axis (𝑦̂). Similar metal structures such as 0.4 mm diameter steel BBs (Hu 2008) and
high-contrast metal balls (Mertelmeier 2006) have been used in phantoms to measure ASF in DBT.
The phantom was constructed by tilting the sample holder plate by approximately 30∘ and then
partially filling the cavity with carrageenan gel. After the gel had set, the BBs were implanted in
the angled face of the carrageenan gel (Fig. 4.16), spaced such that the BBs would be located at
heights ranging from 1.25 cm to 3.50 cm above the XDR sensor in the assembled modular acrylic
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phantom. The remainder of the sample holder cavity was then filled with carrageenan gel to the
surface of the sample holder plate.

Figure 4.16: View looking down on sample holder plate, showing BBs in place on the slanted
surface of the gel slab.
Three endoDPT scans were acquired at 80 kVp using x-ray source currents of 25 mAs, 50
mAs, and 100 mAs (to result in low, medium, and high exposure scans) with the small focal spot
setting (0.6 mm). The modular acrylic phantom was configured as shown in Fig. 4.7. A single
projection image of the BBs is shown in Fig. 4.17.
Image planes were reconstructed using SAA, BP, and FBP from 𝑧 = 0.5 cm to 𝑧 = 4.0 cm in
0.1 mm increments for all three scan sets using all 41 projection images. After reconstruction, the
center points and heights of the BBs were determined for all six BBs. For each BB, an ROI of 30
voxels by 30 voxels was drawn about the center point of the BB. This ROI was used as the signal
measurement for computation of the ASF. An ROI of the same size was also drawn 1 cm from
each BB center point along −𝑥̂ on the reconstructed image. This second ROI was used as a
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background measurement for computation of the ASF. The mean voxel value of these ROIs was
used to compute the ASF. The two ROIs for one of the BBs is shown in Fig. 4.18.

Figure 4.17: Single projection image of BBs, taken at a nominal source location of (0 cm, 0 cm,
100 cm). This image was acquired at 80 kVp with 100 mAs.

Figure 4.18: Image reconstructed with BP at 𝑧 = 1.6 cm showing ROIs (30 pixel by 30-pixel red
boxes) used for computation of the ASF. The left-most ROI is for the background
measurement and the right-most ROI is centered over the reconstructed BB.
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The ASF was calculated for each BB for every combination of reconstruction algorithm and
x-ray source current using
𝐴𝑆𝐹(𝑧) =

𝜇̅𝑎𝑟𝑡𝑖𝑓𝑎𝑐𝑡 (𝑧) − 𝜇̅𝐵𝐺 (𝑧)
𝜇̅𝑓𝑒𝑎𝑡𝑢𝑟𝑒 (𝑧0 ) − 𝜇̅𝐵𝐺 (𝑧0 )

(4.4)

where 𝜇̅𝑓𝑒𝑎𝑡𝑢𝑟𝑒 (𝑧0 ) was the mean voxel value of the in-plane BB ROI, 𝜇̅𝑎𝑟𝑡𝑖𝑓𝑎𝑐𝑡 (𝑧) was the mean
voxel value of the BB ROI in other planes, and 𝜇̅𝐵𝐺 was the mean voxel value of the background
ROI (Wu 2004).
4.6.4 Dose
An acrylic and carrageenan phantom with packets of TLD powder located both on the surface
of the phantom and sandwiched between slabs of the phantom (Fig. 4.19) was used to measure
absorbed dose delivered by an endoDPT scan. Carrageenan gel slabs conformed around the TLD
packets to prevent air gaps from two layers such as would occur if sandwiching TLD packets
between two acrylic plates.

Figure 4.19: Acrylic and carrageenan phantom used to measure ionizing dose from endoDPT and
CT scans. 1” thick acrylic slabs (A) and carrageenan slabs (C) were used. TLD packets are
located on the surface (red arrows), mid, and detector planes of the phantom.
TLD packets were made from two layers of 1 cm by 1 cm thin plastic sheet and contained 45
mg of TLD100 LiF(Mg,Ti) powder (Rexon Components, Inc., Beachwood, Ohio). The edges of
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the plastic packets were heat sealed using a plastic film sealer. TLD100 powder is commonly used
for patient dosimetry at Mary Bird Perkins Cancer Center; the packet formation followed their
clinical process. Each TLD packet was assumed to be a point dosimeter, ignoring the size of the
TLD powder sample and the plastic sheet.
Twenty-seven TLD packets were arranged on three planes on and within the phantom (Fig.
4.19). The surface plane TLDs were on the phantom surface, the mid plane TLDs were located 2”
(5.08 cm) below the surface, and the detector plane TLDs were located 4” (10.16 cm) below the
surface. The XDR sensor was not in place for dose measurements – a solid acrylic plate was used
in place of the XDR sensor holder plate. For the mid and detector planes, TLDs were placed on an
acrylic plate with a carrageen gel slab placed on top of them (e.g., between A2 and C1, and between
A3 and C2).
Nine TLD packets were in each plane in the phantom in the positions shown in Fig. 4.20. These
locations were the same for each plane. The gray box shows the endoDPT field size (6 cm by 6
cm) at the detector plane for the x-ray source location of (0 cm, 0 cm, 100 cm).

Figure 4.20: TLD locations on each plane of dose phantom. The gray box bounded by a red line
shows the endoDPT field size (6 cm by 6 cm) and location of the field at the detector plane
for the x-ray source location of (0 cm, 0 cm, 100 cm).
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With reference to the projected field for the (0 cm, 0 cm, 100 cm) source location, the TLDs
were positioned such that TLD 5 was located above the XDR sensor center point at 𝑥𝐷 = 𝑦𝐷 =
𝑧𝐷 = 0, TLD 4 was at and within the field edge, TLDs 6, 7, and 8 were located 2.0 cm from the
field edge, and TLDs 1, 2, 3, and 9 were located > 2 cm from the field edge. This pattern of TLDs
gave a cross section of the imaging dose in the FoV, near the FoV, and far from the FoV at discrete
depths within the phantom.
Ten identical endoDPT scans of the dose phantom were acquired in the normal manner at 80
kVp and 100 mAs with the small focal spot size (0.6 mm) with the TLDs accumulating dose over
all ten scans. The multiple scans improved the statistics of the TLD measurement. After irradiation,
the TLDs were stored for 24 hours prior to reading. After 24 hours, the 27 irradiated TLD packets,
plus one unirradiated (background) TLD packet, were read on a Rexon UL-320 TLD reader
(Rexon Components, Inc., Beachwood, Ohio). Each TLD packet was divided into three ~15 mg
samples. The mass of each sample was measured using a Mettler Toledo AL54 Electronic
Analytical Balance (Mettler Toledo, Columbus, Ohio). Each sample was placed on a planchette,
inserted into the TLD reader, and heated through pre-heat and heat cycles. Luminescence as a
function of temperature was recorded during the heat cycle, which heated the TLD powder
uniformly from 60∘ C to 240∘ C over 25 seconds. The edges of the planchette that connect to the
electrodes were polished with fine grit sandpaper after each TLD packet (every three readings).
The internal portion of the planchette where the powder resides was polished with a cotton swab
after each reading. This method followed the clinical procedure used for patient dosimetry at Mary
Bird Perkins Cancer Center.
For each TLD packet, the mean thermoluminescence per mass (TL/mass which was measured
in counts per mg) and the standard deviation of the luminescence per mass was found using
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𝑁

1
̅̅̅̅̅̅̅̅̅̅̅̅
𝑇𝐿⁄𝑚𝑎𝑠𝑠𝑖 = ∑ 𝑇𝐿⁄𝑚𝑎𝑠𝑠𝑖,𝑘
𝑁

(4.5)

𝑘=1

and
𝑁

𝜎̅̅̅̅̅̅̅̅̅̅̅̅̅
𝑇𝐿⁄𝑚𝑎𝑠𝑠 𝑖

1
2
=√
∑(𝑇𝐿⁄𝑚𝑎𝑠𝑠𝑖,𝑘 − ̅̅̅̅̅̅̅̅̅̅̅̅
𝑇𝐿⁄𝑚𝑎𝑠𝑠𝑖 )
𝑁−1

(4.6)

𝑘=1

for 𝑁 = 3 samples per TLD packet. To find the net mean luminescence per mass for each irradiated
TLD packet, the background ̅̅̅̅̅̅̅̅̅̅̅̅
𝑇𝐿⁄𝑚𝑎𝑠𝑠𝐵𝐺 was subtracted from each irradiated packet’s ̅̅̅̅̅̅̅̅̅̅̅̅
𝑇𝐿⁄𝑚𝑎𝑠𝑠.
Because 10 scans were collected at 100 mAs for endoDPT, the net ̅̅̅̅̅̅̅̅̅̅̅̅
𝑇𝐿⁄𝑚𝑎𝑠𝑠 for each irradiated
packet was divided by 10 to give the TLD reading for one endoDPT scan at 100 mAs, by 20 to
give the TLD reading for one endoDPT scan at 50 mAs, and by 40 to give the TLD reading for
one endoDPT scan at 25 mAs. This assumed that the TLD luminescence was linear to both number
of scans and x-ray source current (Attix 1986, Knoll 2010).
To report the mean TLD readings as absorbed dose, a TLD calibration curve was measured
using an Elekta Versa linear accelerator (LINAC) (Elekta, Stockholm, Sweden). This was a
relative calibration because the LINAC photon energy was 6 MV (minimum energy setting of the
LINAC) whereas photons produced at 80 kVp were used to measure endoDPT dose. There is a
slight energy dependence of TLD100 powder resulting in kV photons having about 1.1 times more
luminescence for a given dose than MV photons (Attix 1986). However, because the objective of
this study was to determine dosimetric differences between endoDPT and CT, rather than
determining absolute dose, this calibration curve was a satisfactory conversion of luminescence to
dose (Gy).
To create the calibration curve, seven TLD packets were irradiated to the doses listed in Table
4.5. All the TLD packets except for Sample 1 (background measurement) were sandwiched at 10
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cm depth in a 20 cm thick water equivalent plastic material. The TLD packets were aligned to the
center of the field with the source located at 0∘ (AP beam) at 100 cm above the TLD packet (90
cm source to surface distance) using a 6 MV beam. The dose per MU at 10 cm depth with the 6
MV is 0.8 MU/cGy for the LINAC used in this study.
Table 4.5: TLD packets used to create calibration curve. MU is the monitor unit setting for the
LINAC.
Sample

MU

1
2
3
4
5
6
7

0
15
25
50
100
200
250

Dose (cGy) at 10
cm depth
0
12
20
40
80
160
200

The mean luminescence per mass (counts per mg) and the standard deviation of the
luminescence per mass were determined using the readout procedure described above (Table 4.6).
The calibration curve was generated as a linear fit of the TLD reading to delivered to delivered
dose (Fig. 4.21), requiring a y-intercept of zero. TLD100 has a linear response in this dose range
(Attix 1986).
Table 4.6: Readings from irradiated TLD packets for calibration curve. BG is background. σ is the
uncertainty in the BG subtracted value.
Sample

MU

Dose (cGy)

1
2
3
4
5
6
7

0
15
25
50
100
200
250

0
12
20
40
80
160
200

Raw Counts
(TL/mg)
607
1046
1165
1756
2785
5162
6353
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Net BG subtracted
counts (TL/mg)
439
558
1146
2178
4555
5747

σ (counts)
78
55
52
78
92
73

Calibration Curve

Net BG subtracted reading (TL/mg)

7000
6000
5000
4000
3000
2000
y = 28.521x
1000
0
0

50

100
150
Dose (cGy)

200

250

Figure 4.21: TLD calibration curve measured with a 6 MV LINAC. The error bars represent the
standard deviation of the net BG subtracted reading.
4.7 CT Image Quality Metrics
Both MTF and dose were measured using a typical scan protocol on a CT scanner. These
metrics were statistically compared to endoDPT to test the hypothesis of this study. All CT scans
were performed using the CT scanner discussed in Section 4.3.
4.7.1 MTF
The MTF of the CT scanner was measured using an AAPM CT Performance Phantom (Fluke
Biomedical, Cleveland, Ohio). The phantom contained a 0.009” (0.23 mm) steel wire surrounded
by water. The phantom was oriented on the CT scanner couch such that the wire was perpendicular
to the slice plane and parallel to the scanner axis. This wire allowed for measurement of the CT
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system MTF (MTFCT ) in one step (Kayugawa 2013), in contrast to endoDPT which required
measurement of MTFrecon and MTFdetector.
Multiple slices of the wire were collected using helical scanning mode at 120 kVp, 1.25 mm
slice thickness, 0.938 pitch, small reconstruction FoV (512 by 512 matrix, 0.488 mm voxel size),
and automatic x-ray source current. A single slice is shown in Fig. 4.22, with the wire located
within the top ROI (wire ROI). The bottom ROI was used for background measurement
(background ROI). ROIs were collected, rather than single profiles through the wire, to reduce the
effect of noise and of small changes in the wire location throughout the scan.

Figure 4.22: AAPM CT Performance Phantom image, showing wire phantom within the top red
ROI; the bottom ROI was used for a BG measurement. The ROIs have been drawn larger
in 𝑦̂ for clarity (9 voxels instead of 5 voxels).
The MTF of the CT scanner was measured over 24 slices. To measure the MTF, first the ROIs
shown in Fig. 4.22 (101 voxels by 5 voxels) were extracted from each slice. For each slice, the
mean value of the background ROI was subtracted from each voxel in the wire ROI. Each column
array (𝑦̂) in the wire ROI was integrated, creating a single row array that contained the background
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subtracted wire profile. Similar methods of ROI integration have been previously reported
(Kayugawa 2013). The profile was subsampled for every 0.1 voxels and a Hanning window was
applied to reduce the effect of high frequency noise in the tails of the profile (with tunable
parameter 𝑎 = 1.175 cm = 200 subsampled voxels, which was equivalent to the number of voxels
used for 𝑎 in MTFdetector for endoDPT). MTFCT was found by taking the Fourier of the profile.
The composite MTFCT was the average of the set of MTFCT measured over all 24 slices.
4.7.2 Dose
The relative dose of CT was measured using the same acrylic/carrageenan phantom and TLD
packet locations as endoDPT. The phantom was irradiated with 15 typical CT scans with the
horizontal setup lasers aligned parallel to the detector plane, resulting in similar TLD readings as
the 10 endoDPT scans at 100 mAs/image for points within the endoDPT beam. Each CT scan
consisted of anterior-posterior and lateral localizing scans and a single acquisition. The localizing
scans were performed over a 20 cm range at 120 kVp and 80 mAs/image. The helical scan was
performed over the same range at 120 kVp, 1.25 mm slice thickness, 0.938 pitch, and automatic
x-ray source current. The x-ray source current was 150 mAs to 170 mAs over the scan duration.
The TLD packets were read using the same procedure described above – the readings were
background subtracted and then divided by 15 to find the reading for a single, typical CT scan.
4.8 Results
4.8.1 Resolution
Fig. 4.23 shows the mean endoDPT MTFdetector measured at 80 kVp and 12.5 mAs. This MTF
is representative of MTFs found for various kVp and mAs settings. For each set of x-ray source
potential and x-ray source current, the mean frequency values (𝜔
̅) and standard deviations (𝜎𝜔̅ ) at
which the MTF was reduced to 90%, 50%, and 10% are summarized in Table 4.7.
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Figure 4.23: Composite MTFdetector for projection image acquired at 80 kVp and 12.5 mAs. For
clarity error bars were not plotted (typical standard deviations were 1% of the frequency
values measured at 90%, 50%, and 10% MTF and are listed in Table 4.7).
Table 4.7: Frequency values and standard deviation at the 90%, 50%, and 10% MTF for each of
the 15 MTFdetector .
Frequency (mm-1) of the 90%, 50% and 10% MTF

Image
Set

kV

mAs

̅ 𝟗𝟎%
𝝎

𝝈𝝎̅𝟗𝟎%

̅ 𝟓𝟎%
𝝎

𝝈𝝎̅𝟓𝟎%

̅ 𝟏𝟎%
𝝎

𝝈𝝎̅𝟏𝟎%

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15

60
60
60
70
70
70
80
80
80
90
90
90
100
100
100

16.0
32.0
50.0
12.5
20.0
32.0
8.0
12.5
20.0
6.3
10.0
16.0
4.0
8.0
12.5

0.3720
0.3721
0.3728
0.3783
0.3773
0.3777
0.3725
0.3716
0.3731
0.3721
0.3735
0.3734
0.3703
0.3703
0.3704

0.0028
0.0026
0.0022
0.0058
0.0064
0.0058
0.0026
0.0028
0.0022
0.0036
0.0032
0.0033
0.0039
0.0035
0.0037

2.644
2.654
2.643
2.671
2.684
2.686
2.670
2.675
2.681
2.692
2.694
2.695
2.694
2.691
2.694

0.030
0.027
0.033
0.035
0.019
0.030
0.041
0.027
0.023
0.043
0.028
0.036
0.044
0.045
0.030

11.50
11.55
11.56
11.53
11.58
11.57
11.69
11.50
11.68
11.67
11.76
11.71
11.78
11.86
11.70

0.38
0.21
0.15
0.31
0.26
0.20
0.22
0.31
0.21
0.23
0.26
0.26
0.38
0.21
0.18
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Statistical comparisons were performed to determine if the measured frequency values at the
90%, 50%, and 10% MTF values varied significantly with x-ray source potential and x-ray source
current. The first comparison tested for differences due to x-ray source current (low, medium, and
high) in the mean of the measured frequency values for a given MTF value (90%, 50%, or 10%)
and a given x-ray source potential (60 kVp, 70 kVp, 80 kVp, 90 kVp, or 100 kVp). This test was
performed using analysis of variance (ANOVA) and assumed a significance level of 𝑝 < 0.05
which corresponds to the critical F-statistic 𝐹𝑐𝑟𝑖𝑡 = 3.35. The results of this analysis for each MTF
value and x-ray source energy are summarized in Table 4.8. There were no statistical differences
due to x-ray source current in the measured mean frequency at any MTF value or x-ray source
energy (𝑝 > 0.05 for all comparisons). Because this result showed no statistical difference, ad hoc
comparisons between the measured mean frequency values for each x-ray source current (e.g.,
performing the student t-test between the mean frequency measured at 60 kVp, low tube current,
90% MTF, and the mean frequency measured at 60 kVp, high tube current, 90% MTF) were not
performed.
Table 4.8: Summary of the ANOVA test for differences in the mean measured frequency due to
x-ray source current (low, medium, and high) for a given MTF value and a given x-ray
source energy.
Source
Potential
60 kVp
70 kVp
80 kVp
90 kVp
100 kVp

90% MTF
𝑭
𝒑 − 𝐯𝐚𝐥𝐮𝐞
0.28
0.76
0.07
0.93
0.94
0.40
0.57
0.57
0.01
0.99

50% MTF
𝑭
𝒑 − 𝐯𝐚𝐥𝐮𝐞
0.39
0.68
0.81
0.46
0.30
0.74
0.02
0.98
0.03
0.97

10% MTF
𝑭
𝒑 − 𝐯𝐚𝐥𝐮𝐞
0.13
0.88
0.10
0.90
1.83
0.18
0.32
0.73
0.93
0.40

The second comparison tested for differences due to x-ray source potential (60 kVp, 70 kVp,
80 kVp, 90 kVp, or 100 kVp) in the mean of the measured frequency values for a given MTF value
(90%, 50%, or 10%). Because no statistical difference was found as a function of x-ray source
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current (low, medium, or high), all of the frequency values measured for a given MTF value and
a given energy were used in the comparison between x-ray source energies. This test was also
performed using ANOVA with an assumed significance level of 𝑝 < 0.05 (𝐹𝑐𝑟𝑖𝑡 = 2.43), with the
results summarized in Table 4.9.
Table 4.9: Summary of the ANOVA test for differences in the mean measured frequency due to
x-ray source potential (60 kVp, 70 kVp, 80 kVp, 90 kVp, and 100 kVp) for a given MTF
value.

mAs
All

90% MTF
𝑭
𝒑 − 𝐯𝐚𝐥𝐮𝐞
16.23
< 0.0001

50% MTF
𝑭
𝒑 − 𝐯𝐚𝐥𝐮𝐞
10.38
< 0.0001

10% MTF
𝑭
𝒑 − 𝐯𝐚𝐥𝐮𝐞
4.77
0.0012

The results in Table 4.9 indicate that at least one of the x-ray source energies had a significantly
higher or lower mean frequency value for each of the three MTF points. Ad hoc statistical
comparisons were performed between each x-ray source energy for each MTF value using the
student t-test. For each MTF value, there were 10 inter-energy comparisons (e.g., comparing 60
kV to 70 kV), and so a Bonferroni correction was applied the assumed significance level of 𝑝 <
0.05, resulting in a significance level of 𝑝 < 0.005.
The trends in mean frequency values as a function of x-ray source energy for each MTF value
are shown in the box plots in Fig. 4.24, Fig. 4.25, and Fig. 4.26. The mean frequency value at
which the MTF was reduced to 90% was significantly higher for 70 kVp than for the other x-ray
source potentials. The MTF was reduced to 90% at 𝜔
̅ = 0.378 mm−1 for 70 kVp and at 𝜔
̅=
0.370 mm−1 for 100 kVp; 100 kVp had the smallest mean frequency value for the 90% MTF.
While this result was significant, it is overall a small difference (0.008 mm−1). The mean
frequency values at which the MTFs were reduced to 50% and 10% generally increased as energy
increased.
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Figure 4.24: Box plot showing median frequency value (red line) at which the detector MTF was
reduced to 90% for each x-ray source energy. The notches on the boxes represent the 95%
confidence interval, the bottom and top of the box are the 25𝑡ℎ and the 75𝑡ℎ percentiles,
respectively, the whiskers extend to approximately ±2.7𝜎 which contains 99% of normally
distributed data, and the red plus symbols indicate outliers.

Figure 4.25: Box plot showing median frequency value (red line) at which the detector MTF was
reduced to 50% for each x-ray source energy. The notches on the boxes represent the 95%
confidence interval, the bottom and top of the box are the 25𝑡ℎ and the 75𝑡ℎ percentiles,
respectively, the whiskers extend to approximately ±2.7𝜎 which contains 99% of normally
distributed data, and the red plus symbols indicate outliers.

100

Figure 4.26: Box plot showing median frequency value (red line) at which the detector MTF was
reduced to 10% for each x-ray source energy. The notches on the boxes represent the 95%
confidence interval, the bottom and top of the box are the 25𝑡ℎ and the 75𝑡ℎ percentiles,
respectively, the whiskers extend to approximately ±2.7𝜎 which contains 99% of normally
distributed data, and the red plus symbols indicate outliers.
Fig. 4.27 compares MTFendoDPT at 80 kVp and 12.5 mAs for SAA, BP, and FBP with x-ray
source travel of ±40 cm and 2 cm step size. The acquisition parameters shown here (80 kVp, ±40
cm, 2 cm source spacing) are those also used for measurement of the NPS, ASF, and dose. Table
4.10 compares the mean frequencies at which MTFendoDPT was reduced to 90%, 50%, and 10%
for three x-ray source current settings. The mean frequencies at which MTFendoDPT was reduced
to 90% and 50% for FBP were not assessed due to the filtration process removing the lowfrequency information. The FBP MTFendoDPT was a relative measure that demonstrated an
artificially improved frequency response in comparison to BP. The SAA and BP MTFs were
normalized to MTFrecon (0).
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Figure 4.27: MTFendoDPT at 80 kVp and 12.5 mAs for each reconstruction method. The
reconstruction used 41 images taken in 2 cm increments from 𝑥𝑆𝑖 = −40 to 40 cm.
Table 4.10: Mean frequencies at which MTFendoDPT was reduced 90%, 50%, and 10% versus xray source current and reconstruction algorithm. Reconstruction used 41 images taken in 2
cm increments from 𝑥𝑠 = −40 to 40 cm.
mAs

Frequency (mm-1) of the 90%, 50% and 10% SAA MTF
̅ 𝟗𝟎%
̅ 𝟓𝟎%
̅ 𝟏𝟎%
𝝎
𝝈𝝎̅𝟗𝟎%
𝝎
𝝈𝝎̅𝟓𝟎%
𝝎
𝝈𝝎̅𝟏𝟎%

8.0
12.5
20.0

0.3558
0.3551
0.3564

mAs

Frequency (mm-1) of the 90%, 50% and 10% BP MTF
̅ 𝟗𝟎%
̅ 𝟓𝟎%
̅ 𝟏𝟎%
𝝎
𝝈𝝎̅𝟗𝟎%
𝝎
𝝈𝝎̅𝟓𝟎%
𝝎
𝝈𝝎̅𝟏𝟎%

8.0
12.5
20.0

0.3712
0.3703
0.3719

mAs

Frequency (mm-1) of the 90%, 50% and 10% FBP MTF
̅ 𝟗𝟎%
̅ 𝟓𝟎%
̅ 𝟏𝟎%
𝝎
𝝈𝝎̅𝟗𝟎%
𝝎
𝝈𝝎̅𝟓𝟎%
𝝎
𝝈𝝎̅𝟏𝟎%

8.0
12.5
20.0

0.0010
0.0011
0.0008

0.0011
0.0011
0.0009

1.7869
1.7846
1.7867

2.5572
2.5635
2.5672

0.0017
0.0019
0.0016

0.0038
0.0029
0.0025

4.1811
4.1841
4.1804

9.5071
9.5501
9.5568

10.3280
10.2650
10.2840

N/A
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0.0008
0.0009
0.0009

0.0032
0.0031
0.0025

0.0049
0.0032
0.0033

The measured MTFCT is plotted in Fig. 4.28. The frequencies for the 90%, 50%, and 10% MTF
levels are reported in Table 4.11.

Figure 4.28: MTFCT (pre-sampled, helical scan, 120 kVp, 1.25 mm slice thickness, 0.938 pitch,
512 by 512 matrix, 0.488 mm voxel size, automatic x-ray source current).
Table 4.11: Mean frequencies at which MTFCT was reduced 90%, 50%, and 10%.
Frequency (mm-1) of the 90%, 50% and 10% CT MTF
̅ 𝟗𝟎%
̅ 𝟓𝟎%
̅ 𝟏𝟎%
𝝎
𝝈𝟗𝟎%
𝝎
𝝈𝟓𝟎%
𝝎
𝝈𝟏𝟎%
0.144
0.029
0.408
0.039
0.718
0.033
The frequencies at which MTFendoDPT and MTFCT were reduced to 90%, 50%, and 10% were
statistically compared using a one-tailed student t-test with a significance level of 𝑝 < 0.05. The
multiple parameters used to compute MTFendoDPT (MTFdetector measured at 8.0 mAs, 12.5 mAs,
and 20.0 mAs, and MTFrecon measured for SAA, BP, and FBP) were compared to MTFCT. The
results of the statistical comparison are reported in Table 4.12, Table 4.13, and Table 4.14. In all
cases, endoDPT had significantly higher resolution than CT. For comparison a single MTFendoDPT
curve and the MTFCT curve are plotted in Fig. 4.29.
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Table 4.12: Statistical comparison of frequencies at which MTFendoDPT (8.0 mAs) and MTFCT
were reduced to 90%, 50%, and 10%. Freq. stands for frequency.
MTF
Value
90%
50%
10%
MTF
Value
90%
50%
10%
MTF
Value
90%
50%
10%

Freq. (mm-1) of SAA MTF
𝝈𝝎̅
̅
𝝎
0.356
0.001
1.787
0.002
4.181
0.001

Freq. (mm-1) of CT MTF
𝝈𝝎̅
̅
𝝎
0.144
0.030
0.408
0.039
0.718
0.033

Freq. (mm-1) of BP MTF
𝝈𝝎̅
̅
𝝎
0.371
0.001
2.557
0.004
9.507
0.003

Freq. (mm-1) of CT MTF
𝝈𝝎̅
̅
𝝎
0.144
0.030
0.408
0.039
0.718
0.033

Freq. (mm-1) of FBP MTF
𝝈𝝎̅
̅
𝝎
N/A
10.328

0.005

Freq. (mm-1) of CT MTF
𝝈𝝎̅
̅
𝝎
0.144
0.030
0.408
0.040
0.718
0.033

p-value
< 0.0001
< 0.0001
< 0.0001
p-value
< 0.0001
< 0.0001
< 0.0001
p-value
N/A
N/A
< 0.0001

Table 4.13: Statistical comparison of frequencies at which MTFendoDPT (12.5 mAs) and MTFCT
were reduced to 90%, 50%, and 10%. Freq. stands for frequency.
MTF
Value
90%
50%
10%
MTF
Value
90%
50%
10%
MTF
Value
90%
50%
10%

Freq. (mm-1) of SAA MTF
𝝈𝝎̅
̅
𝝎
0.355
0.001
1.785
0.002
4.184
0.001

Freq. (mm-1) of CT MTF
𝝈𝝎̅
̅
𝝎
0.144
0.030
0.408
0.039
0.718
0.033

Freq. (mm-1) of BP MTF
𝝈𝝎̅
̅
𝝎
0.370
0.001
2.565
0.003
9.550
0.003

Freq. (mm-1) of CT MTF
𝝈𝝎̅
̅
𝝎
0.144
0.030
0.408
0.039
0.718
0.033

Freq. (mm-1) of FBP MTF
𝝈𝝎̅
̅
𝝎
N/A
10.328

0.005

Freq. (mm-1) of CT MTF
𝝈𝝎̅
̅
𝝎
0.144
0.030
0.408
0.040
0.718
0.033
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p-value
< 0.0001
< 0.0001
< 0.0001
p-value
< 0.0001
< 0.0001
< 0.0001
p-value
N/A
N/A
< 0.0001

Table 4.14: Statistical comparison of frequencies at which MTFendoDPT (20.0 mAs) and MTFCT
were reduced to 90%, 50%, and 10%. Freq. stands for frequency.
MTF
Value
90%
50%
10%
MTF
Value
90%
50%
10%
MTF
Value
90%
50%
10%

Freq. (mm-1) of SAA MTF
𝝈𝝎̅
̅
𝝎
0.356
0.001
1.787
0.002
4.180
0.001

Freq. (mm-1) of CT MTF
𝝈𝝎̅
̅
𝝎
0.144
0.030
0.408
0.039
0.718
0.033

Freq. (mm-1) of BP MTF
𝝈𝝎̅
̅
𝝎
0.372
0.001
2.567
0.003
9.557
0.003

Freq. (mm-1) of CT MTF
𝝈𝝎̅
̅
𝝎
0.144
0.030
0.408
0.039
0.718
0.033

Freq. (mm-1) of FBP MTF
𝝈𝝎̅
̅
𝝎
N/A
10.284

0.003

Freq. (mm-1) of CT MTF
𝝈𝝎̅
̅
𝝎
0.144
0.030
0.408
0.040
0.718
0.033

p-value
< 0.0001
< 0.0001
< 0.0001
p-value
< 0.0001
< 0.0001
< 0.0001
p-value
N/A
N/A
< 0.0001

Figure 4.29: Comparison of MTFendoDPT (80 kVp, 12.5 mAs, 41 images taken in 2 cm increments
from 𝑥𝑠 = −40 to 40 cm) for all reconstruction algorithms used and MTFCT (helical scan,
120 kVp, 1.25 mm slice thickness, 0.938 pitch, 512 by 512 matrix, 0.488 mm voxel size,
automatic x-ray source current).
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4.8.2 endoDPT NPS and NEQ
The NPS measured at 𝑧 = 1.5 for three x-ray source currents (25 mAs, 50 mAs, and 100 mAs)
are shown in Fig. 4.30 for SAA, Fig. 4.31 for BP, and Fig. 4.32 for FBP. Higher x-ray source
currents resulted in lower amplitude of NPS for a given reconstruction method.

Figure 4.30: SAA NPS measured at 80 kVp using 41 images taken in 2 cm increments for 𝑥𝑆𝑖 =
±40 cm.

Figure 4.31: BP NPS measured at 80 kVp using 41 images taken in 2 cm increments for 𝑥𝑆𝑖 =
±40 cm.
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Figure 4.32: FBP NPS measured at 80 kVp using 41 images taken in 2 cm increments for 𝑥𝑆𝑖 =
±40 cm.
The NEQ provides a metric that can be used to compare the three endoDPT reconstruction
algorithm for each x-ray source current. Fig. 4.33, Fig. 4.34, and Fig. 4.35 show the NEQ for SAA,
BP, and FBP, respectively, for the three levels of x-ray source current used to find MTFendoDPT
and the NPS. The reported x-ray source currents were not the same between the MTF and NPS
scans used to compute the NEQ; for 80 kVp, the low, medium, and high x-ray source current
values were 8.0 mAs, 12.5 mAs, and 20 mAs for measurement of MTFdetector and were 25 mAs,
50 mAs, and 100 mAs for measurement of NPS. For each level of x-ray source current (e.g., the
low x-ray source current setting at 8.0 mAs for measurement of MTFdetector and 25 mAs for
measurement of NPS), the XDR sensor was approximately constant. This was appropriate because
it resulted in approximately the same incident exposure to the detector for measurement of both
MTFdetector and the NPS; additionally, the limited latitude of the XDR sensor did not allow for an
open-air measurement of MTFdetector (for the half of the sensor that was not under the edge
phantom) at 80 kVp with an x-ray source current of greater than 20 mAs without saturating the
sensor.
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Fig. 4.33: NEQ for the MTFdetector and NPS measured at 80 kVp for the low x-ray source current
setting.

Fig. 4.34: NEQ for the MTFdetector and NPS measured at 80 kVp for the medium x-ray source
current setting.
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Fig. 4.35: NEQ for the MTFdetector and NPS measured at 80 kVp for the high x-ray source current
setting.
4.8.3 endoDPT ASF
The 𝑧-location of each of the six BBs was taken to be the 𝑧-plane where the mean value of
each BB ROI was at a maximum value. These 𝑧-locations are summarized in Table 4.15. The SAA
𝑧-locations of the BBs differed marginally (several tenths of a mm) from the BP and FBP 𝑧locations at small 𝑧. At large 𝑧, the effect became larger (variation by up to 1 mm). This effect
occurred due to the parallel beam assumption of SAA.
Table 4.15: BB heights above the XDR sensor for each reconstruction algorithm.
BB
1
2
3
4
5
6

𝒛 (cm), SAA
1.26
1.56
1.95
2.43
2.95
3.44
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𝒛 (cm), BP
1.24
1.54
1.91
2.38
2.88
3.33

𝒛 (cm), FBP
1.24
1.54
1.91
2.38
2.88
3.33

Fig. 4.36, Fig. 4.37, and Fig. 4.38 show the ASF for all 6 BBs using SAA, BP, and FBP,
respectively. The ASF is only shown for the high (100 mAs) x-ray source current because there
was no discernable difference in the ASF as a function of x-ray source current. Fig. 4.39 compares
the ASF across reconstruction algorithms for BB 6, which was representative of all BBs.

Figure 4.36: ASF for SAA using the 100 mAs x-ray source current and full endoDPT scan (41
source locations, with 𝑥𝑆𝑖 nominally ranging from −40 cm to 40 cm in 2 cm increments,
𝑦𝑆 = 0 cm, and 𝑧𝑆 = 100 cm).

Figure 4.37: ASF for BP using the 100 mAs x-ray source current and full endoDPT scan (41 source
locations, with 𝑥𝑆𝑖 nominally ranging from −40 cm to 40 cm in 2 cm increments, 𝑦𝑆 = 0
cm, and 𝑧𝑆 = 100 cm).

110

Figure 4.38: ASF for FBP using the 100 mAs x-ray source current and full endoDPT scan (41
source locations, with 𝑥𝑆𝑖 nominally ranging from −40 cm to 40 cm in 2 cm increments,
𝑦𝑆 = 0 cm, and 𝑧𝑆 = 100 cm).

Figure 4.39: ASF for BB 6 for SAA, BP, and FBP using the 100 mAs x-ray source current and full
endoDPT scan (41 source locations, with 𝑥𝑆𝑖 nominally ranging from −40 cm to 40 cm in
2 cm increments, 𝑦𝑆 = 0 cm, and 𝑧𝑆 = 100 cm).
4.8.4 Dose
Fig. 4.40, Fig. 4.41, and Fig. 4.42 report the doses measured at the surface plane, mid plane,
and detector plane, respectively for a single CT scan and for single endoDPT scans taken at 100
mAs, 50 mAs, and 25 mAs. Statistical comparisons were performed between the CT and endoDPT
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measurements using a two-tailed student t-test. 𝑝 < 0.05 was the threshold for significant
difference.
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Figure 4.40: Mean dose at each TLD point on the dose phantom surface for a single CT scan and
for three discrete endoDPT scans acquired at different x-ray source currents. The vertical
error bars represent the standard deviation. Note the y-axis is 0-30 cGy.
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Figure 4.41: Mean dose at each TLD point on the dose phantom mid plane for a single CT scan
and for three discrete endoDPT scans acquired at different x-ray source currents. The
vertical error bars represent the standard deviation. Note the y-axis is 0-14 cGy.
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Figure 4.42: Mean dose at each TLD point on the dose phantom detector plane for a single CT
scan and for three discrete endoDPT scans acquired at different x-ray source currents. The
vertical error bars represent the standard deviation. Note the y-axis is 0-5 cGy.
̅ ), the standard deviations
Table 4.16, Table 4.17, and Table 4.18 report the mean doses (𝐷
(𝜎𝐷̅ ), and the p-values (between CT and endoDPT) for each point in the surface plane, mid plane,
and detector plane, respectively.
Table 4.16: Surface plane mean doses for CT and endoDPT. endoDPT doses highlighted in green,
yellow, or red indicated the dose at that point was significantly less than, was not different
from, or was significantly higher than the CT dose measured at that point, respectively.

Point
1
2
3
4
5
6
7
8
9

CT Dose
̅
𝜎𝐷̅
𝐷
3.058
3.099
2.777
4.193
4.099
4.044
3.971
3.978
3.886

Dose (cGy) at Surface Plane
endoDPT 100 mAs
endoDPT 50 mAs
̅
̅
𝜎𝐷̅ p-value
𝜎𝐷̅ p-value
𝐷
𝐷

0.190 0.68 0.27
0.205 0.37 0.15
0.084 0.64 0.09
0.425 20.27 0.33
0.073 26.52 0.90
0.306 1.77 0.11
0.204 6.17 0.38
0.086 7.68 0.24
0.382 0.85 0.20

0.001 0.34 0.14
0.000 0.19 0.07
0.000 0.32 0.05
0.000 10.13 0.17
0.000 13.26 0.45
0.004 0.89 0.06
0.003 3.08 0.19
0.000 3.84 0.12
0.004 0.43 0.10
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0.000
0.000
0.000
0.000
0.000
0.000
0.007
0.108
0.000

endoDPT 25 mAs
̅
𝜎𝐷̅ p-value
𝐷
0.17
0.09
0.16
5.07
6.63
0.44
1.54
1.92
0.11

0.03
0.02
0.01
0.04
0.11
0.01
0.05
0.03
0.03

0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000

Table 4.17: Mid plane mean doses for CT and endoDPT. endoDPT doses highlighted in green,
yellow, or red indicated the dose at that point was significantly less than, was not different
from, or was significantly higher than the CT dose measured at that point, respectively.

Point
1
2
3
4
5
6
7
8
9

CT Dose

Dose (cGy) at Mid Plane
endoDPT 100 mAs
endoDPT 50 mAs

endoDPT 25 mAs

̅
𝐷

̅
𝐷

̅
𝐷

𝜎𝐷̅

0.11
0.21
0.06
2.59
3.23
0.48
0.44
0.55
0.21

0.01
0.03
0.03
0.01
0.03
0.04
0.02
0.04
0.03

2.988
2.978
2.782
2.961
2.740
2.372
2.568
2.581
2.374

𝜎𝐷̅

𝜎𝐷̅

0.237 0.44 0.10
0.140 0.84 0.24
0.134 0.24 0.21
0.116 10.37 0.12
0.064 12.93 0.26
0.110 1.91 0.35
0.092 1.77 0.15
0.187 2.19 0.30
0.126 0.86 0.23

̅
𝐷

𝜎𝐷̅

0.22
0.42
0.12
5.18
6.46
0.95
0.88
1.09
0.43

0.05
0.12
0.10
0.06
0.13
0.18
0.07
0.15
0.11

p-value
0.002
0.001
0.000
0.000
0.000
0.113
0.003
0.129
0.002

p-value
0.000
0.000
0.000
0.000
0.000
0.003
0.000
0.002
0.001

p-value
0.000
0.000
0.000
0.000
0.001
0.000
0.000
0.000
0.000

Table 4.18: Detector plane mean doses for CT and endoDPT. endoDPT doses highlighted in green,
yellow, or red indicated the dose at that point was significantly less than, was not different
from, or was significantly higher than the CT dose measured at that point, respectively.

Point
1
2
3
4
5
6
7
8
9

CT Dose
̅
𝜎𝐷̅
𝐷
2.841
3.020
2.480
2.761
2.980
2.556
2.746
2.811
2.220

0.219
0.141
0.108
0.176
0.096
0.172
0.144
0.069
0.082

Dose (cGy) at Detector Plane
endoDPT 100 mAs
endoDPT 50 mAs
̅
̅
𝜎𝐷̅ p-value 𝐷
𝜎𝐷̅ p-value
𝐷
0.05
0.12
0.01
3.47
4.22
0.78
0.52
0.74
0.52

0.10
0.16
0.17
0.14
0.12
0.11
0.16
0.12
0.14

0.001
0.000
0.000
0.007
0.001
0.000
0.000
0.000
0.000

0.03
0.06
0.01
1.74
2.11
0.39
0.26
0.37
0.26

0.05
0.08
0.08
0.07
0.06
0.05
0.08
0.06
0.07

0.000
0.000
0.000
0.001
0.001
0.000
0.000
0.000
0.000

endoDPT 25 mAs
̅
𝜎𝐷̅ p-value
𝐷
0.01
0.03
0.00
0.87
1.05
0.19
0.13
0.19
0.13

0.00
0.02
0.02
0.02
0.02
0.01
0.02
0.02
0.02

0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000

4.9 Discussion
For all x-ray source energies, the physical MTFdetector fell to 90%, 50%, and 10% at
approximately 0.37 mm−1 , 2.67 mm−1 , and 11.50 mm−1, respectively. The physical
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MTFdetector demonstrated a sharper falloff at low frequencies than at higher frequencies, which is
typical for the MTF measured for high resolution indirect x-ray sensors using an opaque edge
(Illers 2005) and is also consistent with the known resolution limits (10% MTFdetector ≥
10 mm−1 ) of intraoral x-ray sensors (Brennan 2002, Farman 2005a, Brullmann 2015). Several
studies have assessed MTFdetector of intraoral x-ray sensors that have a scintillating layer using
slit MTF methods (Welander 1994, Irsigler 1999, Farman 2005b) and edge MTF methods (Chen
1994, Kim 2004, Hong 2005). Overall, those results were similar to the MTFdetector measured for
the XDR sensor. The most comparable result to endoDPT was the study by Kim et al. in which an
x-ray sensor constructed using a scintillating layer and a CCD chipset with 22 𝜇m pixels was used
(Kim 2004). In that study, the measured MTFdetector fell to 90%, 50%, and 10% at 0.25 mm-1 ,
2.50 mm−1 , and 10.00 mm−1, respectively (Kim 2004), which was very similar to the
MTFdetector of endoDPT. Due to the proprietary nature of intraoral x-ray sensor technology and
because the hardware of these sensors has been previously well characterized, there is little
published literature regarding resolution measurements of newer sensors using MTF analysis.
There is some literature regarding intraoral x-ray sensor resolution on various manufacturers
websites, but these are limited to MTF plots or images of line-pair phantoms, with little explanation
of the measurement process.
The physical MTFdetector did not extend to the same high frequency range as the computational
MTFdetector (Chapter 3), because the computational MTFdetector assumed ideal x-ray imaging
conditions: x-ray scatter was not modeled, a point source was used, the central ray of the x-ray
beam was perpendicular to the edge, the edge was modeled in contact with the computational xray sensor (no gap due to the scintillating layer or detector casing), and blur and scatter from the
imaging process was ignored. Direct detection x-ray detectors used in DBT, which do not use a
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scintillating layer, result in a MTFdetector more similar to the endoDPT computational MTFdetector
(Ren 2005, Chen 2007a).
This study found no dependency of the physical MTFdetector on x-ray source current for a
given x-ray source potential. The ability to reduce x-ray source current without reducing resolution
is a positive result because lower x-ray source currents will reduce patient dose in a linear
relationship (Bushberg 2012). However, the endoDPT NPS measurement did show that reducing
the x-ray source current increased noise in the reconstructed images. While NPS was measured
here, the effect of noise on image quality (e.g., on contrast) was not directly assessed. The images
used to analyze both the MTFdetector and ASF were high-contrast measurements where there was
no observed dependence on x-ray source current. It will be important in future work to
quantitatively evaluate the effect of noise on image quality, such as through measurement of the
contrast-to-noise ratio, to determine how noise modifies the ability of endoDPT to visually assess
differences in various tissues in the prostate region (e.g., adipose, prostatic, and muscular). The
visibility of these different tissues was qualitatively assessed in Chapter 5.
This study found that the physical MTFdetector had a small but significant dependence the xray source potential. The mean frequency at which MTFdetector was reduced to 90% was
significantly higher at 70 kVp than other x-ray source energies. Information from the sensor
manufacturer suggested this was due to the XDR sensor’s designed operational energy of
approximately 70 kVii. The details of the XDR sensor construction (detection efficiency for a
given photon energy, exact thickness and diameters of scintillating needles, and other properties)
was not available. The mean frequency at which MTFdetector was reduced to 50% was higher at
70 kVp than 60 kVp or 80 kVp, but lower than 90 kVp and 100 kVp. The mean frequency at which
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MTFdetector was reduced to 10% level showed the MTFdetector increasing as a function of energy.
The slight increase in MTF at higher energies (maximum increase ≪ 1%) was most probably due
to increased photon transmission through the edge device. Previous studies have shown that
measurement of MTFdetector with radiolucent edge device results in larger MTFdetector values in
the high frequency range compared to measuring the MTFdetector with an opaque edge (Neitzel
2004, Illers 2005).
The calculation of MTFendoDPT from MTFdetector and MTFrecon demonstrated that
significantly higher resolution is achievable with endoDPT in comparison to the resolution found
using a typical CT protocol, noting that MTFCT measured in this study was consistent with the
results of a similar study (Kayugawa 2013). The mean frequency at which MTFendoDPT was
reduced to 90% was about 2.5 times and 2.6 times higher than the mean frequency at which MTFCT
was reduced to 90% for SAA and BP, respectively. The mean frequency at which MTFendoDPT
was reduced to 50% was about 4.3 times higher and 6.2 times higher than the mean frequency at
which MTFCT was reduced to 50% for SAA and BP, respectively. The mean frequency at which
MTFendoDPT was reduced to 10% was about 5.8 times higher and 13.3 times higher than the mean
frequency at which MTFCT was reduced to 10% for SAA and BP, respectively. Due to the use of
filtration in FBP, the frequency values at which MTFendoDPT was reduced to 90% and 50% could
not be assessed, similar to experience from DBT (Chen 2007a). The mean frequency at which
MTFendoDPT was reduced to 10% was about 14.3 times higher than the mean frequency at which
MTFCT was reduced to 10% for FBP. This result was artificially increased because the FBP
MTFrecon was a relative measure normalized to the maximum value and not to MTF(0).
There were several limitations of the measurement of MTFendoDPT and subsequent comparison
to MTFCT. The first is that MTFendoDPT was assumed to consist of only two stages, MTFrecon and
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MTFdetector . Important parameters such as the effect of scatter (analogous to the water surrounding
the wire in measurement of MTFCT) and the effect of oblique incidence of photons on the XDR
sensor were not considered. Other studies have shown that incorporating these additional stages
reduces the MTF, but not to a large degree (Mainprize 2006, Zhao 2008, Acciavatti 2011, Chen
2013). Measurement of MTFendoDPT using a thin wire phantom (diameter ≪ endoDPT pixel size)
suspended in water or an equivalent material would provide a fairer comparison to MTFCT, but
was beyond the scope of this study.
Measurements of the ASF, NPS, and dose of endoDPT utilized an x-ray source potential 80
kVp, although the 90% level of MTFdetector demonstrated the highest mean frequency at 70 kVp.
80 kVp was chosen for these measurements to maintain commonality with typical radiographic
procedures of soft tissue in the pelvic and abdominal region (Parry 1999, Bushberg 2012), to
increase the penetrating power of the beam which reduced dose to the phantom surface, and to
remain within the intraoral dental sensor manufacturers stated guidelines of using x-ray source
energies between 60 kV and 80 kViii. While the improved resolution at 70 kVp was significant, it
was also small (the increase in the 70 kVp 90% MTF was a maximum of 0.005 mm−1 →
0.008 mm−1 compared to other energies). This slight increase in resolution is not expected to have
a significant impact in improving the discernibility of structures in the image.
The endoDPT NPS was measured using a different phantom material, different detector, and
different x-ray source from similar studies in DBT, and so the endoDPT NPS was not directly
comparable to other studies. However, the shape of the endoDPT NPS was consistent with these
previous studies (Chen 2007a, Zhao 2008). The primary motivation for measurement of the
endoDPT NPS was to assess differences in the endoDPT reconstruction algorithms, to verify that
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FBP improved the NEQ at high frequency values, and to provide baseline measurements for future
studies. The endoDPT NPS measurements showed that for a given reconstruction algorithm,
higher x-ray source currents reduced the magnitude of noise in the reconstructed images. Using
NPS, MTFdetector, and MTFrecon , the NEQ for endoDPT was computed for SAA, BP, and FBP.
The NEQ can be used to compare reconstruction algorithms. In endoDPT, BP outperformed SAA,
most probably due to the incorporation of beam divergence. Similar to the results in DBT (Chen
2007a) and chest tomosynthesis (Godfrey 2009) FBP had a low NEQ at low frequencies (due to
removal of low frequency information by filtration), but outperformed BP at higher frequencies,
which was expected as FBP reduces the blurring artifact of the BP process.
The ASF provided a measure of how OOP structures affected a given reconstructed plane as a
function of distance from the plane. Due to the nature of tomosynthesis, the contribution of these
OOP structures can never be removed, but they can be reduced. In this work, filtering was used to
reduce the contribution of OOP structures to a given reconstructed plane. The plots of ASF for
endoDPT were shown for planes within ±4 mm of the plane in which the BBs resided, which was
in total 10 times larger than the diameter of each BB (0.79 mm). FBP demonstrated improved
removal of the OOP structure compared to SAA and BP, which was expected due to filtering. This
result was consistent with similar ASF measurements (Wu 2003). The ASF fell off slightly less
for +𝑧̂ planes compared to −𝑧̂ planes for all reconstructions. This result was also seen in a similar
study (Zhang 2006). The current study found no dependence on x-ray source current. For BBs 5
and 6, which were located at relatively large 𝑧, the ASF did not fall off as quickly for +𝑧̂ planes;
this effect occurred because at large 𝑧 fewer projections were used to reconstruct each voxel due
to the limited FoV of the detector, which worsens the ASF. For BBs that were reconstructed from
all projection images (BBs 1, 2, 3, and 4), there was no dependency on the ASF as a function of
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BB 𝑧-location which was also reported in a similar study using thin aluminum discs (Nosratieh
2012).
The point at which the ASF falls to 50% can be used as a metric to estimate the resolution in
the 𝑧̂ direction (Wu 2003). For both SAA and BP, the ASF fell to 50% at approximately (𝑧 − 𝑧0 ) =
−2.2 mm and (𝑧 − 𝑧0 ) = +2.3 mm (approximately ±2.8 BB diameter). For FBP, the ASF fell to
50% at approximately (𝑧 − 𝑧0 ) = −1.3 mm and (𝑧 − 𝑧0 ) = +1.4 mm (approximately ±1.7 BB
diameter). This method is only an estimate of resolution in 𝑧̂ because the ASF is dependent on
both object size, shape, and density (Nosratieh 2012). Other studies using metal spheres or
approximately spherical masses showed similar results for BP and FBP. Wu et al. reported 50%
ASF for a 10 mm diameter mass in a breast phantom to be 19 mm (approximately ±1.9 mass
diameter) for BP and of 14 mm (approximately ±1.4 mass diameter) for FBP (Wu 2003). Zhang
et al. measured the 50% ASF for a 0.5 mm diameter speck of calcium carbonate in a breast
phantom to be 1 mm (approximately ±2 speck diameter) for BP (Zhang 2006). These results
showed improved 𝑧̂ resolution compared endoDPT. This was probably due to the masses being
less dense than tungsten BBs. A study by Hu et al. measured the 50% ASF for a 0.4 mm diameter
steel BB to be 1 mm (approximately ±2.5 BB diameter) for FBP (Hu 2008), which is a worse 𝑧̂
resolution than the result of the current work.
One primary source of error in the ASF analysis is x-ray source localization relative to the
XDR sensor. Precise and accurate knowledge of the imaging geometry is required to accurately
reconstruct the imaged volume (Mainprize 2011). The method used to determine x-ray source
location relative to the XDR sensor utilized several assumptions that could impact the fidelity of
geometry determination, such as assuming the FlashPad detector and the XDR sensor were both
located in the (𝑥̂, 𝑦̂) plane, and assuming 𝑦𝑆 and 𝑧𝑆 were constant for each scan. X-ray source
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locations were determined with uncertainties on the order of 2-7 mm. Uncertainties in source
location using external fiducials in similar imaging methods have reported uncertainties of 0.3-3
mm (Jain 2005, Lee 2011, Kuo 2014), demonstrating the method used for source localization in
the current work could be improved.
The dose was measured solely to assess the differences in dose between endoDPT and CT. The
dose of endoDPT and CT was measured in a comparative manner using TLDs placed on and in a
common phantom. For regions outside the endoDPT beam path, the dose of endoDPT was always
less than CT. For regions inside the endoDPT beam path at the detector plane, the 100 mAs/image
endoDPT scan was higher than CT at points 4 and 5 (all endoDPT beams intersected these points)
but was lower at 50 mAs/image and 25 mAs/image. All other points in the detector plane had
lower dose for endoDPT at all x-ray source currents. In contrast, the dose at the surface of the
phantom for TLDs within the beam path was found to be high for endoDPT. The lowest x-ray
source current setting of endoDPT resulted in doses greater than CT by a factor of about 1.5 for
points 4 and 5. The highest x-ray source current setting of endoDPT resulted in doses greater than
CT by a factor of about 6 for points 4 and 5.
Using the calibration curve generated from a LINAC, the dose due to CT ranged from
minimum of 2.2 cGy within the phantom to a maximum of 4.2 cGy at the phantom surface. These
dose values are likely larger than the actual values due to the energy dependence of TLD100; kV
photons have about 1.1 times more luminescence for a given dose than MV (Attix 1986). The
values are still reasonable, as reported doses from CT range from 0.6 cGy to 6 cGy, depending on
the size of the phantom, the point of measurement within the phantom, and the parameters of the
protocol (Parry 1999, Smith-Bindman 2009, Bushberg 2012). The doses in a given plane closest
to the phantom edges in 𝑦̂, which was along the axis of the CT scanner, were lower than the
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dosimeters near the center of the phantom because they had less scatter contribution (Bushberg
2012). The doses on the periphery of the phantom (in 𝑥̂ and 𝑧̂ ) were higher than the doses towards
the phantom’s center due to attenuation of the kV photons in the phantom material (Bushberg
2012).
The doses from endoDPT showed a much greater spatial variation than CT because some TLDs
in the phantom were not in the beam path for any 𝑥𝑠𝑖 and because all beams from endoDPT entered
through the anterior of phantom. TLDs located outside of the beam path at the detector plane had
measured doses as low as indistinguishable from background for the 25 mAs/image scan. TLDs
located on the phantom surface that were in the beam path for many of the x-ray source locations
had measured doses as high as 26.5 cGy for the 100 mAs/image scan. Regions deeper in the
phantom received less dose due to attenuation of the kV x-ray beam, and regions further from the
beam paths or in the path of fewer beams received proportionally lower doses. Like CT, the doses
in endoDPT were likely higher than actual due to the energy dependence of TLD100 (Attix 1986).
A 26.5 cGy appears very high compared to CT but is consistent with previously measured entrance
skin doses (ESD) in abdominal and pelvic radiography. For AP radiography of the abdomen and
pelvis using 70-85 kVp, 20-40 mAs, 100 cm SID, and a 23 cm thick patient (77 cm source to
surface distance), ESDs range from 0.06 cGy to 0.5 cGy per image (Parry 1999, Hall 2006).
Multiplying these values by 41 images (a typical endoDPT scan), 2.5 (100 mAs/image endoDPT
divided by 40 mAs/image radiography), and (100⁄85)2⁄(100⁄77)2 = 0.82 (85 cm to endoDPT
phantom surface compared to 77 cm to radiography patient surface), the endoDPT ESD would be
expected to range from 5.0 cGy to 42.0 cGy. This assumes the x-ray source in endoDPT remains
fixed at 𝑥𝑆 = 0. Because the source moves along 𝑥̂, both the source to surface distance is increasing
and all surface TLDs move out of the beam for certain 𝑥𝑠𝑖 .
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Overall, the dosimetric results showed that for regions outside of the endoDPT beam, the dose
to the phantom was less than CT. This was due to small field size of endoDPT and demonstrates
that a lower total whole-body dose than CT may be achievable. At the detector plane, the dose
from endoDPT was in most cases lower than CT (it was only higher than CT at two points that
were in the path of all beams). This also demonstrates that endoDPT may be able to reduce dose
at the level of the rectum, prostate, and bladder compared to a typical CT scan. However, because
the endoDPT beams all enter through the anterior of the patient, the dose to the phantom surface
was high compared to CT.
4.10 Conclusion
In this aim, the endoDPT system was physically developed using an intraoral dental x-ray
sensor and a standard radiography unit. The MTFdetector, NPS, ASF, and dose of endoDPT were
measured, providing a set of base measurements for future work. Additionally, The MTF and dose
were measured for a common CT scanner using a typical scan protocol. The MTFs and doses of
endoDPT and CT were compared, which tested the hypothesis of this research effort. MTFendoDPT
demonstrated endoDPT is capable of high resolution imaging. This result was verified by
comparing MTFs of endoDPT to CT, it was found that the frequencies at which MTFendoDPT was
reduced to 90%, 50%, and 10% were significantly higher than the frequencies at which MTFCT
was reduced to 90%, 50%, and 10%. This confirmed the resolution of endoDPT was significantly
higher than CT. endoDPT also demonstrated a reduction in dose compared to CT in regions outside
the endoDPT FoV. For low x-ray source currents, the dose within the endoDPT FoV was in general
lower than or comparable to CT, but in several instances, was up to 50% higher. For higher x-ray
source currents, the dose of endoDPT in the FoV, and especially at the surface of the phantom,
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was significantly higher than CT (up to 600% higher). A reduction in this dose, or the modification
of scanning parameters to reduce dose, may be required for clinical implementation of endoDPT.
In summary, this aim demonstrated endoDPT provides high resolution and that the dose of
endoDPT is in most cases less than CT in a common phantom. This places endoDPT in a favorable
position for future research and design efforts.
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Chapter 5. Aim 3: Image Clinically Relevant Prostatic Structures in Phantoms
5.1 Overview
The purpose of this aim was to demonstrate the high-resolution imaging capability of
endoDPT. Two small nuts were imaged with endoDPT to show the ability to visualize fine detail.
Then, imaging studies were performed of three approximations of clinical scenarios encountered
in PCa management: post-implant imaging of LDRBT seed implants, imaging of the PPAT layer,
and contrast enhanced imaging of PCa vasculature. Ex vivo canine prostate specimens were used
to represent these three clinical scenarios. These phantoms were additionally scanned using a
typical CT scanner and a typical MRI scanner. Visual aspects of image quality relevant to each
scenario were assessed and compared.
5.2 Imaging Systems
The endoDPT and CT imaging systems were described previously (Section 4.2 and Section
4.3). A GE Discovery 750W 3T MRI scanner (General Electric Company, Waukesha, WI) was
used in this study (Fig. 5.1). This MRI scanner has a 3-tesla field strength and a 75 cm bore
diameter. A 32-channel head coil was used for all acquisitions. This MRI scanner located at
Pennington Biomedical Research Center. The acquisition protocols for each approximation of
clinical scenarios is discussed in Section 5.5.3.

Figure 5.1: GE Discovery 750W 3T MRI scanner. Image from www.gehealthcare.com.
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5.3 Canine Prostate Specimens
Nine canine prostate specimens with diameters of 2.5 cm to 3.5 cm were used in this study.
Canine prostates are excellent biological surrogates for human prostates (Starkey 2005) and a
typical canine prostate specimen shown in Fig. 5.2. The canine prostate specimens used in this
study were fixed in formalin and were donated by the Louisiana State University Biology
Department. The Biology Department previously used these prostates in a comparative anatomy
course and followed all required compliances regarding use of animal specimensiv. No additional
approval, such as from an institutional review board or the Institutional Animal Care and Use
Committee (IACUC), was required for this work.

Figure 5.2: Example of canine prostate specimen with attached bladder.
5.4 Phantom Preparation
5.4.1 Nut Phantoms
A pecan (3.5 cm long, 2 cm diameter) and a pistachio (1.5 cm diameter) were imaged in the
sample holder plate with no surrounding carrageenan gel (4.76 mm acrylic separated the nut
phantoms from the XDR sensor). The set up for both phantoms is shown in Fig. 5.3. These nuts
were chosen in part for their small size; they fit in the FoV which reduced the truncation artifact

iv

Dr. Dominique Homberger and Bradley Wood (LSU Biology Dept.), personal communication, December 16,
2015
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seen when imaging objects larger than the detector FoV. The pecan and pistachio had welldifferentiated internal structure and external borders (shells) that when imaged could highlight the
high resolution of endoDPT. Similar examples using tomosynthesis to image fruit have been
previously reported (Levakhina 2013).

Figure 5.3: (a) Pecan in place in the sample holder plate. (b) Pistachio in place in the sample holder
plate.
5.4.2 LDRBT Seed Phantoms
Three prostate specimens were implanted with 27, 30, and 33 BRACHYSOURCE® STM1251
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I LDRBT seeds (Bard Medical, Inc., Covington, Georgia), respectively, using hollow

needles. The number of implanted seeds was similar to previous studies about imaging of seeds
using an endorectal gamma camera (30 seeds) (Alnaghy 2017), CT (17 to 47 seeds) (Siebert 2006,
127

Siebert 2007), and tomosynthesis (45 seeds) (Brunet-Benkhoucha 2009). The seed construction
was a titanium shell (0.05 mm thick, 4.5 mm length, 0.8 mm outer diameter) covering a radiopaque
silver core (3 mm active length, 0.5 mm diameter) (Khan 2014). More than 10 half-lives of
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had elapsed since seed manufacture, so the seeds were no longer radioactive and safe to handle.
The seeds were implanted in the canine prostate specimens using a procedure similar to
previously described methodologies (Yu 1999, Ellis 2002). Two to five seeds were each loaded
into 10 hollow implant needles either end-to-end (0.5 cm spacing between seed center points) or
with a plastic spacer (0.5 cm length) between seed ends (1.0 cm spacing between seed center
points). The placement of seeds end-to-end or with spacers was random. A predrilled template was
used to guide the 10 loaded needles into the prostate, with the needles oriented to be parallel to the
urethra. Uniform seed loading of the prostate was utilized with a needle-to-needle spacing of 0.5
cm to 1.0 cm. The needles were removed from the prostate, leaving the seeds and spacers. The
seed locations were not planned to achieve a specific dose distribution. The seeds were in some
cases closer together than the 1 cm seed spacing typically used for LDRBT PCa treatment (Yu
1999, Zaorsky 2016). After the seeds were implanted in the prostate, each prostate was placed at
the bottom of the cavity in the sample holder plate directly above the center of the XDR sensor.
The remainder of the cavity in the sample holder plate was filled with carrageenan gel to surround
the prostate. Each prostate was made into a separate phantom.
5.4.3 PPAT Phantoms
Because the canine prostates used in the study did not have an attached PPAT layer, thinly
sliced porcine fat, which is similar in composition to human fat (Sumitomo 2010), was wrapped
around two canine prostates and was cut into small sections and arranged near small sections of a
third canine prostate. To create the PPAT layer, a 5 mm thick layer of porcine fat and a 2.5 mm
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thick layer of porcine fat were sliced from a pork leg that had been obtained at a local grocer. One
canine prostate was wrapped completely in the 5 mm thick fat layer and one canine prostate was
wrapped completely in the 2.5 mm thick fat layer. To ensure the fat layer remained securely
wrapped around the prostate, the open ends of the fat wrappings were closed with surgical sutures.
After the fat wrapping, each prostate was placed at the bottom of the cavity in the sample holder
plate directly above the center of the XDR sensor. The remainder of the cavity in the sample holder
plate was filled with carrageenan gel to surround the prostates. Each prostate was made into a
separate phantom.
The third canine prostate was sectioned into small cubes of approximately 5 mm by 5 mm by
5mm and into 1 mm to 2.5 mm thick slabs with lengths ranging from 1 cm to 2 cm. Porcine fat
was sectioned into cubes and slabs of similar dimensions. Cubes and slabs of both materials were
interspersed in a stack on the sample holder plate directly above the center of the XDR sensor.
Carrageenan gel was poured around these cubes and slabs to suspend the prostate and fat tissues.
5.4.4 Tissue Vascularity
Because the prostates used in the study were harvested from decedent canines, perfusion
imaging and angiographic imaging using vasculature within the prostate were not possible (dead
tissue does not perfuse and the vasculature collapses quickly after death). To simulate angiographic
imaging, high-purity silicone rubber tubing with inner/outer diameters (ID/OD) of 0.012”/0.025”
(0.30 mm/0.64 mm), 0.02”/0.037” (0.51 mm/0.94 mm), and 0.025”/0.047” (0.64 mm/1.19 mm)
were embedded in canine prostates and filled with contrast agents. OMNIPAQUE™ (General
Electric Company, Waukesha, Wisconsin), an iodine contrast agent, was diluted with distilled
water and used as the contrast agent for endoDPT and CT imaging. GdCl3 ⋅ 6H2 O (Section 4.4.2),
containing gadolinium, a common MRI contrast agent (Prince 1994, Maki 1998), was diluted with
distilled water and used as the contrast agent for MRI.
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Previous studies have demonstrated that after an injection of iodine contrast agents, contrastenhanced blood in vessel lumens have CT numbers on the order of 300 Hounsfield units (HU)
(Cademartiri 2005). During magnetic resonance angiography (MRA), gadolinium contrast agent
results in the blood in vessel lumens have a T1W signal intensity approximately two to three times
greater than normal blood (Prince 1994, Maki 1998).
To determine the concentration of iodine in distilled water required to produce a CT number =
300 HU, OMNIPAQUE™ (350 mg I/mL in 755 mg Iohexol/mL) was diluted with distilled water
to create five iodine concentrations. The amounts of OMNIPAQUE™ and distilled water mixed
to create 120 mL solutions, and the resulting concentrations iodine are listed in Table 5.1. Three
25 mL plastic vials were filled with each of these solutions and imaged with a CT scanner with
acquisition parameters of 120 kVp, automatic x-ray source current, 0.938 pitch, and 1.25 mm slice
thickness. A representative CT slice through the vials is shown in Fig. 5.4. Circular ROIs (radius
of 10 voxels) were drawn in the center of each vial. The mean value of the ROI over five slices
(15 total measurements for each concentration) determined the CT number and uncertainty for
each concentration (Table 5.1). From this data, the nominal concentration of 10 mg I/mL (vials in
column 3) was selected for the simulated angiographic imaging (see below).
Table 5.1: Concentrations of iodine solutions and measured CT number (HU column).
Planned
Actual
Vial
OMNIPAQUE™ Water
Concentration
Concentration HU 𝝈𝐇𝐔
Row
(g)
(g)
(mg I/mL)
(mg I/mL)
1
0
0.000
120.000
0
-12.6 4.0
2
5
3.003
118.306
4.991
159.1 2.0
3
10
6.060
116.935
10.043
307.7 2.8
4
15
9.002
114.878
15.000
457.5 6.7
5
20
12.063
113.164
20.044
615.9 9.6
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Figure 5.4: CT slice of vials filled with planned concentrations of 0 mg I/mL, 5 mg I/mL, 10 mg
I/mL, 15 mg I/mL, and 20 mg I/mL in rows 1 to 5, respectively. Each column comprised
three vials of the same concentration. Column three (10 mg I/mL) produced the desired
target CT numbers.
A similar procedure was used to determine the concentration of gadolinium in distilled water
to produce a T1W signal intensity 2-3 times greater than distilled water. Solutions of GdCl3 in
distilled water were created for nominal gadolinium concentrations of 0 mg Gd/mL, 0.15 mg
Gd/mL, 0.30 mg Gd/mL, 0.76 mg Gd/mL, 1.5 mg Gd/mL, 2.9 mg Gd/mL, and 6.9 mg Gd/mL.
These concentrations were comparable to diluting a 10-mL bottle of OMNISCAN™ (General
Electric Company, Waukesha, Wisconsin), a common MRI contrast agent containing 287 mg
Gd/mL, with water to 5 L, 2.5 L, 1.0 L, 0.5 L, 0.25 L, and 0.1 L volumes, respectively; however,
OMNISCAN™ could not be readily obtained for this study. GdCl3 is not often used clinically
because it is not chelated, which can result in high degrees of normal tissue toxicity (Aime 2009,
Natalin 2010), but can be used safely in phantoms. GdCl3 has been previously used for magnetic
resonance (MR) imaging of human blood samples (Rogosnitzky 2016) and in small animal
imaging (Aime 2009).

131

Table 5.2 lists the masses of distilled water and GdCl3 ⋅ 6H2 O mixed to produce 50 mL of each
nominal concentration. The GdCl3 solutions were thoroughly stirred and then 25 mL glass vials
were filled with each concentration. A T1W spin echo scan was collected with TR = 650 ms, TE
= 9.48 ms, and 2 mm slice thickness. A T1W slice through the vials is shown in Fig. 5.5. Circular
ROIs (radius of 10 voxels) were drawn in the center of each vial. An additional ROI was drawn in
the air above the vials. The mean value of the ROI over five slices is reported as the T1W signal
intensity for each concentration in Table 5.2. From this data, the nominal concentration of 0.30 mg
Gd/mL (vial 3) was selected for the simulated angiographic imaging (see below).
Table 5.2: Concentrations of gadolinium solutions and measured T1W signal intensities at 3T.
𝐆𝐝𝐂𝐥𝟑 ⋅
Planned
Vial Concentration
𝟔𝐇𝟐 𝐎
(mg Gd/mL) (mg) used
1
0
0.000
2
0.15
18.102
3
0.30
35.752
4
0.76
89.422
5
1.5
176.956
6
2.9
346.705
7
6.9
818.862
Air
0
0

Additional
Water (g)
50.003
50.012
49.985
49.975
49.921
49.911
49.752
0

Actual
Concentration
(mg Gd/mL)
0.000
0.153
0.303
0.757
1.498
2.933
6.930
0

T1W Signal
Intensity
(S.I.)
555
1120
1495
1402
1286
324
203
167

𝝈𝐒.𝐈.
62
113
148
116
117
71
19
18

Figure 5.5: T1W slice of vials containing nominal concentrations of 0 mg Gd/mL, 0.15 mg Gd/mL,
0.30 mg Gd/mL, 0.76 mg Gd/mL, 1.5 mg Gd/mL, 2.9 mg Gd/mL, and 6.9 mg Gd/mL (from
right to left). Vial 7 was not visible (the signal was indistinguishable from air at this
concentration).
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Three canine prostates were each sliced into quarters along the coronal and sagittal planes
through the prostate center point. One prostate had a piece of 0.64 mm OD silicone rubber tubing
placed in each of the sagittal and coronal planes in arbitrary curved paths. The tubing was lightly
sutured to the prostate, and the prostate quarters were re-assembled and sutured together. The
prostate was placed at the bottom of the cavity in the sample holder plate directly above the center
of the XDR sensor, such that both ends of each piece of tubing emerged from the top of the cavity.
The remainder of the cavity in the sample holder plate was filled with carrageenan gel to surround
the prostate, taking care that the free ends of the tubing did not become submerged. This procedure
was repeated for two other prostates using the 0.94 mm OD and the 1.19 mm OD silicone rubber
tubing, respectively.
Prior to imaging with endoDPT and CT, the tubing was filled with the iodine contrast agent
that produced a CT number of 300 HU (10 mg I/mL) and was tied off. After the scans using xrays, the ends of the tubing were opened, flushed thoroughly with distilled water, and refilled with
the gadolinium contrast agent that resulted in the best enhancement in T1W images (0.30 mg
Gd/mL).
5.5 Phantom Imaging
5.5.1 endoDPT
endoDPT scans of all the samples described in Section 5.4 were acquired in the normal manner
as described in Chapter 4 with 41 images, with 𝑥𝑆𝑖 = ±40 cm in 2 cm increments, 𝑦𝑆 = 0 cm, and
𝑧𝑆 = 100 cm, with the central ray of the x-ray source always directed to (𝑥𝐷 , 𝑦𝐷 , 𝑧𝐷 ) = (0,0,0).
Settings of 80 kVp and 0.6 mm focal spot were used. A tube current of 8.0 mAs/image was used
for the nut phantoms. The prostate phantoms were imaged at 100 mAs/image.
For all phantoms, image planes above and parallel to the XDR sensor were reconstructed in 1
mm increments from 𝑧 = 0.5 cm to 𝑧 = 4.5 cm using SAA, BP, and FBP (see Section 3.5). A 1
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mm separation of image planes was chosen because that is a common plane separation distance in
DBT (Sechopoulos 2013b). For display purposes, each image in Section 5.6 is linearly scaled
independently such that the minimum value in the image is set to black and the maximum value in
each image is set to white. Areas corresponding to insensitive regions of the XDR sensor (e.g., the
triangular black voids) were not considered during the display scaling
5.5.2 CT
CT scans of the canine prostate phantoms were acquired using helical scanning at 120 kVp,
1.25 mm slice thickness, 0.938 pitch, small (25 cm) reconstruction FoV for 512 by 512 matrix and
0.488 mm voxel size, and automatic x-ray source current. For all CT images shown in the
following sections, the images were independently scaled so that within the prostate/carrageenan
gel in the CT image the minimum voxel intensity was black and the maximum voxel intensity was
white. The phantom was oriented in the CT scanner such that the 𝑦̂ axis of the phantom (in
endoDPT geometry) was oriented along the axis of the scanner. The same scan protocol was used
for all samples to maintain consistency with the measurements made in Chapter 4.
5.5.3 MRI
T1W and T2W MRI scans of the canine prostates were acquired using a 32-channel head coil.
The gel slabs containing the prostate samples representing a given clinical scenario (LDRBT seeds,
PPAT, or vasculature) were removed from the acrylic sample holder plate and all were imaged
together during a single MRI scan. The prostate and gel slabs were oriented in the MR scanner
such that the 𝑥̂ axis of the phantom (in endoDPT geometry) was oriented along the axis of the
scanner; this orientation was chosen so that the slabs fit in the head coil. Coronal and sagittal image
slices were acquired; The coronal image slices (2 mm slice thickness) were the same view as the
endoDPT reconstructed images while the sagittal image slices (4 mm slice thickness) were in the
same orientation as the CT axial image slices. All MRI image slices were acquired using a 512 by
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512 matrix over a 25 cm FoV (0.488 mm reconstructed voxel size) and used 4 image acquisitions.
All MRI images had their grayscale values adjusted the same as the CT images. For the T1W
scans, TE (echo time) was specified as ‘min full.’ TE = ‘min full’ calculates the minimum TE
value required for full echo acquisition and was recommended for use in this studyv. Each of the
three distinct features in this aim (LDRBT seeds, PPAT, and vasculature) were otherwise imaged
using parameters chosen to match similar studies and are summarized in Table 5.3. For vasculature
imaging, the TR (repetition time) and TE reproduce parameters for anatomic imaging; the T1W
imaging parameters for magnetic resonance angiography were not used because magnetic
resonance angiography requires the use of very short TR/TE (≈3 ms/≈1 ms) for dynamic scans
(Rosenkrantz 2013, Wu 2016).
Table 5.3: MRI parameters used for imaging the three clinical scenarios of PCa imaging discussed
in this dissertation. The parameters were matched to similar studies (footnotes).
Clinical scenario
LDRBTvi
PPATvii
Vasculatureviii

T1W
TR (ms) TE (ms)
247
9.48
836
9.48
650
9.48

T2W
TR (ms) TE (ms)
2700
100
3400
100
4500
93

5.6 Results
5.6.1 Nut Phantoms
Fig. 5.6, Fig. 5.7, and Fig. 5.8 show representative tomosynthesis image planes through the
pecan at 𝑧 = 1.0 cm and 𝑧 = 1.5 cm, reconstructed with SAA, BP, and FBP, respectively. In all
cases, the structures in the pecan are most visible when they are perpendicular to the tomosynthesis
image (e.g., when the shell is orientated perpendicular to tomosynthesis image at 𝑧 = 1.5 cm it is

v

Kevin McKlveen, (Pennington Biomedical Research Center), private communication, January 15, 2018
(De Brabandere 2012)
vii
(Woo 2015)
viii
(Hara 2005, Kitajima 2010, Rosenkrantz 2013, Wu 2016)
vi
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much sharper compared to when the shell is more angled relative to the tomosynthesis image at
𝑧 = 1.0 cm). Both the SAA and BP tomosynthesis images demonstrate the expected blur artifact
which is compensated in the FBP tomosynthesis image. The pecan appears to be slightly wider in
the SAA image compared to BP and FBP; due to the parallel beam assumption of SAA the
reconstructed plane is slightly magnified. Otherwise, the SAA and the BP images are qualitatively
similar. The FBP tomosynthesis images are much sharper due to the reconstruction filter, but are
also noisier. The FBP images display the expected overshoot artifact at the air/shell boundary in
the direction of scan motion (red arrows). The FBP images display an artifact from the triangular
voids in each projection image corner; these voids were excluded from the backprojection process.
This artifact could be reduced or eliminated by changing how these regions are handled in the
reconstruction process for object sizes that are comparable to the detector FoV.

Figure 5.6: SAA pecan tomosynthesis image at 𝑧 = 1.0 cm above the detector face (a) and at
𝑧 =1.5 cm above detector face (b) with 19 µm voxel size (1368 by 1700 voxels).
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Figure 5.7: BP pecan tomosynthesis image at 𝑧 = 1.0 cm above detector face (a) and at 𝑧 =1.5 cm
above detector face (b) with 20 µm voxel size (1400 by 1700 voxels).

Figure 5.8: FBP pecan tomosynthesis image at 𝑧 = 1.0 cm above detector face (a) and at 𝑧 =1.5
cm above detector face (b) with 20 µm voxel size (1400 by 1700 voxels). The red arrows
point to the overshoot artifact. A reconstruction artifact caused by caused by the triangular
voids in the projection images resulted in brighter bands at the top and bottom of the
images.
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Fig. 5.9, Fig. 5.10, and Fig. 5.11 show tomosynthesis images through the pistachio at 𝑧 = 1.1
cm, 1.2 cm, and 1.3 cm, reconstructed with SAA, BP, and FBP, respectively. These images display
the same qualitative features as the pecan for each reconstruction algorithm, except that the artifact
from the triangular voids in each projection image is avoided in the FBP reconstruction because
the object is smaller.

Figure 5.9: SAA pistachio tomosynthesis images at 𝑧 =1.1 cm (a), 1.2 cm (b), and 1.3 cm (c)
above detector face. Images have voxel size of 19 µm (1000 by 1100 voxels).

Figure 5.10: BP pistachio tomosynthesis images at 𝑧 =1.1 cm (a), 1.2 cm (b), and 1.3 cm (c) above
detector face. Images have voxel size of 20 µm (1000 by 1100 voxels).
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Figure 5.11: FBP pistachio tomosynthesis images at 𝑧 =1.1 cm (a), 1.2 cm (b), and 1.3 cm (c)
above detector face (left to right). Images have voxel size of 20 µm (1000 by 1100 voxels).
The red arrows point to the overshoot artifact.
5.6.2 LDRBT Seed Phantoms
Because the SAA and BP images were qualitatively similar, only the BP and FBP endoDPT
images are shown for the LDRBT seed phantoms. Fig. 5.12 and Fig. 5.13 show the tomosynthesis
image plane through the prostate implanted with 30 LDRBT seeds at 𝑧 = 2.3 cm, reconstructed
with BP and FBP, respectively. This tomosynthesis image is representative of all the prostates
implanted with LDRBT seeds. An air pocket is visible in the center of both the BP and FBP images.
The BP tomosynthesis image demonstrates the expected blur artifact, in addition to a truncation
artifact visible on the image edge in the direction of scan motion. FBP reduces the blur artifact but
results in more noise. The expected overshoot artifact enhances the seed edges. The truncation
artifact is less visible in FBP due to the increased noise. Due to the high contrast between seeds
and prostate tissue, the artifact due to the triangular voids is not as pronounced as in the images of
the pecan. Unlike the nut phantoms, the seeds are small and thus reconstruct sharply at each height
above the XDR sensor; Fig. 5.14 for FBP tomosynthesis images reconstructed at 𝑧 = 1.1 cm, 1.4
cm, and 1.7 cm.
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Figure 5.12: BP tomosynthesis image at 𝑧 = 2.3 cm above detector face of the prostate implanted
with 30 LDRBT seeds. Images have voxel size of 20 µm (2200 by 1896 voxels).

Figure 5.13: FBP tomosynthesis image plane at 𝑧 = 2.3 cm above detector face of the prostate
implanted with 30 LDRBT seeds. Images have voxel size of 20 µm (2200 by 1896 voxels).
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Figure 5.14: FBP tomosynthesis image at 𝑧 = 1.1 cm (a), 1.4 cm (b), and 1.7 cm (c) above the
above detector face of the prostate implanted with 30 LDRBT seeds. Images have voxel
size of 20 µm (2200 by 1896 voxels).
Fig. 5.15 shows a representative axial CT axial image slice (in the (𝑥̂, 𝑧̂ ) image plane of
endoDPT geometry) through the prostate implanted with 30 LDRBT seeds. The seeds are easily
identifiable and show slight streaking artifacts expected from high spatial density objects. The air
pocket seen in the endoDPT images is visible in the center of the prostate region. Because the
seeds are high density and because the carrageenan gel is of similar density to the prostate, the
prostate border is not visible at the window and level setting of Fig. 5.15. If the window and level
are adjusted to allow for visualization of the prostate border, the streaking artifacts are more
pronounced.

Figure 5.15: CT axial image slices of the prostate implanted with 30 LDRBT seeds.
Fig. 5.16 shows T1W and T2W axial image slices (in the (𝑥̂, 𝑧̂ ) plane of endoDPT geometry)
for the same prostate specimen. The location of this slice is at the same approximate location as
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the axial CT slice shown in Fig. 5.15. Fig. 5.17 shows T1W and T2W coronal image slices (in the
(𝑥̂, 𝑦̂) plane of endoDPT geometry) through the prostate implanted with 30 LDRBT seeds. The
location of this slice is at the same approximate location (𝑧 = 2.3 cm) as the endoDPT planes
shown in the Fig. 5.12 and Fig. 5.13. The MR images more clearly show prostate anatomy
compared to CT and endoDPT, but there is obvious magnetic susceptibility artifact (voids and
regions of high signal) around the seeds. These artifacts severely impact the ability to differentiate
individual seeds.

Figure 5.16: T1W (a) and T2W (b) axial image slices of the prostate implanted with 30 LDRBT
seeds.

Figure 5.17: T1W (a) and T2W (b) coronal image slices of the prostate implanted with 30 LDRBT
seeds.
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In addition to the qualitative images shown above for the prostate specimen implanted with 30
LDRBT seeds, the number of LDRBT seeds in each of the three prostates implanted with LDRBT
seeds were counted using the FBP endoDPT image set, the CT image set, and the T1W image sets.
The FBP endoDPT image set was used for counting because it provided the best differentiation
between nearby seeds. The T1W images sets were used because the reference used for MRI
LDRBT seed imaging (De Brabandere 2013) used T1W images for seed identification. To count
the number of LDRBT seeds, a marker was manually placed at the approximate center of each
differentiable seed. The results of the LDRBT seed counting for each imaging modality are given
in Table 5.4.
Table 5.4: LDRBT seed counts using endoDPT, CT, and MRI image sets. Cor. represents the
coronal image set and Ax. represents the axial image set.

Modality
endoDPT (FBP)
CT
MRI (T1, Cor.)
MRI (T1, Ax.)

Number of seeds counted
Prostate 1 (27 seeds) Prostate 2 (30 seeds) Prostate 3 (33 seeds)
27
30
33
24
27
31
23
22
27
23
25
30

All LDRBT seeds were identifiable using endoDPT. In CT, the seed count was lower by two
to three seeds in all cases. This was because some of the seeds were implanted end-to-end, and it
was impossible to tell if one or two seeds were occupying a series of adjacent slices due to 1.25
mm slice thickness. More seeds were identified in the T1W axial view compared to the T1W
coronal view. Overall, the seed count was lower by between three and eight seeds for MRI for all
prostates.
5.6.3 PPAT Phantoms
Because the SAA and BP images were qualitatively similar, only the BP and FBP endoDPT
images are shown for the PPAT prostate phantoms. Fig. 5.18 and Fig. 5.19 show tomosynthesis
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image planes through the prostate surrounded by the 5 mm thick PPAT layer at 𝑧 = 1.5 cm and
𝑧 = 2.0 cm reconstructed with BP and FBP, respectively. Fig. 5.20 and Fig. 5.21 show the
tomosynthesis image plane through the prostate surrounded by the 2.5 mm thick PPAT at the
heights of 𝑧 = 2.0 cm and 𝑧 = 3.0 cm, reconstructed with the BP and FBP, respectively. Fig. 5.22
and Fig. 5.23 show the tomosynthesis image plane through the sections of prostate tissue and
porcine fat at the heights of 𝑧 = 1.2 cm and 𝑧 = 3.3 cm, reconstructed with BP and FBP,
respectively.

Figure 5.18: BP tomosynthesis image at 𝑧 = 1.5 cm (a) and 𝑧 = 2.0 cm (b) above detector face of
the prostate surrounded by a thick layer of porcine fat. The red arrow points to an air pocket
and the yellow arrow points to the prostate-PPAT border. Images have voxel size of 20 µm
(2200 by 1896 voxels).
In the phantoms with the thick PPAT layer and thin PPAT layer, portions of the PPAT/prostate
border can be identified in both tomosynthesis images (yellow arrows) and small air pockets can
also be identified (red arrows). The PPAT border is much more distinct when both the PPAT layer
and prostate border are perpendicular to the tomosynthesis image. BP results in images with
qualitatively improved contrast differentiation at the PPAT/prostate border. However, despite
lower contrast, the PPAT/prostate border is still mostly identifiable with FBP as an edge. In the
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image reconstructed at 𝑧 = 3.0 cm (thin PPAT layer), the truncation artifact is visible throughout
the BP reconstruction, and is visible in the FBP reconstruction in the artifact caused by the
triangular voids in the corners of the projection images.

Figure 5.19: FBP tomosynthesis image at 𝑧 = 1.5 cm (a) and 2.0 cm (b) above detector face of the
prostate surrounded by a thick layer of porcine fat. The red arrow points to an air pocket
and the yellow arrow points to the prostate-PPAT border. Images have voxel size of 20 µm
(2200 by 1896 voxels).
In the phantom with the embedded sections of fat and prostate tissues, the tomosynthesis image
at 𝑧 = 1.2 cm contains two cubes of fat (visibly distinct from gel) and two cubes of prostate tissue
(not visibly distinct from gel). The tomosynthesis image at 𝑧 = 3.3 cm contains one large,
triangularly-shaped slab of fat. The borders of the fat are visible (yellow arrows), but the prostate
tissue and carrageenan gel cannot be differentiated. At 𝑧 = 3.3 cm, the OOP blur artifact is
apparent in the BP reconstructed image and so is the truncation artifact. In FBP, the contrast is
reduced and the noise is increased, but blur and the contribution from OOP structures is reduced;
the small air pockets show up much more clearly. The triangular void artifact is also visible. In
addition, there is a small, unknown, high-density structure located at 𝑧 ≈ 3.0 cm that shows up as
a series of repeated structures in the 𝑧 = 1.2 cm planes and as a bright spot in the 𝑧 = 3.3 cm
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planes (white arrow). At the bottom of the image, a dark line is also visible, which is an air gap
between the carrageenan gel and the acrylic sample holder.

Figure 5.20: BP tomosynthesis image at 𝑧 = 2.0 cm (a) and 𝑧 = 3.0 cm (b) above detector face of
the prostate surrounded by a thin layer of porcine fat. The red arrow points to an air pocket
and the yellow arrows point to the prostate-PPAT border. Images have voxel size of 20 µm
(2200 by 1896 voxels).

Figure 5.21: FBP tomosynthesis image plane at 𝑧 = 2.0 cm (a) and 𝑧 = 3.0 cm (b) above detector
face of the prostate surrounded by a thin layer of porcine fat. The red arrow points to an air
pocket and the yellow arrows point to the prostate-PPAT border. Images have voxel size
of 20 µm (2200 by 1896 voxels).
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Figure 5.22: BP tomosynthesis image at 𝑧 = 1.2 cm (a) and 𝑧 = 3.3 cm (b) above detector face
through the sections of prostate tissue and fat. The red arrows point to air, the yellow arrows
point to the fat and prostate or gel border, and the white arrows point towards an unknown
high-density structure. Images have 20 µm voxel size (2200 by 1896 voxels).

Figure 5.23: FBP tomosynthesis image plane at 𝑧 = 1.2 cm (a) and 𝑧 = 3.3 cm (b) above detector
face through the sections of prostate tissue and fat. The red arrows point to air, the yellow
arrows point to the fat and prostate or gel border, and the white arrows point towards an
unknown high-density structure. Images have 20 µm voxel size (2200 by 1896 voxels).
Fig. 5.24 and Fig. 5.25 show representative axial CT axial image slices (in the (𝑥̂, 𝑧̂ ) image
plane of endoDPT geometry) for the specimens surrounded by the 5 mm thick and 2.5 mm PPAT
layers. Fig. 5.26 shows the phantom made of slabs and cubes of prostate tissue and fat. Because
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fat is lower density than both the prostate tissue and the carrageenan gel, it is easily differentiable.
Due to the similar density of the prostate tissue and carrageenan gel, these two materials cannot be
easily differentiated. The image of the prostate/fat sections shows the cubes of fat and prostate
tissue (although the prostate tissue is barely visible) near the bottom of the sample holder cavity,
and the slabs of fat above the cubes.

Figure 5.24: CT axial image slices of the prostate surrounded by the 5 mm thick fat layer.

Figure 5.25: CT axial image slices of the prostate surrounded by the 2.5 mm thick fat layer.
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Figure 5.26: CT axial image slices of the sections of prostate tissue and fat.
Fig. 5.27 and Fig. 5.28 show T1W and T2W axial image slices (in the (𝑥̂, 𝑧̂ ) plane of endoDPT
geometry) for the specimens surrounded by the 5 mm thick and 2.5 mm PPAT layers. Fig. 5.29
shows the phantom made of slabs and cubes of prostate tissue and fat. The locations of the slices
are in the same approximate locations as the CT images shown in Fig. 5.26, Fig. 5.27, and Fig.
5.28, respectively. These axial MR images show that T2W images show the differences between
fat tissue, prostatic tissue, and the carrageenan gel more clearly than the T1W images, which was
expected from the TR/TE chosen for this study (Woo 2015). Because of this, only the coronal
T2W images are shown in Fig. 5.30, Fig. 5.31, and Fig. 5.32.

Figure 5.27: T1W (a) and T2W (b) axial slices of prostate wrapped in 5 mm thick fat layer.
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Figure 5.28: T1W (a) and T2W (b) axial slices of prostate wrapped in 2.5 mm thick fat layer.

Figure 5.29: T1W (a) and T2W (b) axial image slices through the sections of prostate tissue and
fat tissue.
Fig. 5.30 shows the T2W image slices (in the (𝑦̂, 𝑧̂ ) plane of endoDPT geometry) through the
prostate surrounded by the 5 mm thick PPAT layer at approximately 𝑧 = 1.5 cm and 𝑧 = 2.0 cm.
These 𝑧 locations are in the same planes as the endoDPT tomosynthesis images shown in Fig. 5.18
and Fig. 5.19. Fig. 5.31 shows the T2W image slices in the (𝑥̂, 𝑦̂) plane of endoDPT geometry
through the prostate surrounded by the 2.5 mm thick PPAT layer at approximately 𝑧 = 2.0 cm and
𝑧 = 3.0 cm. These 𝑧 locations are in the same planes as the endoDPT tomosynthesis images shown
in Fig. 5.20 and Fig. 5.21. Fig. 5.32 shows the T2W coronal image slices in the (𝑥̂, 𝑦̂) plane of
endoDPT geometry through the fat tissue and prostate tissue sections at approximately 𝑧 = 1.2
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cm and 𝑧 = 3.3 cm. These 𝑧 locations are in the same planes as the endoDPT tomosynthesis
images shown in Fig. 5.22 and Fig. 5.23.

Figure 5.30: T2W coronal slices of prostate surrounded by 5 mm thick fat layer at approximately
𝑧 = 1.5 cm (a) and 𝑧 = 2.0 cm (b).

Figure 5.31: T2W coronal slices of prostate surrounded by 2.5 mm thick fat layer at approximately
𝑧 = 2.0 cm (a) and 𝑧 = 3.0 cm (b).

Figure 5.32: T2W coronal image slices through the sections of prostate tissue and fat tissue at
approximately 𝑧 = 1.2 cm (a) and 𝑧 = 3.3 cm (b).
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For the axial MRI slices, both the T1W and T2W images show a significant chemical shift
artifact due to Larmor frequency differences in the fat and prostate/carrageen gel materials ix. The
T2W images show better soft tissue contrast of the prostate, which is particularly evident in the
prostate tissue and fat tissue sections (the prostate tissue is visible in the MR images compared to
gel, whereas it was not clearly visible in the endoDPT and CT images). In all cases for prostates
surrounded by a PPAT layer, the PPAT is visible and easily differentiable from both the prostatic
tissue and the carrageenan gel.
Because the PPAT thickness was not identifiable in all endoDPT images, a measurement of
PPAT thickness for the prostates wrapped in the thick and thin fat layers using the endoDPT
images was not performed. For the CT and MR images of prostates with the thin and thick PPAT
layers, the mean thickness of the PPAT layers was measured. 10 PPAT thicknesses were manually
measured in random locations over 10 slices in the axial CT images and over three slices in the
axial T2W images. The mean PPAT thickness for the thick PPAT layer was 4.86 ± 1.67 mm for
CT and 5.76 ± 1.28 mm for MRI. The mean PPAT thickness for the thin fat layer was 2.14 ±
1.18 mm for CT and 2.49 ± 1.16 mm for MRI. These thicknesses are approximate as the images
of the prostates wrapped in the thick and thin PPAT layers show that the thickness of the PPAT
varies significantly even in single slices.
5.6.4 Tissue Vascularity
Because the SAA and BP images were qualitatively similar, only the BP and FBP images are
shown for prostate phantoms embedded with silicone rubber tubing filled with iodine contrast
agent. Fig. 5.33 and Fig. 5.34 show the BP and FBP tomosynthesis image planes through the
prostate with embedded 0.64 mm OD silicone rubber tubing at 𝑧 = 1.0 cm and 2.0 cm. Fig. 5.35
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and Fig. 5.36 show the BP and FBP tomosynthesis image planes through the prostate with
embedded 0.94 mm OD silicone rubber tubing at 𝑧 = 1.5 cm and 2.6 cm. Fig. 5.37 and Fig. 5.38
show the BP and FBP tomosynthesis image planes through the prostate with embedded 1.19 mm
OD silicone rubber tubing at 𝑧 = 1.5 cm and 2.0 cm.
In all of the endoDPT tomosynthesis images, the tubing is visible. However, the tubing appears
solid – there is no differentiation between the silicone rubber walls and the internal iodine contrast
agent. This is because silicone rubber has very similar attenuation properties to the concentration
of iodine used to fill the tubing. Choi et al. reported silicone rubber having a CT number = 278 ±
120 HU (Choi 2010) and Mardis et al. reported that silicone rubber stents with similar diameters
to the tubing used in this study had CT numbers ranging from 125 to 360 HU (Mardis 1993). To
verify that the tubing seen in the endoDPT images was the entire silicone rubber tubing diameter
and not just the inner lumen, 10 tubing diameters were measured over 10 FBP tomosynthesis
images for each of the prostate samples. The mean diameters found for the tubing with nominal
ODs of 0.64 mm, 0.94 mm, and 1.19 mm were 0.66 ± 0.05 mm, 0.95 ± 0.07 mm, and 1.18 ±
0.11 mm, respectively. The measured tubing ODs all agreed well with the nominal tubing ODs.

Figure 5.33: BP tomosynthesis image at 𝑧 = 1.0 cm (a) and 𝑧 = 2.0 cm (b) above detector face of
prostate with 0.64 mm OD tubing. The red arrow points to an air pocket. Images have voxel
size of 20 µm (2200 by 1896 voxels).
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Figure 5.34: FBP tomosynthesis image at 𝑧 = 1.0 cm (a) and 𝑧 = 2.0 cm (b) above detector face
of prostate with 0.64 mm OD tubing. The red arrow points to an air pocket. The white
arrows point to a masking artifact. Images have voxel size of 20 µm (2200 by 1896 voxels).

Figure 5.35: BP tomosynthesis image at 𝑧 = 1.5 cm (a) and 𝑧 = 2.6 cm (b) above detector face of
prostate with 0.94 mm OD tubing. The red arrow points to an air pocket. Images have voxel
size of 20 µm (2200 by 1896 voxels).

Figure 5.36: FBP tomosynthesis image at 𝑧 = 1.5 cm (a) and 𝑧 = 2.6 cm (b) above detector face
of prostate with 0.94 mm OD tubing. The red arrow points to an air pocket. Images have
voxel size of 20 µm (2200 by 1896 voxels).
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Figure 5.37: BP tomosynthesis image at 𝑧 = 1.5 cm (a) and 𝑧 = 2.0 cm (b) above detector face of
the prostate that had tubing (OD = 1.19 mm) filled with iodine contrast agent. The red
arrow points to an air pocket. Images have voxel size of 20 µm (2200 by 1896 voxels).

Figure 5.38: FBP tomosynthesis image at 𝑧 = 1.5 cm (a) and 𝑧 = 2.0 cm (b) above detector face
of the prostate that had tubing (OD = 1.19 mm) filled with iodine contrast agent. The red
arrow points to an air pocket. Images have voxel size of 20 µm (2200 by 1896 voxels).
Similar to the LDRBT implant and PPAT prostate scenarios, small air pockets were visible in
both BP and FBP reconstruction (red arrows). Regions where the tubing was perpendicular to the
tomosynthesis image were well resolved. The prostate border was not visible because the prostatic
tissue and carrageenan gel have very similar attenuation properties. The truncation artifact was
seen in some of the BP tomosynthesis images, and for thicker tubing, the blur artifact seen in BP
became much more severe. The overshoot artifact was not very apparent in FBP, but the artifact
from the triangular voids in the projection images was visible. One additional artifact noted with
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FBP in these images (white arrows) was that for tubing with a long axis along the direction of scan
motion, the tubing washed out and had low contrast.
The silicone rubber tubing containing iodine contrast agent was visible for the largest tubing
diameter (1.19 mm OD) in the CT images. A single CT slice of the prostate with the 1.19 mm OD
tubing is shown in Fig. 5.39 (in the (𝑥̂, 𝑧̂ ) image plane of endoDPT geometry). At this window and
level, the prostate border is not visible. Large air pockets within the prostate are visible.

Figure 5.39: CT axial image slices through the prostate with embedded silicone rubber tubing (1.19
mm OD). The red arrows point to the tubing.
The silicone rubber tubing filled with gadolinium contrast agent was difficult to see in most
MR images. Fig. 5.40 shows T1W and T2W coronal image slices (in the (𝑥̂, 𝑦̂) plane of endoDPT
geometry) for the prostate that had 0.64 mm OD silicon rubber tubing. The location of this slice is
at the same approximate location as the endoDPT planes at 𝑧 = 2.0 cm (Fig. 5.33 and Fig. 5.34).
Fig. 5.41 shows the T1W and T2W coronal image slices (in the (𝑥̂, 𝑦̂) plane of endoDPT geometry)
through the prostate that had 0.94 mm OD silicon rubber tubing. The location of this slice is at the
same approximate location as the endoDPT planes at 𝑧 = 2.6 cm (Fig. 5.35 and Fig. 5.36). Fig.
5.42 shows the T1W and T2W axial image slices (in the (𝑥̂, 𝑧̂ ) plane of endoDPT geometry)
through the prostate that had 1.19 mm OD silicon rubber tubing. The location of this slice is at the
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same approximate location as the CT slice shown in Fig. 5.39. Fig. 5.43 shows the T1W and T2W
coronal image slices (in the (𝑥̂, 𝑦̂) plane of endoDPT geometry) through the prostate that had 1.19
mm OD silicon rubber tubing. The location of this slice is at the same approximate location as the
endoDPT planes at 𝑧 = 2.0 cm (Fig. 5.37 and Fig. 5.38).

Figure 5.40: T1W (a) and T2W (b) coronal image slices of the that had tubing (OD = 0.64 mm) at
approximately 𝑧 = 2.0 cm. The red arrows point to the tubing.

Figure 5.41: T1W (a) and T2W (b) coronal image slices of the that had silicon tubing (OD = 0.94)
at approximately 𝑧 = 2.6 cm. The red arrows point to the tubing.
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Figure 5.42: T1W (a) and T2W (b) axial image slices of the that had silicon tubing (OD = 1.19
mm). The red arrows point to the tubing.

Figure 5.43: T1W (a) and T2W (b) coronal image slices of the that had silicon tubing (OD = 1.19
mm) at approximately 𝑧 = 2.0 cm. The red arrows point to the tubing.
All of the tubing appeared hypointense in the prostate phantoms. Per volume, there was more
silicone rubber in the tubing wall than gadolinium contrast agent in the lumen; previous studies
have noted that silicone rubber tubing (stents) are hypointense in both T1W and T2W MR images
(Yunker 2013). The tubing with a 0.94 mm OD did exhibit a hyperintense region, but this was
located near an air pocket which appeared to distort the image. Overall, the tubing did not enhance
due to the gadolinium.
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5.7 Discussion
endoDPT imaging of the pecan and pistachio nuts demonstrated that high resolution is
achievable using this imaging method. Structures of the nut, such as the shell and meat, were
clearly visible, particularly in the midplane. However, the anterior and posterior portions of the
nut were more difficult to visualize. These nut phantoms also demonstrated several artifacts due
to tomosynthesis reconstruction and the imaging hardware. SAA and BP had the expected blur
artifact (Dobbins 2003). FBP removed much of the blur artifact, producing a cleaner but noisier
image. The FBP images also displayed a banding artifact at the top and bottom of the images; this
banding artifact manifested because the triangular voids in the projection images are not used to
reconstruct the images. This banding artifact occurred due to the filtration process; at image edges,
the signal was artificially increased by the filter. Despite removing 1 mm along all edges of the
projection images after filtering, including the voids, the edge enhancement was still evident,
particularly when fewer additions per voxel occurred. The effect of this artifact can be reduced by
removing more of the edge, but this further reduces the already small FoV of the detector.
The most significant artifact seen in FBP was the overshoot (edge enhancement) artifact that
was particularly evident at the low-density air and high-density shell interfaces. This edge artifact
is due to the interplay of limited sampling (endoDPT sampled the imaged volume over ≈ ±21.8∘ )
with the filtration process (Chen 2005, Chen 2007a, Chen 2008, Cong 2011, Mertelmeier 2014).
When the imaged volume is not fully sampled, the negative side lobes of the spatial domain point
impulse inversion filter result in edge enhancement between structures with substantially different
densities. Use of more advanced analytic filters (e.g., incorporate filter weighting for divergent
beam) or iterative/algebraic reconstruction algorithms, in addition to sampling over a larger
angular range, can reduce this artifact. Similar edge enhancement artifacts have been noted when
imaging other phantoms (an apple) (Levakhina 2013).
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The endoDPT images of the LDRBT seeds and the silicone rubber tubing also clearly
demonstrated the high-resolution of this new imaging methods. The primary limitations for
imaging both scenarios were that the prostate border was not visible, and there were truncation
artifacts and artifacts from the triangular voids in the projection images. The images of the
prostates wrapped in a PPAT layer demonstrate that prostate border visualization is possible with
endoDPT. To improve prostate border visibility and to reduce the truncation artifact, a larger xray sensor that allows for detector acquisition FoV would be beneficial. However, a larger sensor
would prove challenging for endorectal imaging.
In the FBP endoDPT images of the LDRBT seeds, the core and shell of each seed was clearly
identifiable, which is a metric of high image quality and resolution (Rozenfeld 2012). For BP, the
blur artifact made it difficult to differentiate the shell from the core. Because the seeds are highdensity, there was a substantial blur artifact from OOP seeds for all reconstruction methods. This
blur was reduced with FBP because filtration reduced the effect OOP structures, as was observed
in the measurement of the ASF. Similar to imaging the pecan and pistachio, FBP resulted in an
edge-enhancement artifact. LDRBT seed orientation and geometry were easily discernable with
endoDPT. While not studied in this work, it is possible that improved knowledge of LDRBT seed
orientation could improve dosimetry of the LDRBT treatment. Dosimetric differences in the
treated prostate volume of up to 1.6% have been reported when comparing one-dimensional (point
source) to two-dimensional (line source) dose calculations using TG-43 formalism (Chng 2012);
incorporating variations in LDRBT seed tilt in post-implant dosimetry has been reported to change
dose to OAR by up to 10% (Collins Fekete 2014).
In CT, the LDRBT seeds appeared as easily identifiable bright spots in the axial images of the
canine prostates; it is for this reason that CT is considered the gold standard imaging method for
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LDRBT (Amdur 1999, Mehrmohammadi 2014). For seeds that were end-to-end, it was difficult
to differentiate seeds, and seed orientation (tilt) was not identifiable. A streaking artifact was
present in the images, which is typical in CT images of LDRBT seeds due to the high-density seed
cores and titanium shells (Han 2003a, De Brabandere 2006, Siebert 2007, Robertson 2012).
Because a thin slice (1.25 mm thick) was used, and because the carrageenan gel and prostate tissue
had similar attenuation properties, the prostate border was difficult to discern. This problem is not
a consequence of the tissue-equivalent gel used here, as other studies have reported that CT has
difficulty in differentiating the prostate from nearby soft tissues such as the pelvic floor muscles
(Amdur 1999, Mehrmohammadi 2014). Overall, these canine prostate images were similar to postimplant images of human prostates (Amdur 1999, De Brabandere 2012, Mehrmohammadi 2014).
Unlike both endoDPT and CT, the LDRBT seeds in the MR images were not directly visible.
The seeds appeared as distorted voids of signal due to the magnetic susceptibility artifact; it was
impossible to identify seed tilt or orientation. Such voids of signal are typical in MR imaging of
LDRBT seeds (De Brabandere 2006, Thomas 2009, Robertson 2012) and are primarily due to the
titanium shell, which is highly paramagnetic (Thomas 2009). The shell distorts the magnetic field
which induces a magnetic susceptibility artifact; this artifact presents as a void of signal with
nearby bright regions corresponding to signal from the protons in the void being mismapped
(Thomas 2009). Overall, the seeds heavily distorted the MR images and were not easily
identifiable, but the undistorted portions of the images clearly showed the internal prostate
anatomy and prostate border, which is consistent with the findings of other groups (Amdur 1999,
De Brabandere 2012, Robertson 2012). While not studied in this work, novel pulse sequences and
MR specific contrast markers have some utility in improving LDRBT seed imaging (Lamberto
2014, Lim 2016).
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To compare seed differentiability between endoDPT, CT, and MRI, all visible independent
seeds were counted. All seeds could be identified in endoDPT. Similar studies have reported 100%
seed identification success rates with tomosynthesis using an external x-ray sensor (Tutar 2003).
In this study, all LDRBT seeds were located within the endoDPT FoV. However, for larger
prostates (such as in men suffering from PCa and BPH) or for migrated the small FoV of endoDPT
may preclude 100% seed counts. Up to 40% of patients experience seed migration (Wang 2015).
CT had seeds counts that missed two to three seeds and MRI had seed counts that missed three to
eight seeds. For CT, this was because some of the seeds were spaced end-to-end, and it was
impossible to determine if it was a single seed or two seeds spanning four to five slices. A larger
number of seeds were missed in MRI due to the magnetic susceptibility (void) artifact obscuring
signals from seeds near each other, making it impossible to differentiate closely-spaced seeds. The
results of seed counting with CT and MRI were comparable to a study performed by Bloch et al.
where he reported seed identification success rates of 91.5% with T1W MRI and 96.7% with CT
(Bloch 2007).
The images of the silicone rubber tubing filled with iodine contrast agent also served to
highlight the high resolution of endoDPT. The tubing was readily visible in all endoDPT images,
although the larger diameter tubing was very blurred in the BP reconstructions. Due to similarity
in the attenuation of silicone rubber (Mardis 1993, Choi 2010) and the iodine contrast solution
used in this work, the tubing wall was indistinguishable from the tubing lumen, which was verified
by measuring the diameters of the tubing in the endoDPT images. The expected blur and truncation
artifacts were seen in the BP images. Because the density of the silicone rubber tubing filled with
iodine contrast was much less than the density of LDRBT seeds, the overshoot artifact was not as
pronounced in the FBP images. However, the artifact from the triangular voids in the projection
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images was still visible in FBP, and an additional artifact presented that washed out the signal of
tubing that was oriented parallel to the x-ray source motion. The tubing in this orientation has the
same appearance as a small structure that is above or below the tomosynthesis image, similar to
the OOP BBs in Fig. 4.19. FBP actively works to remove such OOP structure blur artifacts and
operates in the same manner on the tubing if it presents in a similar orientation.
The largest diameter tubing was visible in CT and all tubing diameters were visible in at least
one MRI view in each image set. The tubing had limited visibility in CT due to a large amount of
noise from the thin slice thickness and the poor resolution in comparison to endoDPT. The tubing
in the MR images was hypointense and indistinct primarily because of the interplay between the
MR signals from the silicone rubber in the tubing walls compared to the gadolinium contrast
solution in the tubing lumen. Silicon rubber generally appears hypointense (Yunker 2013). Overall,
the visualization of the silicone rubber tubing was poor with MRI and CT. Because no other studies
have assessed visibility of contrast agent in silicon tubing or the visibility of individual vessels in
the prostate using angiographic techniques, there was no metric of comparison for this result.
However, imaging of blood perfusion in the prostate is often performed with both MRI and TRUS
(Sankineni 2016) and is under clinical investigation with CT (Luczynska 2014). This study did not
image perfusion because the use of ex vivo canine prostate specimens precluded diffusion of the
contrast medium (iodine for x-rays and gadolinium for MRI) out of the capillaries into the
surrounding extra-cellular space (Padhani 2005).
The endoDPT images of the prostates wrapped in a PPAT layer and of the sections of prostatic
tissue near fat tissue demonstrated that soft tissue contrast between the prostate and surrounding
fat layer is possible with endoDPT. The images of the prostates wrapped in PPAT were the only
endoDPT images that allowed for some visualization of the prostate boarder. Overall, this
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demonstration of soft-tissue contrast is a positive result for endoDPT and future efforts will focus
on improving image contrast to allow for visualization of the prostate border. Overall the
prostate/fat images highlighted the largest flaw of endoDPT, which is the difficulty to visualize
large structures clearly. The PPAT layer was readily visible in CT as a dark (low-density) band
surrounding the prostate, which is consistent with previous studies (van Roermund 2010, van
Roermund 2011). There were no obvious artifacts in the CT images, but the images were noisy
due to the small slice thickness and reconstructed voxel size; the prostate tissue and carrageenan
gel were indistinguishable. The MR images showed excellent soft tissue contrast between the fat,
prostate tissue, and gel, with the T2W images also showing zonal anatomy clearly. Comparable
results have been observed in previous studies (Amdur 1999, Woo 2015). A chemical shift artifact
in the slice selection direction was visible, due to the difference in Larmor frequency between the
fat and prostate/carrageenan gel.
5.8 Conclusion
The objective of this aim was to qualitatively demonstrate the high resolution of endoDPT in
comparison to CT and MRI, two common methods of prostate imaging. The results of this aim
showed that small structures, such as the internal details of nut phantoms, LDRBT seeds implanted
in canine prostates, and small diameter silicone rubber tubing filled with contrast agent, were
visible with high resolution using endoDPT. A limitation of endoDPT was that the prostate border
was not clearly visualized in these images. In CT the prostate border was usually discernable, while
MRI provided the best visualization of the prostate border and internal prostate anatomy. In CT,
the LDRBT seed implants were easily identifiable, but the seed shell and core were not
differentiable; seeds oriented end-to-end made seed counting difficult. The silicon rubber tubing
had very poor visibility in CT. In MRI, the seeds presented as voids of signal due to a large
magnetic susceptibility artifact, and precise knowledge of seed location or orientation was
164

impossible to ascertain. The silicon rubber had more visibility in MRI than CT, but not as much
as endoDPT. Images of the prostates wrapped in a PPAT layer demonstrated the primary limitation
of endoDPT, which is difficulty in discerning larger structures due to the small size of the XDR
sensor. CT and MRI provided much better visualization of the prostate and the fat layer.
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Chapter 6. Conclusion
6.1 Summary of Results
Currently, the prostate region is imaged using CT, MRI, TRUS, PET, and SPECT (Kelloff
2009, Sankineni 2016), which typically have spatial resolutions on the order of 0.3 to 5.0 mm
(Bushberg 2012). The purpose of this work was to explore endoDPT, an imaging method that uses
an endorectal x-ray sensor and external x-ray source to produce high-resolution images of the
prostate region using tomosynthesis. While endorectal imaging of the prostate is clinically
performed or is under investigation using MRI, TRUS, PET, and SPECT (Mukdadi 2014, Musico
2016, Sankineni 2016), the method of imaging described in the previous chapters as endoDPT has
not been previously explored.
This study clearly demonstrated both computationally and by measurement that endoDPT is a
high-resolution imaging method in comparison to the typical resolutions reported for CT, MRI,
TRUS, PET, and SPECT prostate imaging. Results showed that the 90%, 50%, and 10% MTF
occurred at significantly higher (𝑝 < 0.0001) frequencies than CT for all endoDPT parameters.
These improvements in resolution were achievable at endoDPT ionizing radiation doses that were
significantly less (𝑝 <0.002) than CT outside the beam FoV and ranged from significantly less
than to significantly higher than CT in the endoDPT beam FoV.
The high resolution of endoDPT was further demonstrated by using endoDPT to image two
types of nuts, canine prostates implanted with LDRBT seeds, and canine prostates embedded with
small-diameter silicone rubber tubing filled with contrast agent. endoDPT could clearly identify
the LDRBT seeds, including identification of both the seed shell and core for seeds in-plane. The
seed cores were readily visible on CT and presented as void of signal on MRI; for both modalities,
it was difficult to differentiate seeds in close proximity. The current detector size used here limited
the ability of endoDPT to clearly identify large structures, such as fat layers or prostate borders.
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Both the fat layer and prostate border were visible with CT and MRI, although differentiation of
the prostate border from the carrageenan gel was difficult in CT due to similar attenuation in both
materials. Like the LDRBT seeds, endoDPT could clearly identify the silicone tubing, including
finding the OD of the tubing to within 0.02 mm. These small diameter silicon rubber tubes were
difficult or impossible to see in both CT and MRI. This work has overall demonstrated resolution
improvements compared to CT and MRI.
6.2 Response to Hypothesis
We hypothesized that the in-plane resolution of endoDPT was significantly higher than the inplane resolution of a typical CT scanner at an ionizing radiation dose significantly less than the
ionizing radiation dose of a typical CT scan. For the former portion of the hypothesis, the null
hypothesis that endoDPT had the same or significantly lower resolution than CT was rejected.
endoDPT demonstrated that the 90%, 50%, and 10% levels of MTF occurred at significantly
higher frequencies than CT (𝑝 < 0.0001) for all endoDPT parameters tested.
The latter portion of the hypothesis did not allow for complete rejection of the null hypothesis
that endoDPT radiation dose was the same as or significantly greater than CT radiation dose. The
dose outside of the endoDPT FoV was significantly less than CT (𝑝 < 0.002) at all endoDPT xray source currents (100 mAs, 50 mAs, and 25 mAs) at all planes of measurement. The dose
measured near the endoDPT FoV and within the endoDPT FoV ranged from significantly lower
to significantly higher than CT. Future clinical studies will need to address whether the improved
resolution at the cost of increased ionizing radiation dose is a trade-off that benefits the patient.
Some dose reduction may be achieved by optimizing endoDPT scan parameters (such as using a
smaller x-ray source travel distance and fewer projection images) and hardware (such as using a
harder x-ray beam or a detector that requires less exposure).
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6.3 Recommendation
This study clearly demonstrated through quantitative and qualitative evaluation that
endoDPT has high in-plane image resolution. The results of this work indicate that endoDPT has
some favorable characteristics compared to other prostate imaging techniques, whether as a
standalone method or paired with other imaging modalities. While this study provided baseline
data for endoDPT, more development and optimization are required before endoDPT can be
evaluated as a clinical technique for PCa management. Our primary recommendation is to improve
the endoDPT system design through development of a prototype system that allows for automated
endoDPT scan acquisition, image reconstruction, and x-ray source localization. An endoDPT scan
currently takes approximately 1 hour to complete due to manual positioning of the x-ray source
and low frame rate of the XDR sensor. With an automated prototype system, optimizing scan
parameters and pre-clinical studies become both efficient and feasible.
6.4 Limitations of the Study
The primary limitations of this study were the manual positioning of the x-ray source and the
small detector size. Because the x-ray source was manually positioned for each discrete projection
image, scan times were long and the potential for error in positioning of the source was high. This
limited the number of scan parameters that were tested, for example, for measurement of NPS,
ASF, and dose, only one x-ray source kVp setting was used. While the slow frame-rate of the XDR
sensor of 5-7 seconds per image was not a limiting factor in the current study (in comparison to
manual tube positioning), in a clinical environment, short scan times are important so a frame-rate
of 5-7 seconds per image would represent a severe limitation.
The manual source positioning resulted in x-ray source locations that could deviate from the
nominal x-ray source locations. Errors in source location degrade reconstructed image quality.
Fiducial wires were used to identify and correct source position errors, but this method was manual
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and thus time intensive. An automated, reproducible x-ray source positioning method, with actual
source locations integrated in real-time image reconstruction software, would be desirable for
clinical implementation of endoDPT.
The small detector FoV resulted in a significant truncation artifact, particularly in the SAA and
BP reconstructions. The limited FoV made it difficult to visualize the prostate border. A larger
detector size that allowed for full-field imaging of the prostate would alleviate this artifact and
would improve visualization of the prostate border. However, the detector size is limited both by
manufacturing (it is difficult and expensive to produce large area, high resolution CCD or CMOS
imaging sensors) and by the endorectal insertion profile. Increasing the detector size while
maintaining a viable endorectal insertion profile may prove to be the largest challenge in moving
endoDPT into clinical workflow. It may be necessary to combine endoDPT with another clinical
imaging technology and utilize a fusion technique, such that endoDPT provides high-resolution
images and another modality, such as TRUS, provides the prostate border and other large details.
Ultrasound sensors have been fitted onto similar endorectal gamma-ray detection devices
(Rozenfeld 2012).
6.5 Future Work
This study provided baseline data for endoDPT and demonstrated that endoDPT is a highresolution imaging method. The primary recommendation for this work is to move forward in
development of a prototype system that allows for automated image acquisition. It is expected
such work will include design of a probe system with an x-ray sensor optimized for endoDPT,
development of a protocol for existing radiography systems that allows for automated endoDPT
scan acquisition, and a refined method of x-ray source localization relative to the endoDPT x-ray
sensor. With such a prototype, pre-clinical testing becomes feasible.
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The primary goal in endorectal probe and detector design should be maintaining a small
insertion profile while maximizing the detector FoV. One possible solution for this goal is
development of a detector with a small insertion profile that expands within the rectum, similar to
endorectal MRI coils. The insertion profile must be small as the anal sphincter is where pain occurs
in endorectal imaging techniques (Koprulu 2012). After the anal sphincter is bypassed, a detector
within the rectum can move or expand relatively freely; this is utilized during DREs to palpate the
lateral regions of the gland and not just the portion of the prostate proximal to the rectum
(Balkissoon 2009). The expanding detector could be created by patching together multiple imaging
chips, which can be accomplished with gaps in the imaging plane of less than one pixel
(Mertelmeier 2014). Endorectal gamma-ray sensors, such as BrachyView, use multiple imaging
chips in a single probe (Petasecca 2013, Safavi-Naeini 2013, Loo 2014, Safavi-Naeini 2015,
Alnaghy 2017), although in a somewhat more linear arrangement than needed for endoDPT. The
larger FoV afforded by an x-ray sensor larger than the XDR sensor would increase image quality
and improve visualization of the prostate border, as well as reducing the severity of the truncation
artifact.
Development of an automated endoDPT imaging system represents less of a challenge than
large FoV detector design, because automated tomosynthesis imaging systems have been
previously developed for chest and breast imaging (Goodsitt 2014). Adaption to endoDPT should
be straight forward. Similarly, source localization methods for endoDPT should not prove
challenging, due to the large scope of work previously published for localization of fluoroscopy,
C-arm, and CT sources using external or internal fiducial markers (Jain 2005, Kuo 2014, Lee
2017).
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Appendix A: Focal Spot Blur Reduction
Focal spot blurring occurs due to the finite size of the focal spot (e.g., 0.6 mm by 0.6 mm).
This results in the bremsstrahlung x-rays produced in the anode emanating not from a point source,
as is often assumed, but from a finite area. Larger focal spots decrease image resolution due to the
blurring effect. This effect is illustrated in Fig. A.1.

Figure A.1: The focal spot blur effect for CT and for radiography. A large SID and a small OID
result in minimal focal spot blur, improving image quality. The size of the focal spot has
been increased by a factor of 10 for clarity.
In this example, the CT scanner and x-ray source used in this study are illustrated. A radiopaque
point at the location of the prostate using these two imaging modalities is modeled. The focal spot
blur is simply the size of the radiographic shadow cast from the radiopaque point due to x-rays
emanating from a finite area. In the ideal case, the x-rays emanate from a point and the radiographic
shadow is simply a magnified image of the radiopaque point with sharp borders. For a finite sized
focal spot, the focal spot blur is an edge gradient, 𝑓, is given by
𝑓=𝐹∗

𝑂𝐼𝐷
𝑂𝐼𝐷
=𝐹∗
𝑆𝐼𝐷 − 𝑂𝐼𝐷
𝑆𝑂𝐷
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(A. 1)

where 𝐹 is the size of the focal spot, 𝑆𝐼𝐷 is the source to image plane distance, 𝑂𝐼𝐷 is the object
to image plane distance, and 𝑆𝑂𝐷 is the source to object plane distance. For clarity, Eq. A.1 is
given in one dimension. To reduce focal spot blur, imaged anatomy should be placed as close as
possible to the image plane (unless magnification is required, as in magnification mammography)
and the smallest focal spot should be used (Bushberg 2012).
Table A.1 compares the focal spot blur in one dimension of a typical CT scanner (GE
Lightspeed RT16), a typical radiograph of the prostate in the pelvis (GE Proteus XR/a radiography
unit), and endoDPT. For endoDPT, x-ray source parameters from the standard radiography unit
(GE Proteus XR/a) are used. Focal spot blur would be further reduced by use of a higher resolution
x-ray source with a smaller focal spot (the Hologic Selenia Dimensions mammography unit has
focal spot sizes of 0.1 mm and 0.3 mm). In this example, it is assumed that the CT detector array
is planar rather than curved.
Table A.1: Illustration of focal spot blur in CT, radiography, and endoDPT.
Modality
CT
Radiography
endoDPT

F (mm) SID (mm) OID (mm) f (mm)
1.2
0.6
0.6

1063
1000
1000
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456.5
100
15

0.515
0.060
0.009

Appendix B: The Logarithmic Transform
For a monoenergetic, parallel photon beam traveling the distance 𝑙𝑡 through a material 𝑡 with
photon attenuation coefficient 𝜇𝑡 , the incident signal (the line integral, 𝐼) assumes the form
𝐼𝑡 = 𝐼0 𝑒 −𝜇𝑡𝑙𝑡

(B. 1)

where 𝐼0 is the incident signal on the pixel if the beam is not attenuated. This is illustrated in Fig.
B.1.

Figure B.1. Attenuation of x-ray beam through material 𝑡.
The reconstruction algorithms used in this work reconstruct an approximate attenuation value
in the reconstructed image plane through the addition of pixel values from every projection image.
Addition of the line integrals to find an approximate attenuation coefficient is not a linear process
whereas addition of the logarithmic transformed data (which removes the exponential term) is.
Dobbins and Godfrey proved this is true in tomosynthesis, and their result is rederived below
(Dobbins 2003).
If the photon beam from the previous example now passes through a non-uniform volume
consisting of materials 𝑡 and 𝑏, as shown in Fig. B.2, the incident signal on the detector now
becomes
𝐼𝑡,𝑏 = 𝐼0 𝑒 −𝜇𝑡𝑙𝑡−𝜇𝑏𝑙𝑏
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(B. 2)

Figure B.2. Attenuation of x-ray beam passing through materials 𝑡 and 𝑏.
Using a backprojection process, an approximate attenuation coefficient can be reconstructed
at the intersection of the rays shown in Fig. B.1 and Fig B.2 by simply adding together pixel values
where the ray falls on the detector (𝐼𝑡 and 𝐼𝑡,𝑏 ). If the projections are added together, the result is
𝑃 = 𝐼𝑡 + 𝐼𝑡,𝑏 = 𝐼0 𝑒 −𝜇𝑡𝑙𝑡 + 𝐼0 𝑒 −𝜇𝑡𝑙𝑡−𝜇𝑏𝑙𝑏 = 𝐼0 𝑒 −𝜇𝑡𝑙𝑡 (1 − 𝑒 −𝜇𝑡𝑙𝑏 )

(B. 3)

which is not linear. If the logarithmic transform of the data is taken, the result is linear, given by
𝑃 = ln(𝐼𝑡 ) + ln(𝐼𝑡,𝑏 ) = ln(𝐼0 𝑒 −𝜇𝑡𝑙𝑡 ) + ln(𝐼0 𝑒 −𝜇𝑡𝑙𝑡−𝜇𝑏𝑙𝑏 ) =
2 ln(𝐼0 ) − 2𝜇𝑡 𝑙𝑡 − 𝜇𝑏 𝑙𝑏
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(B. 4)

Appendix C: Carrageenan Gel Recipe Example
The required quantities of ingredients given in Table C.1 for a 500 g batch of the carrageenan
gel mixture from Section 4.4.2 are derived below. 500 g of gel was an adequate amount to fill the
cavity of the sample holder acrylic plate. The mass of GdCl3 ⋅ 6H2 O required was calculated using
the following equations in conjunction
55

𝜇mol
1kg
GdCl3 ∗
∗ 500g = 27.5𝜇mol GdCl3
kg
1000g

(C. 1)

and
g
1 mol
GdCl3 ∗ 6
= 0.00725g GdCl3
mol
10 𝜇mol

(C. 2)

g
GdCl3 ⋅ 6H2 O
mol
= 0.010g GdCl3 ⋅ 6H2 O
g
263.61
GdCl3
mol

(C. 3)

27.5𝜇mol GdCl3 ∗ 263.61
and

0.00725g GdCl3 ∗

371.70

The mass of the NaN3 aqueous solution was calculated using
0.03% NaN3 ∗ 500g sample ∗

1g water
= 3g aqueous solution
0.05𝑔 NaN3

(C. 4)

Table C.1: Amounts of materials required for one 500g batch of phantom material. Agarose,
carrageenan, and NaCl we added simply as w/w. The remainder of the mixture was distilled
water.
Material

Nominal concentration

Agarose
GdCl3 ⋅ 6H2 O
Carrageenan
NaCl
NaN3 aqueous solution
Water

1.200% w/w
55.0 µmol/kg (of GdCl3 )
3% w/w
0.291% w/w
0.03% w/w
Remainder
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Quantity Required for 500g
w/w
6.000g
0.010g
15.000g
1.455g
3.00g
474.535g
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